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General Abstract 
It is now well established that exercise of a strenuous and/or prolonged nature can 
lead to transient perturbations in immune function. The clinical significance of 
participating in such acute bouts of exercise in combination with other life stressors 
(e.g. inadequate nutrition) may be an increased incidence of upper respiratory illness 
(URI) (e.g. sore throat, runny nose). Many proposed nutritional countermeasures to 
exercise-induced immune dysfunction have been shown to be ineffective. The aims 
of this thesis were to determine the effects of bovine colostrum (COL) on in vitro and 
in vivo measures of immunity taken at rest and/or following prolonged (≥ 2 h) 
exercise and the incidence of URI during regular training in active males. Study 1 
(Chapter 3) demonstrated that acute COL supplementation improved the recovery of 
bacterial stimulated neutrophil degranulation and enhanced salivary lysozyme 
concentration following 2.5 h of cycling. There was also greater fMLP-stimulated 
oxidative burst throughout the COL trial compared to PLA. These effects are 
suggested to be partly due to components and/or metabolites of COL that become 
bioavailable following digestion of the supplement which may explain why Study 2 
(Chapter 4) demonstrated a greater effect on fMLP-stimulated oxidative burst with 4 
weeks of COL supplementation. Study 3 (Chapter 5) found a lower proportion of URI 
days and lower number of URI episodes with 12 weeks of COL supplementation. 
Although there was no effect on selected measures of in vitro immune function taken 
at rest (fMLP oxidative burst, salivary secretory IgA and antimicrobial peptides), COL 
did blunt increases in salivary bacterial load over the winter period, which may 
provide a novel marker of in vivo immunity. Despite no effect of prior infection with 
Epstein-Barr virus (EBV) on URI incidence in Study 4 (Chapter 6), those who were 
seropositive and undergoing COL supplementation had a lower number of URI days 
vii 
 
than seronegative counterparts. Study 5 (Chapter 7) observed a lack of effect of 
COL supplementation on the overall magnitude of an in vivo measure of T-cell-
mediated immunity to a novel antigen following prolonged exercise but there was 
evidence that COL may increase the sensitivity of responses to such antigenic 
challenge. 
 Keywords: neutrophil function, mucosal immunity, URTI, Epstein Barr virus, DPCP   
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Chapter 1. Literature Review 
1.1 Exercise and upper respiratory illness 
The majority of visits to general practitioners worldwide are due to middle ear 
infections, common cold, coughs and throat infections, collectively termed upper 
respiratory tract infections (URTI) (Eccles, 2005; Graham, 1990; Gulliford et al., 
2009). Given that the ability of the immune system to resist infection is affected by 
environmental, psychological and physiological stressors (e.g. exercise), URTI are 
also suggested to be the most common type of infection in the athletic population 
(Cannon, 1993; Gleeson and Walsh, 2012; Peters, 1997, Roberts, 1986). In fact they 
have shown to be the most prevalent medical condition within athletes at clinics in 
both the summer and winter Olympic Games (Derman et al., 2013; Engebretsen et 
al., 2010, 2013; Robinson and Milne; 2002).  
As maintenance of health and performance are the primary objectives of athletes 
(Matthews et al., 2010), there is a demand for an improvement in the prevention, 
diagnosis and treatment of these illnesses within the athletic population (Spence et 
al., 2007). Athletes have been reported to suffer from a similar rate of URTI to the 
general population (Fricker et al., 2000). However, as these episodes of URTI do not 
always follow the usual pattern of winter prevalence of URTI in the general 
population, it may reflect a mediatory role of exercise habits (Cunniffe et al., 2011; 
Matthews et al., 2010; Pyne et al., 2001). Although patterns vary between sports, a 
review by Walsh et al. (2011b) suggested that athletes tend to report URTI either 
during the high intensity and tapering period prior to competition (e.g. swimming, 
team sports) or in the period following competition (e.g. long distance running). 
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It has long been hypothesised that a J-shaped relationship exists between exercise 
workload and susceptibility to URTI (Figure 1.1A) (Nieman, 1994). This model 
suggests that an individual involved in regular moderate exercise is less likely to 
contract URTI compared to a sedentary individual but prolonged high-intensity 
exercise or periods of strenuous exercise training are associated with an above-
average risk of URTI. Indeed, the J-shaped model was initially based on findings of 
increased self-reporting of URTI in the 1-2 week period following participation in 
competitive endurance races (e.g. Nieman et al., 1990a).  
Further support for an adverse effect of prolonged/strenuous exercise on 
susceptibility to URTI has come from animal studies (Davis et al., 1997; Folsom et 
al., 2001; Gross et al., 1998; Lowder et al., 2005; Murphy et al., 2008). Prolonged 
exercise (treadmill running for > 2 h) has been shown to increase morbidity and 
mortality of mice inoculated with respiratory viruses (e.g. herpes simplex type 1 virus, 
influenza) prior to (Davis et al., 1997; Murphy et al., 2008) or following (Lowder et al., 
2005) this type of exertion compared to resting and/or moderately exercise mice. In 
addition to acute exertion, equine studies have also demonstrated that intensified 
periods (5 - 28 days) of exercise training prior to or following inoculation with 
influenza leads to greater severity of infection in vaccinated (Folsom et al., 2001) and 
non-vaccinated horses (Gross et al., 1998). Generalising these results to the human 
in vivo environment is questionable (Albers et al., 2005) and such approaches (i.e. 
pathogen challenge) with human volunteers do have considerable ethical constraints 
(Hope and McMillan, 2004). Although not yet investigated in an exercise context, 
pathogen challenge studies in humans have demonstrated lower resistance to URTI 
due to other life stressors (e.g. psychological stress, sleep disturbance) (Cohen et 
al., 1991, 2009). In addition to the potential exposure to these stressors in a training 
3 
 
and competition environment (Coutts et al., 2007; Hausswirth et al., 2013), the 
relevance of these findings to athletes is emphasised by the impact of transient 
modulation in host resistance to URTI by a stressor.  
Exercise immunology research (epidemiological and experimental) has grown 
substantially over the last few decades to investigate the relationship between 
exercise and URTI in humans (Shepard, 2010). In contrast to animal research, 
human studies (attempting to discern the effects of prolonged exercise/intense 
training on URTI) have mainly involved monitoring athletes following heavy exertion 
(i.e. relied on natural exposure to pathogens) but only a limited number of these 
have verified that symptoms are due to infectious agents (pathogens) (Schwellnus et 
al., 2010). This has raised concerns regarding the validity of URTI episodes (i.e. self-
reported) in athletes that occur in and around competition or heavy periods of 
training (Bermon, 2007; Walsh et al., 2011b). Discrepancies between physician and 
laboratory diagnosed URTI has also highlighted the limitations with evaluation of 
URTI episodes (Cox et al., 2008). Upon presentation of symptoms at a sports 
medicine clinic, the study of Cox et al. (2008) found that only 57% of cases were 
found to be indicative of infection with laboratory methods (e.g. identified pathogen) 
while 89% were diagnosed as URTI by physicians. In a surveillance study of a range 
of athletes (recreational and elite) and sedentary controls, Spence et al. (2007) 
demonstrated that the first 2 days of symptoms with infectious or non- infectious (see 
later section 1.2) cases were similar but duration and severity of symptoms on 
subsequent days were greater with infectious cases. It is for these reasons that 
unless studies have confirmed (i.e. performed serological analysis and/or pathogen 
identification) that upper respiratory tract symptoms are due to an infection, episodes 
will be referred to as upper respiratory illness (URI) for the remainder of this thesis. 
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Although there were numerous early anecdotal reports and retrospective survey data 
to support the proposed J-shaped relationship (Nieman, 2000; Shepard et al., 1995; 
Simon, 1987), such observations alone cannot validate the influence of exercise on 
URI. However, further support to the J-shaped model (i.e. heavy exercise workload) 
was provided by a number of prospective and retrospective studies which suggested 
that marathon or ultramarathon runners were examples of athletes who may suffer 
from an increased risk of URI (e.g.1-2 weeks following competitions) (Nieman et al., 
1990a; Peters, 1993). Peters and Bateman (1983) were among the first key studies 
to highlight this by randomly recruiting a sample of 140 runners who competed in the 
1982 Two Oceans Marathon in Cape Town. In the 14 days following the 56 km 
event, 33% of runners reported URI compared to 15% of age-matched controls that 
did not participate in the marathon but shared living space with runners (i.e. control 
for exposure to pathogens). 
Compared to equally experienced runners who did not compete, there was a six fold 
increase of URI in runners during the 7 days following the 1987 Los Angeles 
Marathon (Nieman et al., 1990a). Taking into account other factors influencing risk of 
URI (age, stress levels and illness at home), the likelihood of URI was doubled in 
those who ran > 96 km compared to those who ran < 32 km as part of their weekly 
training programmes leading up to the event. Heath et al. (1991) also highlighted 
running mileage as a significant risk factor for incidence of URI in a cohort of runners 
followed for a period of 12 months. More recently, Matthews et al. (2010) have also 
suggested that runners with higher training loads tend to be more prone to URI and 
that endurance athletes in particular suffer from longer episodes of URI than their 
recreational counterparts. However, such findings have not been demonstrated 
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consistently as shorter observational studies have failed to observe any associations 
in URI with differences in training mileage, intensity and load (Fricker et al., 2005). 
Despite much interest, there remain to be more uncertainties than evidence based 
facts regarding the notion that high volumes of training are associated with an 
increase in the incidence of URI (Walsh et al., 2011b). Such inconsistent findings 
may be related to whether participants within studies are considered ‘elite’ or ‘highly 
trained’. Malm (2006) suggests that elite athlete status possesses a prerequisite for 
an immune system which can withstand the strenuous nature of training and 
competition as susceptibility to infections is incompatible with elite performance. For 
this reason, Malm (2006) proposed an S-shaped rather than a J-shaped curve to 
include elite training which is associated with a lower risk of infection compared to 
high exercise workload (Figure 1.1B). However, it is worthy to note that this may not 
reflect a reduced physical stress (exercise workload) per se but rather a reflection of 
the preventive and treatment strategies in place within elite settings to limit the 
effects of URI (i.e. maintain a pre-requisite of an elite athlete to withstand infections). 
Figure 1.1. The proposed J-shaped (A) (Nieman, 1994) and S-shaped (B) (Malm, 
2006) relationship between exercise and risk of URTI. 
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Nieman (2001) suggested most athletes may not report URI or suffer from an 
increased risk if they avoid periods of overreaching/overtraining (Nieman et al., 
2000). It seems that an increase in URI may only be attributed to participation in 
acute prolonged exertion (e.g. marathon, ultra marathon) or more importantly when 
athletes are exposed to a greater strain of training through exceeding individual 
training thresholds coupled with inadequate recovery or other life stressors (e.g. 
sleep disturbance) (Foster et al., 1998; Hausswirth et al., 2013; Pyne and Gleeson, 
1998). 
1.2 Aetiology of upper respiratory illness 
In line with the general population, when pathogen identification has been attempted, 
bacteria are rare causes of URTI in athletes, with viruses being responsible in most 
cases (in particular rhinovirus, adenovirus and parainfluenza) (Mäkelä et al., 1998; 
Roberts, 1986). URTI of viral origin last approximately 3-14 days but clearance of the 
particular virus from the system may take longer (Heikkinen and Järvinen, 2003; 
Winther et al., 1986). The route of entry into the body by most viruses is the 
respiratory tract where symptoms reflect the perturbations in function of infected cells 
and the attempts of the immune system to contain the infection (Roberts, 1986). As 
the nature of symptoms of some (i.e. infectious) URI may be similar to non-infectious 
inflammatory factors and/or presentation of allergic conditions, identification of 
antibody titres and isolation of specific pathogens from body fluids of athletes have 
been recommended to clarify causes of symptoms and provide the most appropriate 
treatment or management strategies (Cox et al., 2008; Gleeson, 2006b). As 
mentioned previously, it was generally believed that upper respiratory symptoms in 
athletes were due to an infective cause, however, it is only more recently that other 
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causes (‘non-infectious hypothesis’) have been proposed during training and 
competition (Bermon, 2007; Schwellnus et al., 2010). 
Robson-Ansley et al. (2012) recently reported that a higher incidence of URI in 
runners following a marathon (47%) compared to non-runners (19%) was 
significantly associated with positive responses in the Allergy Questionnaire for 
Athletes. As the prevalence of inhalant allergy may be as common as 16-32% of 
highly trained athletes, it may partly provide an explanation to incidence of URI 
(Langdeau et al., 200; Lumme et al., 2003; Schwellnus et al., 2010). Environmental 
influences have been considered relevant to certain groups of competitive athletes, 
in particular swimmers who are exposed to chlorine derivatives from swimming pool 
disinfectants while inhaling large amounts of air above the water surface (Bougault et 
al., 2009; Piacentini et al., 2007). In addition to inhaled irritants, the combination of 
high ventilation rate in heavy training and surrounding cold, dry air is another 
possible source of  non-infectious, non-allergenic inflammatory stimuli to URI in 
some athletes (e.g. runners, cyclists) (Bermon, 2007; Cox et al., 2008). 
There is also potential for direct damage in epithelial tissue of the upper respiratory 
tract and/or fibres of the contracting skeletal muscle following strenuous exercise to 
contribute to the non-infectious, local and systemic inflammatory origin of URI 
(Peters, 2004). Schwellnus et al. (1997) reported that the use of an anti-inflammatory 
agent reduced URI in participants following an ultramarathon event, but as this 
nasal, buccopharyngeal spray also contained antimicrobial properties it does not 
provide any conclusive evidence to support a purely non-infectious inflammatory 
cause for URI. In contrast, administration of an anti-inflammatory throat spray in the 
period leading up to and following a half-marathon event had no influence on the 
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incidence of URI in runners but did reduce the severity of recorded symptoms (Cox 
et al., 2010). Although conflicting evidence here may purely reflect site-specific 
differences between agents, together these studies do provide evidence that non-
infectious inflammation may not be the underlying cause of all URI but may interact 
with infectious causes to potentiate the symptoms that occur as a result of responses 
to pathogen challenge.  
In their surveillance study, Spence et al. (2007) demonstrated that the distribution of 
URI closely followed the J-shaped curve in terms of training status (i.e. both the 
control and elite athlete group suffered from greater days of illness than their 
recreational counterparts), but only 30% of reported illnesses were confirmed by 
identification of common respiratory pathogens. It is worthy to note that only specific 
pathogens were tested in Spence et al. (2007), thus URI were possibly caused by 
known pathogens not tested for, unknown pathogens and/or new strains of viruses 
which were yet to be identified (Bermon, 2007). Despite the low number of identified 
pathogens highlighted with laboratory evaluation of URI in some studies (i.e. Cox et 
al., 2008; Spence et al., 2007), it must be emphasised that this does not rule out 
infectious causes for these cases as such diagnostics procedures do have inherent 
limitations in identifying causative agents from an evolving diverse pool of pathogens 
(e.g. ~ 200 common cold viruses) (Eccles, 2005; Heikkinen and Järvinen, 2003).  
Not all cases of URI can present as a typical response to a primary viral infection of 
initial upper respiratory symptoms followed by local and systemic inflammation (e.g. 
fever, aches) (Gleeson et al., 2002). Occasionally symptoms may be minor and/or 
short-lasting (1-3 days) resulting in training being unaffected or be a reflection of 
persistent fatigue and recurrent infections as a result of chronic heavy exertion (Reid 
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et al., 2004). In these cases it has been suggested that, in addition to exercise-
induced inflammation, URI following exercise may be related to reactivation of latent 
viruses within the upper airways rather than the incidence of primary infections in the 
recovery period (Gleeson et al., 2002). Ekblom et al. (2006) found in a group of 
recreational runners that pre-race URI was significantly associated with URI 
incidence following the marathon. This was supported by a recent longitudinal 
observational field study, where it was suggested that reactivation of pre-race 
viruses and exercise-induced inflammatory responses were the primary causes of 
elevated URI incidence prior to and following an 86.5-km Marathon (Peters et al., 
2010). The 57% of runners, who recorded incidence of URI during the 7 to 14 days 
following the race, also recorded symptoms in the time leading up to the race. These 
findings may support the aforementioned animal studies whereby participation in 
prolonged exercise may worsen symptom severity induced by existing infection 
(Malm, 2006). 
The viruses reported to be reactivated following strenuous exercise or intense 
periods of training are the human herpes virus group, primarily cytomegalovirus 
(CMV) and Epstein-Barr Virus (EBV) (Gleeson et al., 2002; He et al., 2013b). These 
herpes viruses typically infect humans early on in life, with ~ 50-60% and ~ 80-90% 
of the world’s adult population infected (i.e. seropositive) by CMV and EBV 
respectively (Bate et al., 2010; Gleeson et al., 2002; Staras et al., 2006). After initial 
primary infection, these viruses lay dormant within the cells of the immune system 
and are asymptomatic in immunocompetent individuals (Crawford, 2001; Kano and 
Shiohara, 2000). However, when significant physical and/or psychological stress is 
placed on the immune system such latent viruses may become re-activated (Glaser 
et al., 1999; Mehta et al., 2000b; Stowe et al., 2001; Tingate et al., 1997).   
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In an exercising population, EBV has received the most attention due to its ability to 
replicate continuously or intermittently from the orpharynx (Faulkner et al., 2000; 
Nadal et al., 2002). Gleeson et al. (2002) found a significant correlation between 
previous EBV infection and URI in elite swimmers while all seronegative swimmers 
remained unaffected (no reported URI) during a 30 day period of intensive training. 
Out of the 11 seropositive swimmers, 7 had EBV DNA detected in saliva during the 
study with 86% of these also reporting URI which appeared 4-18 days following first 
detection of EBV DNA.  
In contrast, He et al. (2013b) in an investigation of 236 endurance athletes found that 
those seropositive for CMV alone or both CMV and EBV groups had a lower number 
of days and episodes of URI compared to their seronegative counterparts. Although 
no differences in URI were observed between EBV seropositive and seronegative 
athletes, the above findings were contrary to their hypothesis and previous 
suggestions that prior infection with herpesviruses may predispose athletes to more 
frequent URI (He et al., 2013b; Hoffmann et al., 2010). There is a need for further 
research to at least ascertain the relationship between prior infection with CMV/EBV 
and risk of URI in athletes. Furthermore, systematic DNA analysis of EBV or other 
members of the human herpes family should be advocated when determining 
causes of URI in athletes as possible unidentified cases (as seen in Spence et al., 
2007) may be related to latent viral shedding (Gleeson et al., 2002).  
As mentioned previously, it has been suggested that viral reactivations may be most 
responsible for shorter episodes of URI than primary infections (Walsh et al., 2011b). 
Athletes have been found to have greater levels of detectable EBV DNA compared 
to controls (Hoffmann et al., 2010), where reactivation-induced cell damage and 
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inflammation have the potential to trigger symptoms in the upper respiratory tract 
(Cox et al., 2004). In a clinical investigation of elite athletes suffering recurrent 
episodes of URI, EBV viral shedding was detected in 22% of the cohort (Reid et al., 
2004). Yamauchi et al. (2011) also found in an intensive training period with rugby 
players that salivary expression of EBV DNA was 1.5 times greater in participants 
with URI compared to those without URI.  
Cox et al. (2004) challenged the role of EBV by demonstrating that an anti-herpes 
virus medication reduced the amount detected in saliva but was not effective in 
influencing URI over a 4 month training period in distance runners. This leads to an 
interesting discussion of EBV not being a cause of URI per se, but rather an in vivo 
indication of immunodepression/compromised immunity and therefore, increased risk 
of developing URI due to other infective causes. Indeed, for the reactivation of EBV 
to occur, there must be a disturbance within certain parameters of the immune 
system which usually keep the virus tightly-regulated and dormant. This reflection of 
immune perturbations within the host (Mehta et al., 2000a) occur in line with the 
most researched hypothesis (‘open window’) behind an increased risk of primary 
infections in athletes who participate in prolonged exercise.  
The ‘open window’ hypothesis suggests that prolonged/heavy exercise causes 
depression of the immune system which leaves the body less resistant to viruses 
and bacteria and thus increases the risk of subclinical and clinical infection for 
between 3 and 72 h (Nieman, 2001). Nieman and Pedersen (1999) introduced this 
addition to the J-shaped model (Nieman, 1994) to reflect that the increased risk of 
URI with heavy exertion was due to a decrease in immunosurveillance and vice 
versa. The immunological response to acute exercise is deemed a subset of stress 
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immunology (Hoffman-Goetz and Pedersen, 1994), where responses have been 
likened to those caused by infection, sepsis, burns or trauma (Pedersen and 
Hoffman-Goetz, 2000). Although exercise does share some similarities to the 
hormonal and immunological responses of these clinical physical stressors, there are 
also important distinct differences in the magnitude of and temporal pattern of 
responses (Shepard, 2001, 2002).  Strenuous exercise induces an ordered 
sequence of modest changes in pro-inflammatory signalling followed predominantly 
by anti-inflammatory responses which down-regulates immune function whereas 
some of the clinical stressors listed above (e.g. sepsis)  trigger excessive and 
overwhelming elevations in systemic pro-inflammatory responses (de Jong et al., 
2010; Netea et al., 2003; Shepard, 2002). Exercise immunologists have controlled 
and adapted the duration and intensity of the stress model of exercise to gain a 
deeper understanding into how alterations in immune function following acute 
exercise and training may lead to changes in susceptibility to dormant and primary 
pathogens.  
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1.3 Immune system and exercise 
The immune system has evolved to protect the human body from pathogens 
(viruses, bacteria and parasites). It encompasses the ability to maintain homeostasis 
even when exposed to a wide range of foreign and self molecules (i.e. antigens). 
The components of the non-specific innate system and the specific acquired system 
overlap to ensure that a state of immunity against infection is established. 
1.3.1 Leukocyte count changes and acute exercise 
The number of circulating immune cells (leukocytes) is profoundly influenced by 
acute exercise with reports from over a century ago highlighting the exercise-induced 
mobilisation following the Boston Marathon (Larrabbe, 1902). Circulating leukocytes 
consist of the granulocytes (neutrophils, eosinophils and basophils; 60-70% of total), 
monocytes (5-15%), dendritic cells (less than 1%) and the lymphocytes (15-25%) 
which can be divided into innate (Natural killer [NK] cells) and acquired (T helper, T 
cytotoxic and B cells) cells. It is now clear that leukocytosis which is an increase in 
the total number of circulating leukocytes (mainly neutrophils and lymphocytes) 
occurs (up to 400%) during and immediately post-exercise (Simpson, 2013). The 
observed changes are dependent on the exercise intensity and duration (Gleeson, 
2007) with prolonged endurance exercise (> 1.5 h) causing a greater leukocytosis (3 
to 4 fourfold increase compared to doubling of neutrophil counts) than brief (20-40 
min) high-intensity exercise (Robson et al., 1999b).  
At rest, it is estimated that an equal amount of leukocytes within the blood are 
circulating or within marginated pools, adhered to blood vessel walls of the 
circulatory system (Athens et al., 1961; Berkow and Dodson, 1987). Foster et al. 
(1986) suggested the increased cardiac output during exercise and the subsequent 
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shear stress (increased blood flow) within capillaries induces leukocytes to enter 
circulation in a process known as demargination. However, it is anticipated that 
marginal pools within the liver, lung, spleen and other vital organs (e.g. bone 
marrow, intestines) also contribute to the large leukocytosis following exercise as 
pools in the lung alone possess lymphocytes which are present in 10 times larger 
amounts than the circulatory pool (Hogg and Doerschuck, 1995; Simpson, 2013).  
Activation of the sympathetic nervous system (elevated concentrations of plasma 
catecholamines) and the hypothalamic-pituitary-adrenal (HPA) axis (cortisol release) 
during prolonged exercise also play an integral role in exercise-induced leukocytosis 
(Anane et al., 2009; Atanackovic et al., 2006; Nieman, 2001). The immediate 
leukocytosis, particularly neutrophilia (increased neutrophil count) upon onset of 
exercise is suggested to be due to the haemodynamic and catecholamine induced 
demargination of vascular and pulmonary pools but this is later followed by a 
cortisol-induced release of neutrophils from the bone marrow otherwise known as 
delayed leukocytosis (Allsop et al., 1992). This effect is seen simultaneously with the 
immediate leukocytosis during prolonged exercise of > 1 h as cortisol level is 
sufficiently elevated and its action is prolonged, explaining the previously mentioned 
greater leukocytosis than following shorter, higher intensity exercise (Robson et al., 
1999b). Neutrophils released from the bone marrow following stimulation by cortisol 
are suggested to include a greater proportion of immature cells (e.g. band cells) 
compared to neutrophils that demarginate from the endothelial walls upon onset of 
exercise which have similar maturity levels to those already in circulation 
(Hetherington and Quie, 1985; McCarthy et al., 1991). Although effects on dendritic 
cells remain unclear, the bone marrow is also a source of maturation for both 
monocytes and B cells where monocytes also increase proportionately with exercise 
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duration and B cells are associated with limited redistribution (Lancaster et al., 
2005a; Nieman et al., 1998; Okutsu et al., 2008; Pedersen et al., 1990; Shek et al., 
1995). 
NK and T cells (mostly cytotoxic) also increase proportionately with exercise intensity 
and duration unlike neutrophils where increases are predominantly influenced by 
duration (Campbell et al., 2009; Gabriel et al., 1991; McCarthy and Dale, 1988; Shek 
et al., 1995). Even though lymphocytes are present at numerous sites within the 
body, evidence suggests that mobilisation of these cells during exercise mainly 
occurs from secondary lymphoid organs e.g. spleen, intestinal Peyer’s patches (PP) 
rather than primary lymphoid organs such as the thymus or bone marrow (Campbell 
et al., 2009; Simpson et al., 2007; 2008). The spleen is considered to be an 
abundant source of the lymphocytes deployed during exercise (Baum et al., 1996; 
Nielsen et al., 1997), with shear stress and catecholamines being important release 
mechanisms (Benschop et al., 1993; Dmitrov et al., 2010; Kappel et al., 1991; 
Shepard, 2003; Timmons and Cieslak, 2008). There is a clear consensus developing 
that exercise triggers a redistribution of T cells with a longer history of antigen 
exposure rather than naive T cells (Campbell et al., 2009; Simpson, 2011).    
Following the lymphocytosis during and upon completion of prolonged exercise, the 
high concentrations of adrenaline and cortisol often cause lymphocytopenia 
(lymphocyte count below resting levels) during the recovery (Nieman, 2001; Nieman 
et al., 1994). This biphasic response (lymphocytosis during exercise and 
lymphocytopenia during recovery) has been found with various protocols requiring 
heavy/prolonged exertion or exhaustive exercise (e.g. Fry et al., 1992; Shek et al., 
1995), with lymphocyte count up to 60% below resting levels reported post-exercise 
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(Simpson, 2011). Lymphocytopenia is due to the selective extravasation of 
lymphocyte subsets, NK and T cytotoxic cells, from blood to the surrounding tissues 
(Gabriel et al., 1991; Kruger et al., 2008; Simpson et al., 2006). The return of total 
leukocyte count to resting levels generally begins immediately post-exercise with 
diminishing activation of the sympathetic nervous system and HPA axis but in the 
case of very intense exercise, leukocyte (primarily neutrophils) count may continue 
to increase as described above (Allsop et al., 1992; McCarthy and Dale, 1988). 
Given these leukocyte perturbations, an increase in neutrophil:lymphocyte ratio is 
suggested to be an indicator of the overall magnitude of the stress response induced 
by exercise (Nieman, 1998). 
1.3.2 Innate immune cell function and acute exercise   
The immune system consists of many physical barriers (e.g. skin, mucus, cilia) which 
act to prevent entry of pathogens into the human body. If such attempts fail, 
infectious agents will be detected by receptors present on the cellular components of 
the innate immune system such as the granulocytes (mostly neutrophils but include 
basophils and eosinophils), NK lymphocytes, monocytes (which mature into 
macrophages within tissue) and dendritic cells. 
The recognition of foreign material is one way in which the innate and acquired 
immune systems differ from one another. Unlike acquired immunity, the innate 
system does not exhibit memory of previous encounters with antigens (i.e. foreign 
molecule), therefore a similar response is believed to take place during any future 
exposure. Present on the cell surface of innate cells are pattern recognition 
receptors (PRR) that distinguish self from non-self material by recognising molecules 
on microbes which have been conserved through evolution due to their essential 
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function i.e. bacterial DNA, lipopolysaccharide (LPS) and other bacterial cell wall 
components (Beutler and Rietschel, 2003; Kimbrell and Beutler, 2001). The majority 
of these structures comprise of the Toll-like receptors (TLR) which are crucial 
components of the antigen presentation cells (APC) (discussed later in this section) 
of innate immunity (monocytes/macrophages).  
Neutrophils also known as polymorphonuclear (PMN) cells (due to their multi-lobed 
nucleus) are the most abundant circulating leukocyte population of the immune 
system. These leukocytes are considered specialised short-lived cells with deficits in 
numbers and/or function of this subset being associated with increased risk of 
potentially fatal bacterial infections (Boxer, 2003; Smith et al., 1996a; Viscoli et al., 
2005). Once released from the bone marrow, neutrophils migrate out of the 
circulation within 4-10 h to marginated and tissue pools where they reside for a 
further 1-2 days (Smith, 1994; Summers et al., 2010).  
Neutrophils respond to chemotactic stimuli (e.g. formylated peptides such as formyl 
methionyl leucyl phenylalanine, fMLP) from fragments of invading microorganisms 
and tissue damage at sites of infection and inflammation respectively where they 
engage in numerous intrinsic conformation adaptations during and following their 
migration (chemotaxis) (Smith and Pyne, 1997). Similar to other phagocytes (e.g. 
APC, discussed later in this section), the detection of pathogens or tissue damage 
through PRR (e.g. FPR1, a fMLP receptor) on the neutrophil surface leads to 
internalisation (phagocytosis) and holding of these fragments within the cytoplasm 
(via a membrane bound vesicle known as phagosome) thereby activating a series of 
effector functions in the cell (Borregaard, 2010; Nathan, 2006). The mechanistic 
detail of engulfment by neutrophils may depend on the involvement of the specific 
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ligand (i.e. antigen) attached to the receptors or whether fragments have been 
opsonised by soluble immune factors but the process will ultimately involve 
internalisation into a phagosome (Amulic et al., 2012). Soluble components which 
act as opsonins (promote attachment of antigen to phagocyte) include acute phase 
proteins, antibodies (see section 1.3.3) and complement proteins (e.g. C3) (Brekke 
et al., 2007; Gordon, 2002; Thiel et al., 1992). It is worthy to note that elevations in 
circulating concentrations of acute phase proteins (c-reactive protein, CRP) in 
response (i.e. acute phase response) to perturbations in homoeostasis (e.g. trauma, 
tissue damage) are considered one example of why the strenuous nature of 
prolonged exercise is likened to medical conditions (e.g. sepsis, burns) (Fallon, 
2001; Kushner and Rzewnicki, 1994; Pedersen and Hoffman-Goetz, 2000). 
Neutrophils are also known as granulocytes due to the characteristic release 
(degranulation) of primary azurophil (defensins, elastase, myeloperoxidase [MPO]) 
and secondary specific (lactoferrin, lysozyme) granule contents (degranulation) into 
the cytoplasm to fuse with the phagosome or the plasma membrane to create an 
antimicrobial milieu inside and outside of the cell. These granules do show varying 
readiness to mobilise in response to inflammatory signalling, with the azurophilic 
subset being the most difficult to mobilise (Amulic et al., 2012). The degradation of 
particles within the phagosome or extracellular space of infected or damaged tissue 
is aided further by the process of neutrophil oxidative burst involving the formation of 
reactive oxygen species (ROS) through the NADPH oxidase system (Babior, 1999; 
Weiss, 1989). Depending on the stimulus (see section 2.4.3.1 for relevant stimuli of 
this thesis), the NADPH oxidase system may assemble on the membrane of the 
phagosome and/or the cell where the main ROS produced are the superoxide anions 
which react to form other intermediates including hydrogen peroxide, hypochlorous 
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acid, hydroxyl radical and singlet oxygen (Peake, 2002). It has been suggested that 
components of azurophilic (e.g. MPO) and specific (e.g. flavocytochrome b558) 
granules may regulate the activity of the NADPH oxidase (Tal et al., 1998; Amulic et 
al., 2012), highlighting that intracellular signalling cascades triggered by attachments 
of ligands to surface receptors, may lead to coordinated degranulation and oxidative 
burst responses to invading pathogens (Daniels et al., 1994; Pyne, 1994).  
Recently, it has been demonstrated that neutrophils also possess antimicrobial 
capacity independent of phagocytosis known as neutrophil extracellular traps (NETs) 
(Mantovani et al., 2011). Although mechanisms of NETs are not completely 
understood, it has been established that classical effector functions of neutrophils 
(degranulation and oxidative burst) play important roles in mediating the response 
(Amulic et al., 2012; Fuchs et al., 2007; Metzler et al., 2011; Patel et al., 2010). NETs 
are suggested to form upon an active form of cell death which results in the release 
of a network of nuclear filaments (DNA and histone) into the extracellular space from 
the degrading neutrophil (Brinkmann et al., 2004; Fuchs et al., 2007).  
On the basis of the exercise-induced changes in neutrophil counts it is not surprising 
that exercise also affects functional responses, but due to the variation in study 
design the early evidence was conflicting (Peake, 2002). Nevertheless, it can be 
argued that when responses are controlled for on a per cell basis the effects of 
exercise duration (i.e. prolonged exercise) are clearer. Neutrophils may present on a 
continuum of state of activation from dormant to primed through to being fully 
activated (Smith, 1994). During exercise, there is a release of agents into the 
circulation which may prime (e.g. induce assembly of NADPH on membrane) or 
desensitise (internalisation of receptors) the capacity of neutrophils for enhanced 
20 
 
responsiveness to later stimulation or inhibit such functional responses respectively 
(Amulic et al., 2012; Peake, 2002; Pyne, 1994).  
The number of neutrophils engaging in phagocytic activity is increased following 
prolonged exercise but the phagocytic capacity of each neutrophil is decreased 
within the circulation and the nasal cavity (Blannin et al., 1996a; Chinda et al., 2003; 
Gabriel et al., 1994; Muns, 1994; Nieman et al., 1998). Albers et al. (2005) 
suggested that neutrophil phagocytosis may have low suitability as a marker of the 
immunomodulatory effects of exercise and assessing the degranulation and/or 
oxidative burst may be more sensitive to reflect a susceptibility to infection.  
Simultaneous with neutrophilia following prolonged exercise there is an increase in 
unstimulated degranulation and oxidative burst responses (e.g. measured by total 
plasma elastase, spontaneous ROS production) (Bishop et al., 2003; Blannin et al., 
1996b; Suzuki et al., 1999). These findings provide support that prolonged exercise 
induces neutrophil activation (possibly due to muscle damage) that may result in the 
cells entering a ‘refractory period’ in the recovery from prolonged exercise whereby 
there is a transient window of an inability to respond to subsequent stimulation (e.g. 
in vitro) (Peake, 2002).  
Numerous studies have found significant decreases in neutrophil degranulation 
and/or oxidative burst responses to in vitro stimulation by bacterial peptides (fMLP 
and LPS) and/or synthetic stimuli (Phorbol-12-Myristate-13-Acetate, PMA) during the 
recovery from prolonged (> 1.5 h) exercise (Chinda et al., 2003; Davison and 
Diment, 2010; Davison and Gleeson, 2005, 2006, 2007; Davison et al., 2007; Laing 
et al., 2008; Suzuki et al., 2003). This decline in function has not been coupled to 
changes in cell surface receptors, suggesting that the modulatory effects of exercise 
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on in vitro stimulants occur downstream in intracellular signal transduction pathways 
of neutrophils such as phosphorylation cascades or secondary messengers (e.g. 
cyclic adenosine monophosphate, calcium) (Mooren et al., 2001; Peake, 2002). The 
magnitude of the effects of prolonged exercise on neutrophil effector functions will 
depend on the balance of immunosuppressive (e.g. ‘refractory period’) and 
immunostimulating factors (e.g. priming agents) which largely depend on the extent 
of neutrophilia (Peake, 2002). As previously mentioned, prolonged exercise (i.e. 
elevations in stress hormones) induces a mobilisation of immature neutrophils into 
the circulation which have been shown to exhibit reduced NADPH oxidase activity 
and granular content (Berkow and Dodson, 1986: Hetherington and Quie, 1985). The 
immunodepressive effects of cortisol and the subsequent release of subpopulations 
from the bone marrow was supported by Robson et al. (1999b) who found that the 
degree of exercise-induced decrease in stimulated degranulation per neutrophil and 
neutrophilia was greater following prolonged exercise ( 3 h) compared to short, 
intense exercise ( 40 min).  
Although considered to be a major factor, activation of the HPA axis alone cannot 
wholly account for changes in the neutrophil function (Laing et al., 2008), as some of 
the noted inhibitory effects of cortisol on receptor mediated responses (e.g.fMLP) 
would not explain decreased responses to stimulants that activate neutrophils 
independent of surface receptors (e.g. PMA) (O’Flaherty et al., 1991; Peake, 2002; 
Tomchek et al., 1991). Thus, other mechanisms have also been suggested to be 
involved in neutrophil dysfunction, where elevations in catecholamines, cyclic 
adenosine monophosphate, complement proteins (C5a), direct cellular oxidative 
damage and growth hormone are responses which may occur with the inflammatory 
response to prolonged exercise and have been shown to interfere with calcium 
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signalling or other intermediates of intracellular pathways (Hack et al., 1994; Henson 
et al., 1978; Laing et al., 2008; Robson et al., 2003; Suzuki et al., 1999; Thibault et 
al., 2000; Tintinger et al., 2001). 
The susceptibility of phagocytes to modulation by strenuous exertion are also 
demonstrated by the decreased expression of TLR on the cell surface of monocytes 
immediately and up to 2 h following prolonged exercise (Lancaster et al., 2005b; 
Oliveria and Gleeson, 2010) which are not explained by exercise–induced changes 
in monocyte numbers alone (Simpson et al., 2009). The phagocytic function of 
monocytes has been shown to increase following prolonged exercise which may be 
related to the increased pro-inflammatory phenotype observed with exercise in this 
leukocyte (Hong and Mills, 2008; Steppich et al., 2000). Once monocytes reach the 
tissues they will form mature macrophages, therefore the biological significance of 
changes in monocytes is currently unclear as it may not reflect exercise-induced 
changes in immunosurveillance within tissue (i.e. at sites of inflammation or 
infection) (Simpson et al., 2009; Walsh et al., 2011b). These macrophages along 
with other phagocytes (dendritic cells) are present in majority of body tissues where 
unlike the direct killing capacity of neutrophils, macrophages and dendritic cells 
mostly act as professional APC (Beutler, 2004; Iwazaki and Medzhitov, 2004) . 
Investigations within exercise stress models thus far have been limited to animal 
studies which are difficult to generalise to the human response but do suggest 
dysfunction in the capacity of these cells to present antigens following prolonged 
exercise (Ceddia and Woods, 1999; Ceddia et al., 2000; Chiang et al., 2007; Davis 
et al., 1997; Liao et al., 2006; Murphy et al., 2004; Woods et al., 1997, 2000).  
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NK cells are large granular cells that can sense structures of high-molecular weight 
glycoproteins expressed on virus infected cells via PRR on their cell surface. They 
form up to 15% of the lymphocytes within the body and are vital in defence against 
viral infection. However, compared to other peripheral lymphocytes (B and T cells, 
see section 1.3.3), prior sensitisation is not required (Cerwenka and Lanier, 2001). 
Thus upon activation NK cells trigger apoptosis or lysis of a virus-infected cell by 
releasing granule contents such as the pore forming proteins perforin and cytolysin. 
The initial investigations into NK cell activity (NKCA) showed that exercise-induced 
responses were largely mediated by the duration and intensity of the bout (Gannon 
et al., 1995). The NKCA was demonstrated to mirror the increases in NK cells 
following moderate or exhaustive exercise (Gannon et al., 1995; Woods et al., 1998). 
However, when the exercise bout is intense and prolonged, NCKA on a per cell 
basis has been shown to be reduced for several hours (Kappel al., 1991; McFarlin et 
al., 2004; Nieman et al., 1993). 
1.3.3 Acquired immune cell function and acute exercise 
Binding of microorganisms to PRR (e.g. TLR) of innate immune cells not only 
triggers activation of innate parameters but also induces the generation of protein 
messengers (i.e. cytokines) and other signalling components to stimulate acquired 
immunity (Takeda and Akira, 2005). However, compared to innate immunity, the 
acquired immune response to a pathogen is delayed due to a lag period for 
recognition by the vast range of antigen receptors within B and T lymphocyte  
populations, clonal selection/expansion of the pertinent lymphocytes and clonal 
elimination for tolerance of self to occur (Kimbrell and Beutler, 2001; Medzhitov, 
2001). 
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T and B cells form 60-80% and 5-15% of the circulating pool of lymphocytes 
respectively, where the T cell population mature in the thymus gland and the B cells 
in the bone marrow. T lymphocytes are subdivided further into cytotoxic (Tc, CD8+), 
helper (Th,CD4+ ) and regulatory (Treg) where the Treg are formed from a naive CD4+ 
cell and modulate immune responses compared to the primary involvement in 
removal of pathogens by Tc and Th. 
The induction of a primary immune response to pathogens involves presentation of 
antigens to the cell surface receptor of T lymphocytes (T cell receptor) by dendritic 
cells (Lanzavecchia and Sallusto, 2001; Mellman and Steinman, 2001), while all 
other APC (e.g. monocytes, macrophages) are involved in the initiation of secondary 
immune responses via memory T cells which have encountered the antigen 
previously (Gallucci and Matzinger, 2001). T cells are able to recognise antigens via 
Major Histocompatibilty Complex (MHC) class I and II molecules on the cell surface 
of an APC (Banchereau and Steinman, 1998). The number of antigens encountered 
by an individual will determine the proportion of naive (unactivated) or memory 
(activated) T cells circulating within the body.  
Although structurally similar to the T cell receptor, the surface receptor of the B 
lymphocyte is a membrane-anchored immunoglobulin (Ig) (also termed antibody). 
Upon interaction of antigen and receptor, the B cell undergoes clonal expansion to 
form both short-lived plasma effector cells and long-lived memory cells or internalise 
the bound antigen and act as an APC to T cells (LeBien and Tedder, 2008). The 
short-lived plasma cells secrete Igs into the blood to aid destruction of the pathogen 
while the memory cells with their greater affinity to the antigens can remain in the 
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circulation throughout life to rapidly differentiate into plasma effector cells if the same 
antigen is encountered again (Walsh et al., 2011b).  
The circulating Igs fall into five major classes, IgM, IgG, IgA, IgD and IgE where each 
of these classes can be divided further into subclasses. This diverse repertoire of Igs 
possess functional regions capable of binding to a vast range of antigen sites 
(epitopes) to form immune (antigen-antibody) complexes that neutralise the toxicity 
of certain antigens or common Ig regions which can activate phagocyte ingestion 
and soluble innate factors (e.g complement) (Nieman and Nehlsen-Cannarella, 
1991). Following a lag period for accumulation of Igs within the blood, the IgM class 
predominates during any primary response to an antigen whereas IgG predominates 
under normal resting conditions as well as in the rapid Ig response to secondary 
antigen exposure (McKune et al., 2005; Stavnezer, 1996). 
Therefore, the acquired immune system consists of a cellular (i.e. T cells) and 
humoral component (i.e. Ig). Determining which component of the acquired immune 
system predominates, are the subpopulations of Th cells (Th1 and Th2) and the 
cytokine profile they produce and release (Walsh et al., 2011b). Cytokines act as 
protein messengers between one immune cell and other, where the cell receiving the 
signal may proliferate, secrete additional cytokines, migrate to the area of origin of 
the signal, differentiate into another type of cell or die (undergo apoptosis) (Curfs et 
al., 1997). The main cytokine group responsible for leukocyte communication is the 
interleukin (IL) family but other major cytokine groups are the colony stimulating 
factors (e.g. granulocyte macrophage colony stimulating factor [GM-CSF], 
granulocyte-colony stimulating factor [G-CSF]), tumour necrosis factors (TNF) and 
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interferons (IFN) where their main roles are stimulation of cell growth, tumour 
cytoxicity and inhibition of viral replication respectively (Curfs et al., 1997). 
The stimulation of Th1 cells and production of cytokines such as IL-2, and IFN  
promotes cell-mediated immunity (Tc responses) for defence against intracellular 
pathogens while activation of Th2 cells (IL-4, IL-5, IL-6 and IL-13) coordinates 
humoral immunity (B cells) and release of Igs for defence against extracellular 
pathogens (Seder, 1994). It has been suggested that intense/prolonged exercise can 
modulate this balance by decreasing the proportion of Th1 cells in circulation 
whereas Th2 cells remain unaffected (Lancaster et al., 2004, 2005a; Steensberg et 
al., 2001). This shift in immunity has been proposed to provide an explanation for 
potential increases in the susceptibility to URI following prolonged exercise given the 
importance of type 1 responses (Th1)  towards viral infection (Fabbri et al., 2003; 
Steensberg et al., 2001).   
Such effects of exercise are suggested to be mediated via the suppression of type 1 
cytokine production by elevations in stress in hormones (adrenaline and cortisol) and 
the release of cytokines from contracting skeletal muscle (primarily IL-6) that favour 
production of type 2 (Th2) cytokines (Gleeson, 2007). Supporting evidence for 
cytokine modulations following intense exercise has been provided by decreases in 
IL-2 and IFN and no changes in IL-4 shown with in vitro mitogen-stimulated isolated 
cells and whole blood culture (Moyna et al., 1996; Smits et al., 1998; Starkie et al., 
2001; Tvede et al., 1993). These changes in cytokine production overlap with 
influences on other stages of T cell activation where decreases in mitogen-induced T 
cell proliferation have been observed following intense/prolonged exercise (Bishop et 
al., 2005; Fry et al., 1992; Henson et al., 1998; Nieman et al., 1994, 1995). 
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Despite these observations, the evidence suggesting that T cell activation is down-
regulated by prolonged exercise is confounded by numerous methodological 
limitations (Walsh et al., 2011b). T cell proliferation assays generally use a fixed 
amount of total lymphocytes or whole blood so changes following exercise may only 
reflect changes in the proportion of lymphocyte subsets due to the greater increase 
in NK cells post-exercise which do not respond to mitogen (Green and Rowbottom, 
2003). Depletion of NK cells from cell culture has been found to remove the 
significance of changes in mitogen-induced proliferation following exercise (Green et 
al., 2002). Nieman et al. (1994) found that proliferative responses were substantially 
different based on adjustments for T cell populations, but there was still a significant 
fall in proliferation following intense exercise compared to pre-exercise. 
Nevertheless, the validity and sensitivity of mitogen-induced culture to assess T cell 
function have been questioned due to their non-specific effects (activating other cell 
types e.g. B cells) and lack of ability to detect subtle changes in individual T cell 
populations (Bishop et al., 2005). 
Bishop et al. (2009) demonstrated that ex vivo migration of CD4+ and CD8+ cells to 
a human-rhinovirus infected bronchial (lung) epithelial cell line was decreased 
following a prolonged exercise bout (2 h of running). It is also difficult to extrapolate 
such observations on isolated cells from a circulating pool that is considerably lower 
than total lymphocyte mass within the complex in vivo environments at the skin, 
mucosa, and lymph nodes (Gleeson, 2007). Although investigations on whole blood 
maintains the proximity of leukocytes and the extracellular milieu of leukocytes 
compared to leukocyte isolation, the use of in vivo measures to assess response to 
antigenic challenge may be more clinically relevant (Albers et al., 2005; Walsh et al., 
2011b). 
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Delayed Type Hypersensitivity (DTH) is a complex local immunological reaction to 
an intracutaneous antigen (following previous encounter/sensitisation) that is 
primarily T-cell-mediated but involves interaction of various cell types and chemical 
mediators of the immune system to induce a cell mediated immune response (Albers 
et al., 2005; Harper-Smith et al., 2011). Although the antigen presentation to T cells  
within a DTH reaction is similar to response to intracellular pathogens (Kaufmann, 
1995), it can be considered an amplified reflection of the stages that occur with a 
‘conventional’ antigen which allows for the cell-mediated immune response to be 
non-invasively quantified (Kobayashi et al., 2001; Harper-Smith et al., 2011). The 
DTH reaction is characterised by an infiltration of predominantly peripheral 
mononuclear cells (PBMC: T cells (antigen specific) and monocytes/macrophages) 
which release cytokines and other inflammatory mediators that present as 
eczematous plaques at the site (i.e. skin) (Bruunsgaard et al., 1997; Kaplan et al., 
2012; Malaijan and Belsito, 2013; Schwarz, 2003). Such epidermal indurations 
(oedema and erythema) that peak in the 24-48 h following antigen re-exposure can 
then provide the means by which cell mediated immune response can be measured 
(Albers et al., 2005). 
Bruunsgaard et al. (1997) showed that triathletes who completed prolonged exercise 
prior to intra-dermal injections of 7 previously encountered antigens had significantly 
reduced skin responses compared to resting controls, indicating immunodepression. 
This method, however, is limited to the recall (elicitation) of pre-existing 
immunological memory and does not provide any evidence on the effects of 
prolonged exercise on the primary immune (induction) response to a novel antigen 
(Harper-Smith et al., 2011). Contact sensitisation which involves topical skin 
exposure to novel synthetic chemicals provides an experimental model where both 
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the elicitation and induction of T-cell-mediated responses can be measured (Albers 
et al., 2005; Friedmann, 2007; Palmer and Friedmann, 2004).  
Harper-Smith et al. (2011) found that participating in prolonged exercise (2 h of 
running) compared with seated rest prior to cutaneous sensitisation with a novel 
antigen (Diphenylcyclopropenone, DPCP) reduced the recall (elicitation) of the 
immune response (skin erythema and oedema) to that same antigen 4 weeks later. 
When participants completed the same prolonged exercise immediately prior to the 
elicitation phase (recall at 4 weeks), there was also a reduction in skin responses to 
DPCP compared to resting controls. However, the magnitude of reduction in 
response to DPCP at this phase (elicitation, 20%) was considerably lower than the 
reduction observed when prolonged exercise was completed prior to DPCP 
sensitisation (induction, 50%). This suggests that the primary immune response to 
antigens (APC and induction of T cell specific memory) is more susceptible to the 
perturbations induced by prolonged exercise than responses to recall (previously 
exposed) antigens.  
Simultaneously to the aforementioned assessment of cell-mediated immunity, 
Bruunsgaard et al. (1997) also vaccinated all groups with previously encountered 
antigens that would stimulate B cell function. There were no differences between the 
prolonged exercise and control group in the ability of B cells to generate antibody 
responses to these recall antigens in the 14 days following vaccination. This may 
provide supporting evidence to proposals that primary immune responses are more 
susceptible to the effects of exercise or it may suggest that perturbations are more 
pronounced in the immediate period following prolonged exercise (0-48 h, i.e. 
proposed open window). The response of circulating Igs to prolonged exercise has 
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not been extensively researched with the studies that have investigated the 
predominant Igs in blood (A, G, M) reporting conflicted findings (decreases, 
increases and no change) (Bishop, 2013; Nieman and Nehlsen-Cannarella, 1991; 
Peters et al., 2010; Walsh et al., 2011b). This may not be surprising given the small 
proportions of B cells (5-15%) in the circulating lymphocyte pool and little 
redistribution of this subset following exercise. For the investigation of activated B-
cells and Ig responses to exercise, studies have focused primarily on other immune 
compartments which may have greater relevance to URTI (i.e. mucosa).  
1.3.4 Mucosal immunity and acute exercise 
Both cell-mediated and adaptive parameters contribute to the largest component of 
the immune system, mucosal immunity (total surface area of 400 m2) (Brandtzaeg et 
al., 1999). The importance in host defence against pathogens becomes apparent 
when recognising that the mucosal surfaces of the upper and lower respiratory tract 
account for ~ 50-60% of total immune protection by the body and the small intestine 
along with the colon are responsible for 70% of all Igs produced (Kudsk, 2002). 
Increases in illness and morbidity have been attributed to impairment in mucosal 
immunity (Daele and Zicot, 2000), highlighting the importance that immune 
competence at mucosal surfaces has in the health and well-being of athletes (West 
et al., 2006). Although not functioning independently of the systemic immune system, 
mucosal immunity is also considered a distinct entity due to its autonomously 
regulated, localised defence mechanisms (Toy and Mayer, 1996).    
The gut-associated lymphoid tissue (GALT), urogenital tracts, lacrimal glands, 
lactating mammary glands and respiratory tracts which include the bronchus-
associated lymphoid tissue (BALT), salivary glands and nasal-associated lymphoid 
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tissue are all mucosal surfaces which fall under the network of immune structures 
known as the common mucosal immune system (CMIS) (Gleeson and Pyne, 2000). 
The immunological protection provided by this network may be via organised tissue 
with well-formed follicles (mucosa-associated lymphoid tissue) such as PP of the 
small intestine or as a diffuse accumulation of leukocytes (lymphocytes, plasma cells 
and phagocytes) as found in the lung and the lamina propria (connective tissue) of 
the small intestine (Kyd and Cripps, 1999). These immune structures are pivotal for 
the mono-layered epithelial layer of mucosal surfaces which is continually exposed 
to a wide array of antigens or allergens including pathogenic bacteria or viruses, gut 
microflora and ingested food (Johansen et al., 2000). Indeed, the mucosae are 
considered to be the first line of defence as they are the sites where most pathogens 
enter the body (Macpherson et al., 2012).  
The CMIS are differentiated into inductive and effector sites, where the induction 
sites (primarily PP) involve the sensitisation of immune response following antigen 
presentation while the effector sites consist of interconnected distal sites (respiratory 
tract, lamina propria) where the array of activated B-cells and plasma cells home and 
migrate to provide local protection (Kyd and Cripps, 1999; Kudsk, 2002). At least 
80% of the body’s plasma cells (activated B-cells) reside in the mucosal effector 
tissues, whereby local production of Igs represent a major immunological barrier at 
all mucosal surfaces with IgA being the predominant antibody (Bishop and Gleeson, 
2009; Brandtzaeg et al., 1999).  
Within the bloodstream, IgA under most circumstances is found as a monomeric 
peptide (Yel, 2010). However, in all mucosal secretions IgA exists as a dimeric 
protein covalently linked by a J chain containing another peptide termed the 
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secretory component (Gleeson and Pyne, 2000). The secretory component is the 
cleaved segment of the polymeric Ig receptor (pIgR) that is produced by the mucosal 
and glandular epithelial cells and expressed on the basolateral membrane (Bishop 
and Gleeson, 2009; Teeuw et al., 2004). The proteolytic cleavage of pIgR occurs 
following its binding and induction of the active transport (exocytosis) of dimeric IgA 
through epithelial cells on to the mucosal surface (Strugnell and Wijburg, 2010). The 
remaining secretory component wrapped around the J chain-linked dimeric IgA 
forms secretory IgA (SIgA) which is considered to be resistant to proteases secreted 
at mucosal sites (e.g. intestinal mucosa) (Johansen et al., 2001; Lindh, 1975; 
Strugnell and Wijburg, 2010; Underdown, 1974). It is this local production of SIgA 
that forms the major effector function of mucosal immunity (Bishop and Gleeson, 
2009). Only in the neonate or situations of IgA deficiency does IgM represent a 
significant defence at mucosal surfaces with IgG also being found in low quantities at 
mucosae (Brandtzaeg et al., 1999; Gleeson and Pyne, 2000). 
IgA can be further divided into subclasses, where IgA2 is the most abundant in the 
distal gastrointestinal tract (60%), whereas IgA1 predominates in the salivary glands 
(60% - 80%) and nasal lymphoid tissue (NALT) (> 90%) (Gleeson, 2000). Protection 
of mucosal surfaces via SIgA occurs through multiple mechanisms. One such 
mechanism known as immune exclusion involves the binding of antigens to regulate 
the commensal microorganisms (microbiota) and prevent the attachment and 
invasion of mucosal surfaces by pathogens (Strugnell and Wijburg, 2010; Sutherland 
and Fagarsan, 2012). Other mechanisms include the binding of antigens which have 
already crossed the mucosal barrier and actively transporting them back across the 
epithelial layer into the lumen or intracellular neutralisation of viruses when bound to 
pIgR within the mucosal epithelia (Lamm, 1998). 
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The presence of SIgA (formed by B cells adjacent to salivary ducts and glands) in 
saliva has tended to be the mucosal immune marker of choice due to the ease of 
collection (Bishop and Gleeson, 2009; Gleeson, 2000; Korsrud and Brandtzaeg, 
1980; Sari-Sarraf et al., 2006). Most of the salivary fluid itself is formed by 3 pairs of 
major salivary glands (parotid, submandibular, sublingual) but production is 
supplemented by a vast amount of small submucosal glands that lie on and around 
the tissue (e.g. palate, tongue) within the oral cavity (Proctor and Carpenter, 2007). 
Although saliva drains from the acini (cluster of cells) of each of these glands into the 
mouth via striated and excretory ducts, the nature of the secretion differs whereby a 
serous (watery) fluid is produced by the parotid, mucous fluid by the submandibular 
and sero-mucous mixture by the sublingual (Aps and Martens, 2005). In 
unstimulated saliva secretion, the proportion of the fluid provided by parotid, 
submandibular, sublingual and the remaining submucosal glands are on average 
suggested to be 25%, 60%, 8% and 8% respectively (Dawes, 2008). 
In addition to the aforementioned transcytosis of SIgA into the mucosal secretion, 
saliva benefits from the import of several antimicrobial peptides (AMPs) that 
contribute to the first line of defence by providing innate defences compared to the 
specific nature of IgA (Bals, 2000). AMPs are categorised as being small cationic 
peptides (< 100 amino acids) that represent inducible, constituent factors of mucosal 
secretions (West et al., 2006). Although numerous AMPs require some form of 
enzymatic modification prior to their functional configuration, they act in synergy with 
other components of the innate immune system to prevent and aid clearance of 
infections (Bowdish et al., 2005; De Smet and Contreras 2005; Ibrahim et al., 2005; 
Radek and Gallo, 2007; Wakabayashi et al., 2003). Several AMPs can modulate 
other immune processes such as leukocyte cytokine secretion, chemotaxis and 
34 
 
remodelling of injured epithelia (Bowdish et al., 2005; Ganz, 2003; Tjabringa et al., 
2005).  
The most abundant AMPs in the secretions of the upper respiratory tract are 
lysozyme and lactoferrin (Singh et al., 2000). Lysozyme is a small protein (145 kDa) 
released into saliva by neutrophils, macrophages and the submucosal glands that 
possesses antibactericidal capacity through hydrolysing the polysaccharide of 
bacterial cell walls (Bosch et al., 2002; Fabian et al., 2012; Jolles and Jolles, 1984; 
Travis et al., 2001; West et al., 2006). The antimicrobial properties of the smaller 
molecule lactoferrin (80 kDa) from neutrophils and submucosal glands are due to its 
ability to bind free iron, depriving bacteria of this nutrient that is essential for growth 
and multiplication (Bowdish et al., 2005; Legrand et al., 2004; Ward et al., 2005). 
Although not an inhibitor of the main causative agent of URTI (rhinovirus), lactoferrin 
is considered to be effective against other common respiratory viruses (adenovirus, 
respiratory syncytial virus (West et al., 2006). 
There is a wide variety of other AMPs, most of which have been grouped into 3 main 
families; cathelicidins (e.g. LL37), defensins ( and  sub-families) and histatins 
(Bals, 2000). These are primarily released into the oral cavity by the epithelial cells, 
salivary glands, and/or neutrophils (De Smet and Contreras, 2005; Fabian et al., 
2012). The AMPs work synergistically in low concentrations to destabilise cell walls 
of microorganisms and provide a broad spectrum of activity against gram-positive 
and gram-negative bacteria (Bals, 2000). Other salivary proteins that contribute an 
important line of defence via the inhibition of adherence and growth of specific 
bacteria (e.g. Streptococcus) at the oral mucosa include -amylase (Scannapieco et 
al., 1994).  
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In addition to influx of invading microorganisms from the external environment, the 
human mouth has a constant microbial presence that needs to be regulated (Bender 
et al., 2006). Surfaces of the oral cavity are bathed with saliva, whereby the fluid is 
recognised to provide a ‘fingerprint’ of the vast range of the resident microorganisms 
(Boutaga et al., 2007; Dewhirst et al., 2010; Fabian et al., 2008; Li et al., 2005). 
Reduced salivary flow rate can directly impact on the oral microbiome by inducing a 
shift towards colonisation via pathogenic microorganisms (Meurman, 2012). Indeed, 
the entire surface of the respiratory tract is a source of commensal microorganisms 
which similar to exogenous antigens possess the ability to become pathogenic in the 
host (Bosch et al., 2013; Watson et al., 2006). AMPs not only play a crucial role in 
the protection against foreign pathogens but also act as a synergic arsenal of 
molecules that regulate the response to commensal bacteria (Boman, 1995). 
Therefore, the importance of AMPs is twofold; preventing disruption of the epithelial 
layer by acting as a critical first line of defence (biofilm) against pathogens and 
maintaining homeostasis of the commensal community that act to outcompete 
invading microorganisms (Blaser and Falkow, 2009; He et al., 2013a; Murphy et al., 
2009). 
The overlapping nature of these defences is highlighted when reduction in 
expressions of AMPs in in vitro models lead to changes in bacterial colonisation 
(Bals, 1999; Liu and Modlin, 2008). Subsequently, perturbations in the balance of the 
microbiota on the mucosal surface can lead to overgrowth and further amplification 
of microbes which may have direct effects locally (e.g. oral infection, URTI) or have 
indirect effects through predisposing respiratory illness with the many established 
interactions between microorganisms (bacteria-bacteria, virus-bacteria) (Blaser and 
Falkow, 2009; Bosch et al., 2013; Murphy et al., 2009; Meurman, 2012; Slots and 
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Genco, 1984). Such debilitating effects are likely to occur if the imbalance in 
microbiota occurred due to a lack of immune competence (e.g. decreased AMPs) 
(Bosch et al., 2013).   
The resistance of the microbiota within the upper respiratory tract to the immune 
perturbations associated with prolonged exercise is currently unclear. The most 
popular parameter of mucosal immunity that has been investigated in an acute 
exercise setting has been salivary SIgA due to the notion that individuals who suffer 
from IgA deficiency contract URTI regularly (Gleeson and Pyne, 2000). Physiological 
changes (e.g. nervous stimulation, dehydration) during exercise can influence the 
secretion of saliva and its protein components (Bishop and Gleeson, 2009; Walsh et 
al., 2004). The salivary glands are innervated by both the parasympathetic and 
sympathetic nervous system, with changes in stimulation of either of these having an 
influence on the volume, viscosity, protein and mucin concentration (Aps and 
Martens, 2005). Parasympathetic nervous stimulation via vasodilation of the salivary 
glands is believed to trigger a high volume of watery saliva, low in protein 
concentration (Bishop and Gleeson, 2009). On the other hand, sympathetic 
stimulation produces salivary secretions which are low in volume but high in protein 
that is primarily due to enhanced active transport of proteins from salivary cells 
(Proctor and Carpenter, 2007). Thus, similar to the other discussed immune 
parameters, salivary SIgA concentration is susceptible to effects (sympathetic and 
parasympathetic responses) of exercise intensity and duration (Walsh et al., 2011b).  
The following discussion will consider those studies which have used the most 
reproducible collection method, unstimulated whole saliva collection (also termed 
passive drool), due to the potential for stimulated saliva flow (e.g. chewing) and other 
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collection methods (e.g. swabs) to preferentially induce secretion from certain glands 
and/or influence saliva composition once secreted (Allgrove et al., 2013; Beltzer et 
al., 2010; Bishop and Gleeson, 2009; Granger et al., 2012; Harmon et al., 2007; 
Navazesh and Christensen, 1982; Navazesh, 1993; Proctor and Carpenter, 2001). 
Although there is inconsistency in study design within the literature to draw a 
definitive conclusion, Walsh et al. (2011b) suggested that SIgA concentration in 
saliva generally decreases (e.g. Nieman et al., 2002a; 2003; Palmer et al., 2003; 
Tomasi, et al., 1982) or remains unchanged (e.g. MacKinnon and Hooper, 1994;; 
Sari-Sarraf et al., 2006) following prolonged exercise (≥ 1.5 h at 50-75% maximum 
oxygen uptake, 
2OV
 max). It seems that the combination of high-intensity and 
exercise of a long duration has the most significant impact (i.e. depressive) on 
salivary SIgA concentration (Mackinnon, 1996; Nieman et al., 2002a). The 
discrepancies in the literature are also believed to be partly due to the way in which 
salivary SIgA concentration is expressed relative to the exercise-induced changes in 
physiological responses (Walsh et al., 2002). In an attempt to account for such 
changes, salivary SIgA concentration has been expressed as a secretion rate or 
relative to total salivary protein/albumin/osmolality (Gleeson, 2000), but this makes 
the comparison between studies difficult (Bishop and Gleeson, 2009). 
The secretion rate or expression relative to saliva osmolality are preferred over 
measures of SIgA as ratio to total protein (Blannin et al., 1998). One reason for this 
is that other salivary proteins (e.g. amylase) are known to increase with exercise 
without a change in SIgA (Walsh, 1999). Furthermore, expression as a secretion rate 
may better reflect the amount of available SIgA on the mucosal surface (MacKinnon 
et al., 1991). In contrast, it has been argued that salivary SIgA concentration is of 
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greater significance as secretion rate may only provide an explanation to how 
salivary flow rate has changed (Bishop and Gleeson, 2009). Having said that, 
salivary SIgA when expressed as a secretion rate has been found to be the best 
predictor of URI incidence in athletes following a 160 km race (Nieman et al., 2003) 
or during intense training and competitive phases (Fahlman and Engels, 2005). 
Additionally, given that the majority of saliva is water, expression relative to secretion 
rate also accounts for the concentrating effect of other salivary components following 
any dehydration (Bishop et al., 2000; Oliver et al., 2007). As saliva osmolality reflects 
the inorganic electrolyte concentration (rather than protein content) and hence falls in 
proportion with decreases in flow rate, SIgA:osmolality provides an alternative 
method (Bishop and Gleeson, 2009; Blannin et al., 1998). 
Although IgA is the dominant Ig in mucosal secretions, some have also attempted to 
identify changes in salivary IgG and IgM concentrations following exercise. Limited 
findings suggest IgG remains unchanged but IgM parallels decreases in salivary 
SIgA, highlighting the potential effects that acute strenuous exercise has on salivary 
immune parameters (Bishop and Gleeson, 2009; Gleeson and Pyne, 2000). Another 
aspect of mucosal immunity which has received little attention to date is the 
responses of AMPs to exercise (Walsh et al., 2011b). Despite the interest of the 
dentistry field in the role of AMPs in oral health and infection, (Dale et al., 2006; 
Putsep et al., 2002; Tanida et al., 2003; Tao et al., 2005), the relationship of AMPs 
with exercise-induced immune dysfunction is yet to be explored conclusively 
(Davison et al., 2009).  
To date, the few investigations that have been conducted suggest in accordance 
with other immunological measures, responses of AMPs may be dependent on the 
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intensity and duration of the exercise bout (Hoffman-Goetz and Pedersen, 1994). A 2 
h cycling bout at ~ 65% 
2OV
 max resulted in a significant decrease in salivary 
lysozyme (sLys) concentration, sLys secretion rate and sLys:osmolality which 
recovered  after 1 h of recovery (Davison and Diment, 2010). In contrast, 
expressions of other AMPs (LL37 and defensins: human neutrophil peptide 1-3) 
following similar stressors (2.5 h at ~ 60% 
2OV
 max) have been shown to significantly 
increase immediately post-exercise. In the recovery period (0-1.5 h post) following a 
50 km mountain trail race (mean running time  8 h) there was a significant decrease 
in salivary lactoferrin (sLac) concentration and non-significant decreases in sLac and 
sLys secretion rate (Gillum et al., 2013).  
The mechanism behind the effects of prolonged exercise on salivary parameters 
(AMPs, SIgA) remains unclear (Walsh et al., 2011b). The flow rate of saliva is 
considered to be the major source of variation in concentration of mucosal 
parameters (Gleeson and Pyne, 2000). In general, saliva flow rate decreases in 
response to a prolonged exercise bout (Bishop et al., 2000; Walsh et al., 1999). 
Decreases have been attributed to a withdrawal of parasympathetic stimulation 
rather than sympathetic-induced vasoconstriction of salivary glands (Bishop and 
Gleeson, 2009). Parasympathetic withdrawal associated with sensations of a dry 
mouth in response to other acute stressors (e.g. psychological) supports such 
proposals as does the lack of effect on saliva flow rate with interventions aimed to 
increase sympathetic stimulation (Bishop et al., 2006; Bosch et al., 2002)  
A crucial determinant of SIgA release into saliva is the presence of pIgR to permit 
transport across the epithelial layer (Bosch et al., 2002). Evidence from animal 
studies suggest that increased mobilisation of pIgR occurs only above a certain 
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threshold of increased sympathetic stimulation (Proctor et al., 2003). This may 
explain why a brief bout of high-intensity exercise leads to increases in salivary SIgA 
(e.g. Davison, 2011). However, this does not explain the decrease found with 
prolonged exercise bouts (Bishop and Gleeson, 2009). It has been speculated that 
this nervous stimulation over a longer period (i.e. prolonged exercise) may deplete 
the available IgA (Allgrove et al., 2008; Proctor et al., 2003) or there may be a further 
threshold (duration) where pIgR mobilisation is down-regulated (Walsh et al., 2011b). 
As brief bouts of maximal effort exercise results in increased sLac and sLys, it is 
reasonable to suggest that mobilisation of AMPs during exercise is also influenced 
by sympathetic stimulation in relation to certain thresholds (Allgrove et al., 2008; 
Usui et al., 2011; West et al., 2010). Alternatively, the reductions in sLys following 
prolonged exercise may be related to an increased stimulation of the HPA axis (West 
et al., 2010). However, investigations thus far have not found a cause-and-effect 
relationship, rather only reporting an association between increases in salivary 
cortisol and reduced sLys (Perera at al., 1997). It is worthy to note that the source of 
sLac and sLys (phagocytes, epithelial cells) is different to SIgA. Therefore, it is 
possible that increases in AMPs during high-intensity exercise may be as a result of 
the effects of hyperventilation (e.g. drying of the mucosal surfaces) given that some 
of these changes are lost or reduced when expressed relative to osmolality or as a 
secretion rate (Davison, 2011). Additionally, the exercise-induced damage to the 
epithelial layer could induce an inflammatory response whereby epithelial cells 
increase release of AMPs and other sources of production of AMPs are recruited 
(e.g. neutrophils) (West et al., 2010). The relative contribution of AMPs from each of 
these sources to saliva at both rest and following exercise is unclear. However, it is 
reasonable to suggest that an airway inflammatory response partly accounts for the 
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increases in AMPs identified immediately following prolonged exercise (Davison et 
al., 2009).  
Certain AMPs (defensins) have been suggested to make up 50% of the protein 
found in neutrophil azurophilic granules (Radek and Gallo, 2007). Muns (1994) 
demonstrated a significant (twofold) increase in the neutrophil count of mucosal 
secretions (nasal lavage fluid) following a prolonged exercise bout. Although 
neutrophils continually migrate into saliva from the circulation via gingival crevices 
(Bender et al., 2006; Lukac et al., 2003), the extent of neutrophila that occurs in the 
circulation following exercise may lead to the presence of neutrophils and their 
contents in saliva (e.g. AMPs) being substantially increased (Davison et al., 2009). 
Increased levels of AMPs (e.g. defensins) have been observed in other body fluids 
(e.g. plasma) following a circulating neutrophila (Shiomi et al., 1993). The variation in 
the responses of different AMPs to prolonged exercise (Davison et al., 2009; 
Davison and Diment, 2010), therefore, may be due to the changes in the maturity of 
circulating neutrophils (as expressions of AMPs can vary throughout the maturation 
of the neutrophil in the bone marrow) or decreases in some AMPs may merely reflect 
neutrophils undergoing a refractory period post-exercise (Borregard and Cowland, 
1997; Cowland et al., 1995; Gullberg et al., 1997; Nagaoka et al., 1997, 1998, 2000; 
Peake, 2002; Sorensen et al., 1997) .  
1.3.5 Exercise training and immune function 
Based on the evidence presented to date regarding acute prolonged exercise, it may 
be expected that the highly trained demonstrate lower immune function at rest 
compared to non-exercising controls. However, numerous cross-sectional studies in 
an attempt to discern such differences have found that when measures of immune 
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function are gathered in a ‘resting state’ (at least 24 h following the previous bout) 
there seems to be very little difference between athletes and controls (Gleeson, 
2007). A review of early investigations in the area (Nieman, 2000) suggested even 
when significant immune perturbations had been observed in athletes participating in 
strenuous exercise, investigators had limited success in identifying such measures 
that influence alteration in rates of URI (Gleeson et al., 1999; Mackinnon et al., 1991; 
Nieman et al., 1990b, 1998, 2000).    
Despite the large inter-individual variation in concentration of salivary SIgA, (Walsh 
et al., 2011b) some of the early work (salivary SIgA responses to training) reported 
lower concentrations in endurance athletes compared to sedentary counterparts 
(Tomasi et al., 1982). In contrast, most of the recent investigations support evidence 
of other parameters by showing salivary SIgA to be broadly similar in the two 
populations (Bishop and Gleeson, 2009; Gleeson and Pyne, 2000). Conversely, 
recent findings in elite rowers had 50-60% lower sLac concentration than controls at 
the start and mid-way through a 5 month training period (West et al., 2010), 
suggesting investigations of the mucosal immune compartment in a ‘resting state’ 
between these populations requires further attention. Inverse relationships between 
salivary SIgA concentration/secretion and URI incidence in some studies of athletes 
undergoing periods of intensive training (i.e. athletes not necessarily in ‘resting 
state’) (Fahlman and Engels, 2005; Gleeson et al., 1999; Neville et al., 2008) further 
supports the need for longitudinal research on mucosal immunity with large athletic 
populations (Nieman, 2001). The common observations of this mucosal parameter 
within intensive training studies represents a narrow range that have established a 
link between an immune measure and URI in athletes (Gleeson, 2007; Walsh et al., 
2011b).  
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Given the complexity of the immune system, it is unlikely that salivary SIgA alone 
would explain URI risk for all athletes, thus other factors in combination with the 
immune measure need to be determined (Nieman and Bishop, 2006). Investigators 
have begun attempts to address this by examining differences between illness prone 
and healthy athletes with early evidence suggesting that the blood obtained from the 
illness prone have greater ex vivo production of anti-inflammatory cytokines (e.g. IL-
4 and IL-10) in response to multiantigen challenge, indicative of a down regulation of 
cell-mediated immunity (Gleeson and Bishop, 2013; Gleeson et al., 2012b).  
Multifactorial mechanisms beyond salivary SIgA alone in URI incidence become 
more apparent when athletes intensify their training over a short period of time 
(Gleeson, 2007). Indeed, 1–3 weeks of intensified training has been shown to induce 
marked reductions in neutrophil and monocyte function, lymphocyte proliferation and 
the circulating number of T cells (Lancaster et al., 2003, 2004; Robson et al., 1999a; 
Verde et al., 1992). In addition to intensive experimental protocols, longitudinal 
monitoring over competitive seasons showed that team sports (rugby) and 
endurance athletes (cyclists) are sensitive to the intensive training periods with 
decreases in T cell counts, sLys, neutrophil oxidative burst and IL-2 production (Baj 
et al., 1994; Cunniffe et al., 2011).     
These findings suggest that there is a cumulative effect of repeated bouts of 
strenuous exercise due to an inadequate recovery time for the immune system 
(Papacosta and Gleeson, 2013). Furthermore, it may be that responses to acute 
prolonged exercise are more clinically relevant than resting immunity in athletes 
where the immediate recovery period represents the ‘open window’ when athletes 
are most vulnerable to infection (Abbasi et al., 2013; Nieman et al., 1990b, 1994; 
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Pedersen and Bruunsgaard, 1995). Despite the lack of clear difference in measures 
at rest, as athletes are exposed to more frequent acute bouts (‘open window’) of 
immunodepression, the overall risk may be considered greater than non-exercising 
controls. The presence of any other risk factors (e.g. dietary energy deficiency, sleep 
disturbance, psychological stress) will have additive effects on the transient 
immunoendocrine responses and increase the risk of illness following prolonged 
exercise (1.5 h at 55–75% 
2OV
 max), as seen in military studies (Gleeson, 2007). 
Although underlying causes of URI remain uncertain, decrements in performance as 
a result of URI have been reported (Pyne et al., 2001, 2005; Reid et al., 2004). The 
monitoring of the risk status of an athlete is paramount in order to determine the 
appropriate preventive or therapeutic interventions required during stages of 
strenuous training/competition (Pyne et al., 2000, 2001). 
1.4 Immunonutrition and bovine colostrum 
Numerous factors are known to influence the immune response and infection risk 
following prolonged/strenuous exercise (Walsh and Gleeson, 2013). Modulation of 
the immune response to prolonged exercise with nutrition is an active and ongoing 
area of research (Nieman and Bishop, 2006). Macronutrients play an integral role in 
immune cell metabolism and protein synthesis while micronutrients are important in 
immune cell replication and antioxidant defences (Bishop et al., 1999). It is well 
accepted that both macronutrient and micronutrient deficiencies impair immune 
function, the magnitude of which is determined by the severity or duration of the 
deficiency (Gleeson, 2006a). Such inadequate nutrient availability can have direct or 
indirect effects on the immune system (Gleeson and Bishop, 2000). Although 
correcting for a nutritional deficiency usually restores immune function and 
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resistance to infection (Calder and Kew, 2002), physiological stress placed on the 
immune system by exercise and/or presence of infection may require additional 
immunonutrition support (Calder and Jackson, 2000; Nieman, 2008). 
As important as direct effects of nutrients (e.g. fuel source for cells) are on immune 
activity, it is considered that most of the immune perturbations following prolonged 
exercise are mediated by indirect effects such as changes in immunoregulatory 
neuroendocrine hormones (e.g. adrenaline, cortisol, noradrenaline) that occur in 
response to low nutrient availability (e.g. low blood glucose) (Akerstorm and 
Pedersen, 2007; Gleeson et al., 2004). For this reason additional carbohydrate 
during prolonged exercise (which can maintain blood glucose) can reduce much of 
the physiological stress (stress hormone responses) placed on the immune system 
(Nieman and Bishop, 2006). Although prolonged exercise can also reduce circulating 
concentrations of certain amino acids and induce a state of oxidative stress, 
nutritional agents aimed to attenuate these responses (e.g. glutamine, vitamin C) 
have shown inconsistent effects in regards to limiting exercise-induced immune 
dysfunction, particularly if dietary intake is adequate (Hiscock and Pedersen, 2002 
Nieman et al., 1997a, 2002b). Indeed, with the exception of carbohydrate beverages, 
many immunonutrition support strategies during exercise have been shown to be 
ineffective (Gunzer et al., 2012).  
However, use of carbohydrate supplementation during exercise in some studies has 
also shown minimal effects on the exercise-induced dysfunction of innate (e.g. 
neutrophil degranulation, NKCA) or mucosal parameters of the immune system 
(salivary SIgA and AMPs) (Bishop et al., 2000; 2001a, 2001b; Nieman et al., 1997b; 
Walsh et al., 2011a). Therefore, it seems that carbohydrate feeding may act as a 
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partial countermeasure to exercise-induced immunodepression (e.g. cytokine 
release, leukocyte trafficking) (Nieman, 2008). This has led to suggestions that a 
cocktail strategy which combines carbohydrate with a mixture of advanced 
supplements will be more effective by targeting the diverse complexity of the immune 
system (Bakker et al., 2010; Nieman et al., 2009; Walsh et al., 2011a). Furthermore, 
there is an increased prevalence of undertaking some training in a low carbohydrate 
state for a proposed enhancement in adaptation from exercise bouts (Philp et al., 
2012). Although the efficacy of training in a low carbohydrate state is a whole other 
area (not for discussion here) with current debate on the effectiveness of this method 
in practice (i.e. to actually increase performance more), it is nonetheless becoming a 
more common practice for some athletes. It is essential that other nutritional 
strategies are sought to prevent the expected immune disturbance with such 
strategies (Bishop et al., 2001b; 2001c), particularly when athletes may also exercise 
later on in the day (Ronsen et al., 2001a, 2001b). It is also worthy to note that even 
with the ability of carbohydrate to attenuate the stress hormone response to 
prolonged exercise, there is limited evidence to suggest that these effects translate 
into a reduced incidence of URI (Gleeson et al., 2004; Nieman et al., 2002a). As 
such, it has been proposed that nutritional supplements which target the non-specific 
first line of defence (innate immunity) compared to the slower responding adaptive 
immune system may provide more effective sources of immunosurveillance and 
resistance to a wide range of pathogens (Walsh et al., 2011a) 
Bovine colostrum (COL) is the initial milk produced by a cow in the first few days 
following parturition. In addition to a different composition of macronutrients (higher 
percentage of protein, lower percentage of lactose and fat) compared to mature milk 
(Ontsouka et al., 2003) COL is richer in antimicrobial, growth and immune factors 
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(Uruakpa et al., 2002). In fact, the bioactivity of COL is at its greatest in the first 
milkings with the concentrations of such components decreasing over the 
subsequent days (Ginjala and Pakanen, 1998; Hagiwara et al., 2000; Korhonen et 
al., 2000; Mandalapu et al., 1995). The collection of COL closer to the first day of 
calving is not only essential for the calf but along with processing methods is a 
crucial determinant of quality of COL as a nutraceutical for other species (e.g. 
humans) (Shing et al., 2009a). It is proposed that the greater concentration of 
bioactive peptides (compared to other mechanisms in the neonate e.g. Ig) at this 
stage are the important modulatory components of COL for human immunity 
(Davison, 2013).    
For the newborn calf, the delivery of COL is crucial for provision of energy and 
growth factors for the development and maturation of the gastrointestinal tract 
(Blattler et al., 2001; Rawal et al., 2008). COL also manifests antioxidant properties 
(e.g. Vitamin A and E) that provide crucial protection for the calf against the sudden 
increase in oxygenation and hence oxidative stress in the external compared to 
intrauterine environment (Przybylska et al., 2007). Unlike humans, in utero antibody 
transfer during foetal life is limited (Coons et al., 2012). Therefore, the antimicrobial 
and immune components of COL play important roles in promoting resistance 
against pathogens and ensuring the survival and health of the newborn (Brinkworth 
and Buckley, 2003). Lactoferrin and lactoperoxidase are the dominant non-specific 
antibacterial and antiviral components of COL that protect the calf from numerous 
infectious microorganisms (Thapa, 2005; van Hooijdonk et al., 2000). Other 
components such as oligosaccharides and glycoconjugates are also important 
bioactive molecules that provide protection by inhibiting pathogen adhesion to 
epithelial surfaces (Gopal and Gill, 2000). However, it is the rich source of acquired 
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immunity (IgA, IgG and IgM) in COL that has a well-recognised role of laying the 
foundations for the neonate immune system through the non-selective 
macromolecular transport of passive immunity following birth (Korhonen et al., 2000).  
The accumulation of Ig in COL from maternal circulation occurs several weeks prior 
to parturition and thus reflects the antigen exposure of the mother (Gapper et al., 
2007; Kelly, 2003; van Hooijdonk et al., 2000). This has evolved into the use of 
selective inoculation of cows in order to raise specific Ig in COL which provides 
immunisation for the calf against certain enteric infections (Solomons, 2002). Such 
hyperimmune colostrum has also been investigated as a potential strategy for the 
prevention and treatment of gastrointestinal diseases in humans with beneficial 
effects reported against rotavirus, cryptosporidiosis and other opportunistic 
pathogens which prevail under situations of immune deficiency (e.g. HIV) (Floren et 
al., 2006; Hurley and Theil, 2011; Kelly, 2003).  
COL (i.e. non-hyper immune) still contains amounts of Ig which are up to a 100 times 
greater in concentration than mature milk that can aid in neutralisation or clearance 
of pathogens (Mach and Pahud, 1971). However, it has been suggested that 
collection needs to be refined to less than 6 h post-partum to possess IgG 
concentrations which offer optimal protection in other species (i.e. humans) (Gapper 
et al., 2007). For this reason, it has been suggested that the level of IgG (most 
abundant colostral Ig) is a determinant of COL quality (Gulliksen et al., 2008). 
 Investigations of the bioavailability of bioactive components in vivo following the oral 
digestion of COL in humans is an underexplored field whereby most studies to date 
have speculated on the effects on humans through activity of isolated peptides in 
vitro (Ross et al., 2013). However, the bioavailability of COL in the adult human 
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intestinal tract can be based on the few studies of milk protein digestion (Boutrou et 
al. 2013; Chabance et al., 1998; Mahe et al., 1991), which demonstrate that 
bioactive peptides can reach concentrations in the intestine that are likely to exert 
biological and/or synergistic activity locally or in the blood stream upon absorption 
(Boutrou et al. 2013). The casein fraction of milk protein precipitates within the 
stomach and leaves as degraded products resulting in a slower gastric transit time 
than the whey fraction (6 h vs. < 3 h) which is soluble in the stomach and proteins 
leave partially intact (Boutrou et al. 2013). Due to the presence of other immune 
regulating components (cytokines, growth factors) in COL which act as messengers 
within the human immune system, COL has been considered a ‘universal donor’ to 
humans (Pakkanen and Aalto, 1997). Indeed, although sharing a homologous 
composition, the concentrations of immune factors in COL are in vastly greater 
concentrations than human colostrum (Shing et al., 2009a). This has led to 
suggestions that COL could enhance human immune function and hence afford 
prophylaxis of infections at sites other than the gastrointestinal system, with the area 
of URI receiving much interest (Brinkworth and Buckley, 2003; Shing et al., 2009a).  
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1.4.1 Bovine colostrum and upper respiratory illness 
Historically, COL has been considered to have many purported benefits to humans 
(Thapa, 2005). This is largely due to its nutraceutical properties showing similarity in 
structure and function across species (Pandey et al., 2011). Prior to the antibiotic 
era, COL was used in the treatment of bacterial infections (Thapa, 2005). More 
recently, however, COL has been advocated as a nutritional supplement for children 
and adults to prevent, or treat, URI (summarised in Table 1.1). As shown in Table 
1.1, these studies have used a range of methods to report and/or monitor URI. For 
clarity, as none of these studies used serological analysis to identify a causative 
pathogen, all episodes defined within the studies will be considered as a URI. 
Brinkworth and Buckley (2003) were the first to investigate the effects of COL on URI 
in a double-blind placebo (PLA) controlled manner. This involved the retrospective 
analysis of log books of self-reported URI obtained from previous studies which 
investigated the effects of COL on physiological responses  in physically active 
males (Brinkworth and Scamell, 2000; Buckley et al., 2001, 2002). Following 
randomised allocation, it was shown that there was a significantly lower proportion of 
participants who reported URI episodes (32%) in the COL group (60 g∙day-1) 
compared to the PLA group (48%). This effect was observed when comparing both 
groups in the final 7 weeks of the supplementation period. The total duration of 
supplementation was 8 weeks but authors chose to analyse the first week of 
supplementation separately to avoid symptoms arising from illness prior to the start 
of study. There were no differences between groups (COL = 11%, PLA = 5%) in the 
proportion of participants who reported URI within this first week. Further 
investigation of participants who only reported URI episodes during the final 7 weeks 
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demonstrated no difference in mean number of episodes between COL (mean ± 
standard deviation, 1.2 ± 0.4) and PLA (1.1 ± 0.3). Additionally, there was no 
difference in the duration of URI episodes between groups. A limitation of this study 
was the lack of data from the individual studies. These studies included participants 
who were involved in endurance and resistance training, hence it is difficult to 
ascertain whether the effects of COL on URI are universal or more apparent in those 
who partake in endurance exercise (i.e. experience the most immunodepression). 
Nevertheless, these findings suggest a role of COL supplementation in reducing the 
proportion of human participants reporting URI. The lack of effect of COL on the 
mean number of episodes in those who did report URI was not surprising given the 
short duration of the intervention.  
Crooks et al. (2006) followed this with a prospective investigation of the effects of 
COL on URI in a homogenous sample (distance runners). Although there was a 
lower mean number of URI days (5) in a group who received 12 weeks of COL 
supplementation (10 g∙day-1) compared to PLA group (8), this difference was not 
significant. Additionally, there was no difference between the mean number of URI 
episodes in the groups. Such findings did not support Brinkworth and Buckley 
(2003), however, this could be explained with the six fold difference in dose of COL 
and hence potential bioactive components. When Shing et al. (2007) investigated a 
shorter duration (8 weeks) but similar daily dosage (10 g∙day-1) of COL in highly 
trained cyclists there was a trend for a lower number of reported URI (using the 
validated Wisconsin Upper Respiratory Symptom Survey) compared to the PLA 
group during periods of high-intensity training. Recently, Shing et al. (2013) also 
investigated the effects of 10 g∙day-1 of COL for 8 weeks prior to and during a 5 day 
competitive cycle race on susceptibility to URI. There were tendencies for a lower 
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number of reports and days of URI in the COL group compared to PLA, where it was 
suggested that the statistical significance of such outcomes may have been limited 
by the small sample size of the pilot study. In another cohort of endurance athletes 
who may be considered most at risk of URI due to intensive training (elite 
swimmers), Crooks et al. (2010) found trends for a lower proportion of participants 
reporting URI in a COL group (10 weeks supplementation of 20 g.day-1) and lower 
number of URI days in these participants than PLA swimmers. There were no 
differences in URI between a non-exercising COL and PLA groups. 
Such evidence may suggest that the effects of COL on URI become more apparent 
when there is a greater scope for intervention (i.e. periods of immunodepression). 
Although the study of Crooks et al. (2006) would not support this hypothesis, it would 
provide an explanation behind the efficacy of COL intervention studies involving IgA 
deficient children (Patiroglu and Kondolot, 2013) or children who suffer from 
recurrent infections (Patel and Rana, 2006). Patel and Rana (2006) found that a 
daily dose of 3 g of COL reduced the number of URI episodes at 4 weeks (73%), 8 
weeks (83%) and 12 weeks (91%) supplementation compared to baseline (6 months 
prior to enrolment for study). Compared to baseline there were also significant 
reductions in the number of children who reported URI at 4 weeks (21%), 8 weeks 
(36%), and 12 weeks (64%) following COL supplementation. 
The study of Patel and Rana (2006), however, was confounded by a number of 
limitations. As noted by Menon et al. (2010), the baseline URI data should have been 
based on the mean reports at monthly intervals not the whole 6 months prior to 
enrolment to the study. The comparisons completed in this study provides an 
inaccurate and biased interpretation of the effects of COL as monthly episodes of 
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URI would likely be lower than the incidence in a 6 month period, particularly in a 
cohort of children who suffer from recurrent infections. Although the study states a 
high involvement of paediatricians within the study, there is no detail on how URI 
episodes were diagnosed. The study reports that the number of episodes was 
assessed at the end of each 4 weeks with no indication of daily reporting of 
symptoms which significantly undermines the validity of the data. This is highlighted 
further by the lack of PLA controlled comparison and open label design of this study 
given that this cohort would require interpretation from others (i.e. parents) prior to 
observation by the paediatrician.  
In a separate cohort of immune-deficient children, Patiroglu and Kondolot (2013) 
randomly allocated 1 week of COL (3 sucking tablets daily, each containing 14 mg 
COL and 2.2 mg of lysozyme) or PLA (sucking tablet prepared as ‘candy’) treatment 
upon presentation of symptoms in the upper respiratory tract at the hospital. 
Although there were no differences in duration of symptoms, there was a significantly 
lower severity of illness in the COL group. However, this study is confounded by 
symptom severity being reported by the mothers of the children and that COL tablets 
also contained lysozyme which alone could be suggested to have a preventive effect 
on symptoms. 
In addition, to the above mentioned specific effects of COL on URI, it is worthy to 
note that that COL has been shown to have prophylactic effect against influenza in 
both healthy participants and high-risk cardiovascular patients (Cesarone et al., 
2007). Although it was not clear how participants were blinded or allocated into 
groups, the comparison of healthy participants included a COL group (8 weeks of a 
daily 400 mg dose as a chewable tablet), COL and influenza vaccination (8 weeks of 
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a daily 400 mg dose within 2 weeks of vaccination), vaccination or a control group 
(receiving no vaccination or COL). It was found that within the 8 week 
supplementation period and in the 4 weeks following all interventions, both COL 
groups suffered fewer episodes of influenza. The COL groups were comparable in 
terms of influenza episodes, suggesting no additive effect of vaccination. This 
intervention was followed up in the second part of the study with high risk 
cardiovascular patients. Given the health status of these patients, investigators 
deemed it was not plausible to have a group who had no prophylaxis (i.e. no control 
group). Nevertheless, in this cohort it was again demonstrated that the group who 
received vaccination only had significantly greater number of influenza related 
complications than both COL groups. 
The findings of Cesarone et al. (2007) along with those summarised in Table 1.1, 
suggest that there is a role for COL in preventing URI. The evidence to date, 
however, is based on a number of studies which have examined a range of 
supplementation periods (duration and dosage), populations (children and adults) 
and study design (lacking PLA groups or use of similar URI monitoring). It is 
reasonable to suggest, however, that the effects of COL are more pronounced in 
those populations who are in a state of immune deficiency or suffer from greater 
periods of transient exercise-induced immune dysfunction. It can therefore be 
hypothesised that COL may contribute as a source of additional immune 
components in these situations and/or stimulate host immunity. For this reason, 
numerous investigators (some already mentioned above) have attempted to identify 
whether COL and/or its components influence human immune function (Jensen et 
al., 2012). 
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Table 1.1 Summary of studies that have examined the effect of COL on URI 
 CON- control; DB – double blind; NC; non-comparative; OL- open label; P – pilot study, PC – placebo controlled; R- randomised;   
Reference Design Population Supplementation URI monitoring URI criteria Findings 
Brinkworth and 
Buckley, 2003 
DB, 
PC, R 
174 Physically active 
males aged 18-35 
years 
8 weeks of 60 g.day
-1
 of 
concentrated COL (n = 93) or 
whey protein (n =  81) 
Daily self-reports of 
symptoms  
Coded on criteria of Centre 
for Disease control; URI:  2 
consecutive days of coded 
cold/flu symptoms 
Lower proportion of participants reported 
URI in COL over the 8 weeks (p < 0.05).  
No difference in number of and duration of 
episodes (p> 0.05). 
Crooks et al., 
2006 
DB, 
PC, R 
35 distance runners 
(15 females, 20 
males) aged 35-58 
years 
12 weeks of 12 g.day
-1
 COL (n = 
18) compared to  
isomacronutrient skimmed milk 
(n = 17)   
Daily self-reports of 
symptoms  
2 consecutive days of 
cold/flu symptoms 
No difference in mean number of URI 
episodes (p > 0.05). 
No effect on total number of URI days (p > 
0.05). 
Patel and Rana, 
2006 
OL, NC 551 children aged  1-8 
years with recurrent 
URTI (> 6 episodes in 
previous 6 months) 
12 weeks of 3  g.day
-1
 of COL  Follow up with 
Paediatrician at end of 
each 4 weeks 
Not specified Lower number of URI episodes and patients 
reporting URTI at 4 weeks, 8 weeks and 12 
weeks compared to baseline (previous 6 
months) in all age groups (p < 0.05). 
Shing et al., 2007 DB, 
PC, R 
29 highly trained 
cyclists 
8 weeks of 10 g.day-
1
 of 
concentrated COL (n = 14) or 
whey protein (n =  15)  
Daily self-reports of 
symptoms (Wisconsin 
Upper Respiratory 
Symptom Survey) 
 2 upper respiratory 
symptoms 
Trend for lower number of self-reported 
illnesses in COL group (p = 0.06) 
No difference in duration of illness (p > 0.05) 
Crooks et al., 
2010 
DB, 
PC, R 
25 (12 male, 13 
female) elite 
swimmers, 28 aged-
matched non-
exercising CON  
10 weeks of 20 g.day
-1
 of low 
protein COL (12 swimmers, 16 
CON) or isomacronutrient 
skimmed milk (13 swimmers, 12 
CON)
1
 
Daily self-reports of 
symptoms 
2 consecutive days of 
cold/flu symptoms 
Trend for lower mean number of URI days 
reported per participant in COL swimmers 
compared to PLA swimmers (p = 0.08). 
Trend for lower proportion of subjects 
reporting URI in COL group weeks 1-4 (p = 
0.06). 
No difference between COL and PLA CON 
(p > 0.05.) 
Patiroglu and 
Kondolot, 2013 
DB, 
PC, R 
31 (18 male, 13 
female) IgA-deficient 
children aged 5-17 
years with acute 
respiratory symptoms 
1 week, 3 sucking tablets daily 
of COL(14 mg and 2.2mg 
lysozyme) (n = 16) or matched 
PLA (n = 15) tablet (not 
specified)  
Daily 10-point symptom 
severity scale completed 
by Mother 
Diagnosis of URI by 
paediatrician for study 
inclusion;  Daily 10-point 
symptom severity scale 
completed by Mother 
Lower severity score after COL (p < 0.05). 
No difference in duration of symptoms (p > 
0.05). 
Shing et al., 2013 DB, 
PC, R, 
P 
16 highly trained 
cyclists 
8 weeks and 5 days of 10 g.day-
1
 of concentrated COL  (n = 8) or 
whey protein (n =  8) 
Daily self-reports of 
symptoms (Wisconsin 
Upper Respiratory 
Symptom Survey) 
 2 upper respiratory 
symptoms 
Mean number of URI days tended (non-
significant, p > 0.05) to be higher in PLA 
group.  
No difference in number of reports URI 
(COL = 2 versus PLA = 4, p > 0.05). 
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1.4.2 Bovine colostrum and cellular innate immunity 
The use of COL as a nutraceutical is an expanding niche (Severin and Wenshui, 
2005), with research being performed on whole COL, and on isolated COL 
compounds (e.g. whey, casein, lower molecular weight fractions) (Jensen et al., 
2012). Although the composition of COL will rapidly change over the first few days of 
lactation, many animal studies have shown that many of its components act in an 
adjuvant manner on the immune system in a range of species (Pandey et al., 2011). 
Even though findings from animal models can be considered to have questionable 
relevance and transferability to humans (Vukmanovic-Stejic et al., 2006), it is worthy 
to note that they have played an important role in directing investigations of COL 
within human in vitro culture (Table 1.2). Due to the importance of innate immunity in 
resisting infection of the mammary gland of dairy cows in the periparturient period 
(Roth et al., 2001), in vitro studies have investigated how COL may affect capacity of 
innate cells. As impaired neutrophil function of the cow is common during this period 
and COL contains a vast amount of cytokines which regulate neutrophil function it is 
a prudent area of research (Dosogne et al., 1999; Kerhli et al., 1989).  
In vitro treatment of PMN cells (i.e. neutrophils) obtained from cattle with COL or milk 
components shows improvement in chemotaxis, phagocytosis and killing capacity 
(Roth et al., 2001; Sugisawa et al., 2001, 2002, 2003). Such evidence may suggest 
that the exposure of neutrophils to priming cytokines such as IL-1, IL-6 and 
TNFwithin COL amplifies the response to subsequent activation in vitro (Goto et 
al., 1997; Hagiwara et al., 2000; Sugisawa et al., 2002). Although the effect of 
priming depends on the agent responsible it may involve increased 
expression/affinity of surface receptors, modulation of secondary messengers (e.g. 
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calcium) or mobilisation of intracellular components (e.g. NADPH complex) (Atkinson 
et al., 1988a, 1988b; Peake, 2002, Rusu et al., 2009; Tennenberg and Solomkin, 
1990). However, such hypothesis may be upheld by these priming effects of COL 
also being observed with investigations of bovine milk (lower concentrations of 
cytokines) (Sugisawa et al., 2002). As the greater concentrations of COL (50%) 
incubated with PMN cells inhibited rather than promoted oxidative burst responses in 
the study of Sugisawa et al. (2002), it was suggested that within in vitro culture the 
antioxidant activity of COL may mask the priming activity. Dose dependent increases 
of PMN phagocytosis have only been apparent up to a pre-treatment of 25% COL 
concentration when compared to milk and bovine serum (Sugisawa et al., 2001). 
Similar to IgG levels the greatest promotion of phagocytosis was observed in COL 
obtained immediately after parturition with such activity declining in COL obtained at 
a later date but at a slower rate than IgG levels. Sugisawa et al. (2002) suggested 
that the enhancement of neutrophil functions were due to priming of responses 
rather than an opsonisation mechanism as there was no enhancement of oxidative 
burst when Staphylococcus aureus was opsonised by COL.   
Sugisawa et al. (2003) further investigated by fractionating both COL and bovine milk 
and exposed neutrophils from cows to identify any differences in oxidative burst 
activity. In vitro culture demonstrated that only a low molecular weight fraction (< 10 
kDa) of COL and milk had a priming effect on oxidative burst activity to neutrophil 
activation by Staphylococcus aureus. It was suggested that that beneficial effects on 
neutrophil function may not be related to the previously mentioned pro-inflammatory 
cytokines where all (except for IL-8) have molecular weights between 10-30 kDa 
(Cerretti et al., 1986; Cludts et al., 1993; Ebrahimi et al., 1995; Maliszewski et al., 
1988; Swain et al., 2002), but smaller constituents (< 10 kDa) of COL that are not 
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well understood (e.g. proteose peptones) (Merin et al., 2001; Sugisawa et al., 2003). 
Of interest, given that COL was diluted 10 fold compared to bovine milk, these 
constituents like many other bioactive peptides are present in greater quantity in 
COL (as reported by Sugisawa et al. (2001)). The priming effect of this low molecular 
weight fraction of COL was deactivated by heat exposure and not effective prior to 
activation with all subsequent neutrophil activation agonists (e.g. PMA). 
The priming effects of bovine derived products on neutrophil function have also been 
demonstrated with human in vitro cell culture studies (Rusu et al., 2009, 2010). 
Compared to a control medium, prior incubation with bovine whey protein extract 
was shown to significantly amplify chemotactic and phagocytic responses, 
generation of superoxide ions and release of primary granules content of neutrophils 
upon stimulation by fMLP (Rusu et al., 2009). This study suggested that priming 
effects occurred through the components, -lactogloulin and -lactalbumin of whey 
protein extract. The relevance of these priming agents to those reported with COL in 
animal culture is unclear, but does suggest that COL and bovine milk may play a role 
in promoting innate immunity in humans.  In addition to the ability of whey protein 
extracts to induce intracellular signalling within neutrophils and translocation of the 
NADPH-oxidase subunits (e.g. p47phox) to the plasma membrane, it was also 
shown to induce neutrophil cytokine production (e.g. IL-1 receptor agonist) similar to 
other priming agents (e.g. GM-CSF) (Malyak et al., 1994; Roberge et al., 1994; Rusu 
et al., 2010). Direct effects on production of other cytokines (IL-8, IL-6, TNF) by 
neutrophils was also observed. 
The ability of COL in particular to modulate cytokine production has also been shown 
in other cell subsets of the immune system. Increasing concentrations of COL, in 
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vitro, have been shown to modulate cytokine production in PBMC from resting 
healthy humans, including: increased IFN , IL-10 and IL-2 production and 
decreased TNF production in unstimulated samples; decreased TNF and IL-4 
production in LPS-stimulated samples; and increased IL-10 production and 
decreased IFN , TNF and IL-4 production in PHA-stimulated samples (Shing et al., 
2009b). Although some of these findings suggest an anti-inflammatory profile, 
following 24 h incubation of PBMC with COL, only IFN and IL-2 remained elevated, 
indicative of a Th1 cytokine profile. 
Effects on PBMC in an unstimulated state (e.g. increase IL-2 production) may 
provide an explanation to the increase in CD4+ T cell counts found in 
immunosupressed patients following a period of COL supplementation (Floren et al., 
2006). However, as there was no comparable PLA group of immunosupressed 
patients in this study, the effects observed are similar to those seen with other 
micronutrient supplementation (Evans et al., 2013) which may suggest that 
addressing the poor nutritional status associated with the infection of these patients 
is the important contributing factor. Nevertheless, the findings of Shing et al. (2009b) 
do propose a role for COL in modulation of cytokine production with particular 
dominance of a Th1 cytokine profile. However, this may depend on the stimulus as 
COL did inhibit T cell proliferation following induction by mitogens (e.g. PHA).This 
supports the differential effects of COL observed by Biswas et al. (2007) who 
demonstrated that COL had a slight (non-significant) inhibition of PMBC proliferation 
but showed a dose-dependent increase in IL-12 which promotes a Th1 profile during 
antigen challenge. Although COL enhanced IFN production under weak antigenic 
stimulation, it inhibited IFN  with strong antigenic stimulation (Biswas et al., 2007).  
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This biphasic mechanism of COL was also observed in Jenny et al. (2010) where a 
Th1 immune response was promoted in unstimulated PBMC but suppressed in 
mitogen-stimulated PBMC. Furthermore, in a culture of peripheral blood leukocytes 
obtained following 6 weeks of COL or PLA supplementation, it was found that the 
COL group had a substantially lower mitogen (concanavalin A)-induced IFN 
production (Appukutty et al., 2011). These inhibitory effects on aspects of T cell 
proliferation may be supported by a preliminary in vivo investigation suggesting that 
a topical ointment containing COL may alleviate skin lesions of patients suffering 
from conditions (atopic dermatitis, psoriasis) which are characterised by dermal 
infiltration of T cells (Pedersen and Hidayat, 2010).  
Wolvers et al. (2006) reported no effects of 6 weeks of COL supplementation on 
mitogen-induced lymphocyte proliferation or DTH response to the CMI Multitest ®  
containing six previously encountered antigens (Tetanus, Diptheria, Streptococcus 
group C, Candida albicans, Trichophyton mentagrophytes, Proteus mirablis). 
Although not all data were shown, this study also suggested no effect of COL on 
granulocyte phagocytosis and oxidative burst. The lack of effect on granulocyte 
function are not in accordance with in vitro studies (Sugisawa et al., 2001, 2002, 
2003) but this could be explained by the low daily dose given to participants (1.2 g) 
which may have been an insufficient dosage for the accumulation of bioactive 
peptides suggested to affect innate immunity.  
Despite previously mentioned benefits towards reduction of URI with low doses of 
COL (e.g. Cesarone et al., 2007), the majority of these studies have included 
participants with underlying immune dysfunction which potentially would acquire 
greater benefits from COL rather than the healthy cohort of Wolvers et al. (2006). It 
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is reasonable to suggest that for the priming/immune enhancing effects on innate 
immune cells to take hold systemically, in healthy individuals, the COL must be of a 
sufficient dose to augment the bioavailability of COL or the effects may be localised 
to the sites with greatest exposure to the bioactive peptides. 
1.4.3 Bovine colostrum and mucosal immunity 
COL is a precursor for vast amounts of potentially bioactive peptides that are 
embedded within the intact structure (Clare and Swaisgood, 2000; Pihlanto and 
Korhonen, 2003). Although some proteins can pass intact through the neonatal 
intestine (e.g. Ig) and offer vital protection against pathogens, protease digestion of 
other proteins leads to peptides becoming bioavailable to have localised effects 
within the intestinal environment and passage through the GI tract (Jorgensen et al., 
2010). 
Most of the studies of GALT and COL have involved the use of animal tissue but 
these may shed light on the potential in vivo mechanisms within humans. Yoshioka 
et al. (2005) demonstrated that T cells (intestinal intraepithelial lymphocytes) of mice 
following 6 weeks COL supplementation were polarised to the Th1 type. The 
reported effects of COL in the GALT were deemed to be direct on the T cells as 
there were no changes in fecal SIgA or intestinal microflora. Direct effects of COL 
were also observed in a culture of murine PP cells where there were significant 
increases in IL-12 and IFN  (type 1 cytokines) in a dose-dependent manner (Uchida 
et al., 2011). Similar dose dependent effects of COL were shown within NKCA of PP 
cells (in the same study) whereby a group of mice who received 400 mg∙g-1body 
mass (BM) (6 doses per week for 3 weeks) were not different to a control group but 
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there was a significantly higher NKCA in mice who received a higher dose of COL 
(2000 mg∙g-1BM). This pattern was replicated in both splenocytes and lung cells.  
As the in vitro effects of COL on IL-12 and IFN  were not present in serum following 
COL supplementation but there were direct effects in vitro on IFN production in 
lung cells, it was suggested that augmentation of NKCA in the lungs was due to NK 
cells activated in PPs (by COL), homing to the spleen and lungs. Such mechanism 
remains unclear as other investigations involving immunosuppressed mice have 
shown direct pleiotropic effects on splenocyte cytokine production, with COL 
supplementation enhancing IL-2, IFN , GM-CSF (Wan et al., 2010). Nevertheless, 
the COL group (2000 mg∙g-1BM) in Uchida et al. (2011) showed a lower accumulated 
symptom rate compared to the PLA group when mice were nasally infected with 
influenza at the end of the supplementation period. This infection method involved 
spreading the virus from the nasal cavity to the lower respiratory tract. The above 
mentioned transfer of innate immunity from intestinal tract to the respiratory tract was 
advocated to have triggered the amelioration of infection by COL. 
Further investigations conducted by Benson et al. (2012) support the hypothesis of 
local protection at mucosal sites with COL. It was shown that mice that underwent 
treatment (0.5 and 5.0 mg) with a lactose-reduced, low Ig extract of COL (CLMWF) 
30 min prior and 4 h following intranasal Streptococcus infection had a lower 
bacterial load in the lungs compared to a control group. Additionally, in mice treated 
with similar doses of CLMWF at 24 h and 1 h prior to intranasal influenza infection, 
CLMWF groups had significantly lower viral loads in the lung than a control group. 
Both of these infection models involved intranasal and oral treatment with CLMWF, 
with oral treatment showing the greatest antibacterial and antiviral activity.  
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Benson et al. (2012) and a companion paper (Jensen et al., 2012), suggest that 
these effects were likely due to a combination of cellular events that occur at 
mucosal sites following CLMWF. Benson et al. (2012) found that human PMN cells 
(rather than murine) treated in vitro with CLMWF compared to non-treatment 
resulted in a greater phagocytosis and chemotaxis in response to fMLP. Jensen et 
al. (2012) observed an increase in phagocytic activity from baseline in human PMN 
obtained at 1 h and 2 h following consumption of CLMWF (150 mg) compared to 
PLA, ran in a counterbalanced fashion (Jensen et al., 2012). 
In vitro culture of PBMC cells also involved treatment with COL where it was shown 
that expression of CD69 was increased by CLMWF and CD25 by COL with these 
changes being associated with increased cytotoxic activity and proliferation 
respectively (Benson et al., 2012). Cell surface expression for both CD69 and CD25 
was also significantly increased in T cells by CLMWF but not COL. The translation of 
such effects on human cells to the animal infection models completed in the same 
studies is difficult but as these studies involved a COL derived product lacking Ig it 
does suggest the need for studies to investigate whether acute exposure to COL 
triggers immune priming or enhancing events at local mucosa which may also result 
in systemic effects. 
As there is a major involvement of Igs at all mucosal surfaces, much interest in the 
effects of COL have been devoted to Ig. Similar to influenza immunisation (Cesarone 
et al., 2007), humans who were exposed to an oral Salmonella vaccine (which 
mimics enteropathogenic infection) during COL supplementation (100 ml∙day-1) 
showed trends for a greater production of specific IgA (He et al., 2001). Igs are 
essential mediators of humoral and mucosal immunity but even with the high 
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endogenous levels of IgG within COL, investigators have failed to see changes in 
resting circulating levels of IgG or other analogues (IgA, IgE, IgM) in humans 
following supplementation (Mero et al., 1997, 2002; Shing et al., 2007) which is likely 
due to the digestion of such components (Davison, 2013).  
Given the potential for COL to promote the integrity of the human epithelium (He et 
al., 2001) and its ability to stimulate GALT in animal models, it would be expected to 
see benefits on mucosal Ig. As IgA is the most predominant mucosal Ig, most 
investigators have focused on this parameter (Table 1.3). These have primarily 
involved an assessment of SIgA in saliva due to the non-invasive nature of sample 
collection and as production here may be influenced by stimulation of other MALT 
(PP and tonsils) (Brandtzaeg et al., 1999; Crooks et al., 2006) (summarised in Table 
1.3). 
COL is a source of transforming growth factor (TGFconsidered to play a role in 
mucosal biosynthesis and secretion of IgA (Chen et al., 1990). Mero et al. (1997) 
found no changes in IgA concentrations in saliva following 8 days of 25 ml or 125 ml 
COL supplementation compared to PLA. However, when the COL supplementation 
period is increased (2 weeks) and the dosage is split across the day (4 × 5 g), Mero 
et al. (2002) found a 33% increase in resting salivary IgA concentration. These 
findings were confounded with limitations such as the use of a PLA which did not 
have similar macronutrient content (maltodextrin) and lack of detail in analytic 
procedures. The methodology is particularly important given that COL contains IgA 
of bovine origin so analysis of saliva for changes in IgA should be controlled for the 
human form of Ig. However, in comparison to an isomacronutrient PLA, Crooks et al. 
(2006) also observed significant increases (79%) in median resting salivary IgA 
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concentrations from baseline to 12 weeks of COL (12 g∙day-1) supplementation in a 
group of distance runners. Although this result was of statistical significance, 
investigators did stress that interpretation should be met with caution due to the large 
variability in IgA levels. 
Only one further study of active young adolescents has shown beneficial effects of 
COL supplementation on resting salivary IgA concentration (Appukutty et al., 2010) 
whereas many other studies involving exercising (elite swimmers; highly trained 
cyclists, recreationally active) and non-exercising cohorts have not been able to 
replicate such findings (Crooks et al., 2010; Davison and Diment, 2010; Patiroglu 
and Kondolot, 2013; Shing et al., 2007, 2013). Such evidence does suggest that the 
lack of universal effect of COL on salivary IgA may be due to methods of IgA 
determination or  the variance in dosage and supplementation duration with splitting 
the dose across the day or longer periods of supplementation (> 4 weeks) being 
most effective (Davison and Diment 2010; Shing et al., 2009a). 
In the one study which has investigated other salivary immune parameters, it also 
found no benefit in resting sLys concentration following 4 weeks of COL 
supplementation (Davison and Diment, 2010). Given the role of mucosal immunity in 
conferring defence against respiratory pathogens, it may therefore be expected to 
see benefits to both URI and mucosal immunity (e.g. IgA) when both are measured 
simultaneously. To date, however, when benefits to URI incidence have been shown 
there has been no concurrent increase in resting salivary IgA or vice versa (Crooks 
et al., 2006; 2010; Patiroglu and Kondolot; Shing et al., 2007). This supports 
proposals that the effect of COL may occur through other or a combination of 
mechanisms (Shing et al., 2007).  
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One other reported indirect mechanism of COL on the immune system yet to be 
discussed is the ability of COL to maintain intestinal integrity as found in a recent 
PLA controlled, counterbalanced, crossover investigation (Marchbank et al., 2011). 
Following a strenuous exercise protocol which triggered a rise in core temperature of 
1.5 - 2°C, intestinal permeability within the PLA group increased 2.5 fold whereas 
this rise was truncated 80% by prior COL supplementation (2 weeks of 20 g∙day-1). 
An in vitro investigation ran in conjunction suggested that the in vivo effects may be 
attributable to growth factors present in COL (e.g. epidermal growth factor) which 
mediate apoptosis and induction of proteins (e.g. heat shock  proteins) that provide 
cellular protection against environmental stressors. Therefore, COL may also act by 
preventing additional stressors on the immune system that are induced by an 
increase in intestinal permeability such as the translocation of luminal bacteria into 
the systemic circulation following strenuous exercise. Based on the above evidence 
it may be suggested that the benefits and mechanisms of COL as a nutritional aid to 
enhance human immune function and resist infection may be more apparent in the 
recovery from an acute stressor (e.g. exercise) that induces perturbations in both  
cell-mediated and mucosal immunity rather than effects on resting immune function. 
This may have important implications towards the hypothesis that acute windows of 
immunodepression rather than resting immunity provide the overall greater risk of 
URI in athletes. 
.
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Table 1.2 Summary of studies that have examined the effects of COL or bovine milk derived components on PMN cells in vitro. 
Reference Origin of PMN COL/milk preparation Exposure to COL/milk Stimulants tested Findings 
Sugiasawa et al., 
2001 
Bovine 0.1% - 50% COL 
concentrations 
30 min  Fluroesbrite Carboxylate 
Microspheres (latex beads)  
Dose dependent  in phagocytosis with COL which peaked at 25% 
concentration and conditions of 37C. 
Phagocytic activity with 25% COL greater than both milk and 
serum (p < 0.01). 
Phagocytosis promoting effect decreased gradually in COL 
obtained from 0 h to 12, 24 and 48 post-parturition.  
Sugisawa et al., 
2002 
Bovine 0.1% - 50% COL 
concentrations 
1-10 min Staphylococcus aureus 
PMA  
 in oxidative burst to Staphylococcus aureus with 0.1% COL 
concentration (p < 0.05). 
 in oxidative burst with COL was greater with Staphylococcus 
aureus than PMA stimulation in comparison to control. 
Effect of COL on oxidative burst not dependent on pre-incubation 
time. 
Enhancement of oxidative burst not triggered by opsonisation with 
COL. 
Sugisawa et al., 
2003 
Bovine Range of molecular 
weight fractions of10 
fold diluted COL  
30 min for all fractions 
(findings displayed for 10 
min)  
Staphylococcus aureus 
PMA 
Only low molecular weight fraction of COL (<10 KDa) enhanced 
oxidative burst (p < 0.05). 
Low molecular weight fraction primed response to Staphylococcus 
aureus (p < 0.05) but not PMA. 
Priming of oxidative burst lost in heat exposure (≥ 60°C). 
Rusu et al., 2009 Human Whey protein extract 24 h for all measures  Zymosan A 
fMLP 
Compared to control medium dose dependent  (compared to 
untreated PMN cells) with COL in the chemotactic, phagocytic, 
oxidative burst and degranulaton response to fMLP (p < 0.05). 
 translocation of NADPH-oxidase subunits to plasma membrane 
of neutrophils with WPE.     
Benson et al., 
2012 
Human Low molecular weight 
fraction of COL 
(0.001-1 gL-1) 
2 min for phagocytosis 
18 h for chemotaxis 
Carboxylated fluroospheres 
fMLP 
 in PMN cells engaged in phagocytosis (p < 0.001) and 
phagocytic activity (p < 0.05) of these cells compared to cells 
untreated and pre-exposed to fMLP and LPS. 
Dose dependent  (compared to untreated PMN cells) with COL  
in migration towards fMLP (p < 0.05). 
Jensen et al., 
2012 
Human Low molecular weight 
fraction of COL (150) 
Blood drawn 1 h and  2 h 
following intake  of COL 
and PLA (white rice flour) 
Not specified  in phagocytic activity from baseline to 2 h post COL 
consumption, trend at 1h (p = 0.08), significant at 2 h (p < 0.05). 
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Table 1.3 Summary of studies that have examined the effect of COL on salivary IgA 
C – crossover; DB – double blind; P - pilot study; PC – placebo controlled; R- randomised
Reference Design Population Supplementation Saliva collection method IgA determination Findings 
Mero et al., 1997 DB, PC, R, 
C 
9 male sprinters and 
jumpers 
8 days of 125 ml COL or 25 ml 
COL (with 100 ml milk whey 
[PLA]) or 125 ml milk whey  
Not specified ELISA No change in mean saliva IgA over 8 
day period in either COL group.  
Mero et al., 2002 DB, PC, R 19 active adult athletes 
(10 males and 9 
females) 
2 weeks of 20 g.day
-1
 (split as 
four 5 g dose) of COL or  
maltodextrin (PLA ) -participant  
numbers not specified 
Not specified Immunoprecipitation  in mean saliva IgA concentration at 
end of supplementation period with 
COL (p < 0.05) but not in PLA group. 
Crooks et al., 
2006 
DB, PC, R 35 distance runners (15 
females, 20 males) 
aged 35-58 years 
12 weeks of 12 g.day
-1
 COL (n 
=18) compared to  
isomacronutrient skimmed milk 
(n =17)   
Unstimulated passive drool ELISA for human IgA (IgA1and 
IgA2)   
 in median saliva IgA concentration at 
end of supplementation period with 
COL (p < 0.05) but not in PLA group. 
No effect of COL on IgA:osmolality. 
Shing et al., 2007 DB, PC, R 29 highly trained 
cyclists 
8 weeks of 10 g.day-
1
 of 
concentrated COL  (n = 14) or 
whey protein (n = 15)  
Unstimulated passive drool Nephelometry for human IgA No change in mean IgA concentration, 
secretion rate or relative to albumin. 
Crooks et al., 
2010 
DB, PC, R 25 (12 male, 13 female) 
elite swimmers, 28 
aged-matched non-
exercising CON  
10 weeks of 20 g.day
-1
 of low 
protein COL (12 swimmers, 16 
CON) or isomacronutrient 
skimmed milk (13 swimmers, 
12 CON)
1
 
Unstimulated passive drool Immunoturbidemtry No effect of COL on  saliva IgA 
concentration or relative to osmolality. 
Davison and 
Diment 2010 
DB, PC, R 20 recreationally active 
males (10 COL, 10 
PLA) 
4 weeks of 20 g.day
-1
 of COL 
or isomacronutrient/isocaloric 
milk PLA 
Unstimulated passive drool ELISA for human SIgA  No increase in mean IgA 
concentration, secretion rate or 
relative to saliva osmolality. 
Appukutty et al., 
2010 
Abstract only 
PC, R Active young 
adolescents (20 COL, 
20 PLA) 
6 weeks of 20 g.day
-1
 of COL 
or skimmed milk PLA 
Not specified Not specified  in saliva IgA concentration at end of 
6 weeks with COL but not in PLA 
group. 
Patiroglu and 
Kondolot 2013 
DB, PC, R 31 (18 male, 13 female) 
IgA-deficient children 
aged 5-17 years with 
acute respiratory 
symptoms 
1 week 3 sucking tablets daily 
of COL(14 mg and 2.2mg 
lysozyme) (n =16) or matched 
PLA (n =15) tablet (not 
specified)  
Unstimulated passive drool ELISA for human SIgA Median SIgA concentration was 
greater (non-significant) in COL 
compared to PLA after the first tablet 
but no differences between group sat 
end of 7 days.  
Shing et al., 2013 
 
DB, PC, R 
P 
16 highly trained 
cyclists 
8 weeks of 10 g.day-
1
 of 
concentrated COL  (n = 8) or 
whey protein (n =  8) 
Unstimulated passive drool ELISA for human SIgA No change in mean SIgA 
concentration or secretion rate. 
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1.4.4 Bovine colostrum and immune response to exercise 
Investigation into the effect of COL on the immune response to acute, endurance 
exercise in humans remains unclear. Although the combined data from animal and in 
vitro stress models suggests possible immune modulatory effects in humans 
(Benson et al., 2012), evidence to support such findings in an exercise-induced 
immune dysfunction is lacking. The need for such evidence is highlighted by the 
many nutritional supplements which exert substantial effects within in vitro culture 
and animal studies but fail to show such beneficial effects within human athletes 
under double-blind PLA-controlled procedures (Walsh et al., 2011a). 
COL supplementation (10 g∙day-1) was found to attenuate decreases of 
cytotoxic/suppressor T cells and serum IgG2 during and at the end of a high intensity 
training period involving cumulative acute exercise bouts (Shing et al., 2007). These 
effects occurred following 8 weeks of supplementation with no such influence of COL 
on these parameters after any other acute bout within the study. Of interest, was the 
limited effect of COL on all other immune parameters following exercise (NKCA, 
salivary IgA, neutrophil surface markers, serum cytokines, serum Ig). It is difficult to 
separate whether the effects of COL were most effective at the 8 week stage 
because of the longer term supplementation or because there was an overall larger 
scope for intervention in and around the high-intensity period (i.e. greater 
immunodepression). It was apparent in this study that the effects of COL on 
phagocytic cells in an exercise setting was still unclear given that the value of 
receptor expression as a marker of human immune modulation is questionable 
(Albers et al., 2005). 
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In a study of a acute, prolonged exercise (2 h cycling at 64% 
2OV
  max), Davison 
and Diment (2010) found that 4 weeks of COL supplementation (20 g∙day-1) 
enhanced the recovery of neutrophil degranulation (stimulated elastase release at 1 
h post exercise) and reduced the exercise-induced decrements in sLys concentration 
and secretion rate (immediately post exercise). There was no effect of COL on 
another aspect of mucosal immunity, salivary SIgA, but this could well be due to the 
lack of significant exercise-induced change (i.e. no specific pattern of immune 
dysfunction) in the concentration and secretion of this parameter.   
It was suggested that the results may provide support to the in vitro hypothesis that 
COL contains bioactive peptides which prime or enhance innate immunity (Jensen et 
al., 2012; Sugiswa et al., 2003). This is supported further by the lack of direct effect 
of COL on the stress response to the exercise such as leukocytosis and increase in 
stress hormones suggested to induce falls in neutrophil function (e.g. cortisol). The 
lack of influence on leukocyte counts and plasma cortisol was also demonstrated 
following a bout of moderate exercise (1.5 h cycling bout at 50% of maximum power 
output proceeded by a glycogen depletion trial) in a recent study of a shorter period 
of COL supplementation (2 × 12.5 g for 10 days) (Carol et al., 2011). There was also 
no reported effect of COL compared with PLA on circulating Ig, cytokines and CRP 
to which the investigators concluded that there was no role for COL in preventing 
exercise-induced immune dysfunction. However, the ‘immune variables’ investigated 
and conclusions drawn within this study are confounded by several limitations. As 
there were no decrements in immune parameters (e.g. serum Ig) in the PLA group it 
would be cautious to exclude any possible impact of COL. The magnitude of the 
stress on the immune system within this study could also be questioned by the lack 
of significant lymphocytopenia post-exercise (a commonly reported change following 
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prolonged exercise in the literature). There were also no leukocyte function 
measurements undertaken and within the cytokines measured, concentrations at 
some timepoints were undetectable and replaced with the arbitrary lowest 
measurable concentration. The above study should be interpreted with caution given 
that mechanisms most likely to underpin the effects of COL as a nutritional 
countermeasure were not explored (i.e. actual measures of immune function).       
1.5 Summary and aims 
Prolonged exercise induces transient immune perturbations (e.g. salivary SIgA, 
neutrophil function) that may increase the incidence of URI. The exercise-induced 
immune dysfunction is primarily mediated by increases in stress hormones 
(noradrenaline and cortisol). To date many nutritional supplements have failed to 
counter the effects of prolonged exercise on the immune system. Acute 
carbohydrate supplementation indirectly reduces immunodepressive effects by 
maintaining blood glucose concentration and thus limiting increases in stress 
hormones. However, such effects are yet to translate into a prevention of URI 
incidence which has detrimental effects on athletes 
There is evidence accumulating that COL reduces the incidence of URI but its effect 
within a model of exercise-induced immune dysfunction is unclear. The findings of in 
vitro culture studies suggest that COL contains low molecular weight components 
which have direct effects on neutrophils by priming oxidative burst responses to 
subsequent activation. It was beyond the scope of this thesis to determine the effects 
of various COL preparations on immune function. Nevertheless, the one study thus 
far which has assessed the effects of COL on neutrophil function within an exercise 
stress model has observed beneficial effects (enhanced recovery of stimulated 
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degranulation). This may suggest that the above mentioned components are in an 
adequate concentration in whole COL or other components (e.g. not present in 
whole COL but become bioavailable following digestion) enhance human immune 
function. If such components become bioavailable following COL consumption then it 
would be expected to also see priming effects on in vitro oxidative burst and 
degranulation upon acute supplementation (Study 1, Chapter 3). Study 2 (Chapter 4) 
further investigates  whether any effects on in vitro neutrophil function would be more 
apparent following 4 weeks of COL supplementation and hence greater opportunity 
for the absorption or accumulation of bioactive peptides.  
In addition to the primary outcomes (neutrophil function) study 1 and study 2 also 
investigate whether acute or longer term COL supplementation would trigger 
beneficial effects on mucosal parameters (salivary SIgA, sLac, sLys) following 
prolonged exercise. Chronic supplementation of COL may reduce the incidence of 
URI and also lead to changes in the above cellular and mucosal parameters at rest. 
Study 3 (Chapter 5) was designed to investigate the effects of 12 weeks of COL 
supplementation on URI incidence, salivary microbiome, innate and mucosal 
immunity. At present, there is conflicting evidence regarding prior infection with 
herpesviruses and susceptibility to URI. Study 4 (Chapter 6) aimed to determine the 
effect of COL on frequency, severity and duration of URI episodes in active males 
with or without previous EBV infection. COL has been shown in vitro to modulate 
cytokine production to promote cell-mediated immunity. Therefore, Study 5 (Chapter 
7) investigates whether COL would influence an in vivo T-cell-mediated immune 
response to a novel antigen following prolonged exercise.  
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COL in these studies was donated from Neovite, UK, as used previously (Davison 
and Diment, 2010; Marchbank et al., 2011). Given that the above product 
encompasses all the current proposed underlying mechanism(s) (priming 
components, intestinal integrity), it allowed for an investigation into the potential 
additive and/or synergistic effects of components within COL on human immune 
parameters and risk of URI.   
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Chapter 2. General Methods 
2.1 Ethics approval 
All studies were approved by the University Research Ethics Committee prior to the 
recruitment of any participants. Participants in each study provided both verbal and 
written consent following information on experimental procedures. All participants 
were non-smokers, non-allergic to dairy products and reported no symptoms of 
infection or taking any medication or dietary supplements 4 weeks prior to each 
study. If a visit to the laboratory involved exercise, participants completed a physical 
activity readiness questionnaire prior to commencing the exercise bout (see 
Appendix A). 
2.2 Determination of maximal oxygen uptake (Study 1 and 2) 
Gas exchange threshold (GET) and
2OV
 max were determined via a continuous 
incremental test (30 W∙min-1 ramp rate following 3 min of unloaded baseline 
pedalling) to volitional exhaustion on an electrically braked cycle ergometer (Lode 
Excalibur, Groningen, The Netherlands). The handlebars and seat of the cycle 
ergometer were adjusted for participant comfort. These settings as well as the fitting 
of the participants’ own pedals (if applicable) were maintained in all subsequent 
visits. Participants were instructed to reach their preferred cadence (70-100 rpm) 
during the 3 min unloaded baseline cadence and then maintain that cadence for the 
entire test. Throughout the duration of the incremental test, expired gas was 
analysed by the use of an online breath-by-breath gas analysis system (Jaeger 
Oxycon Pro, Hoechberg, Germany). The test was terminated when the participant’s 
cadence fell 10 rpm below their preferred cadence for more than 10 s as used 
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previously (Vanhatalo et al., 2007). Strong verbal encouragement was provided in 
the later stages of the test to encourage maximal participation. For each participant 
2OV
 max was determined by the highest 30 s average during the test. GET was 
estimated for each participant via the V-slope method (detecting the beginning of the 
excess CO2 output generated from the buffering of Hydrogen Ions) (Beaver et al., 
1986). The exercise intensity was set to the power output that would elicit 15%  
(15% of the difference between power output at GET and 
2OV
 max) which was 
equivalent to ~ 55-60% of the participant’s 
2OV
  max. An intensity equivalent to 55-
60% 
2OV
 max was chosen as it was deemed sustainable for 2.5 h in a recreationally 
active population and in accordance with previously published trials of nutritional 
interventions and similar exercise duration (Davison and Gleeson, 2005, 2006, 
2007). The use of % was also used to provide a stricter control on the relative 
intensity as GET (also lactate threshold in most circumstances) is an important 
contributor to physiological responses (e.g. metabolic) during exercise and the 
perceived demands (i.e. rating of perceived exertion, RPE) of the exercise bout 
(Coggan et al., 1992; Mihevic, 1981) 
2.3 Familiarisation trials (Study 1 and Study 2) 
A familiarisation trial took place 7 days prior to the main trials to accustom 
participants to the testing procedures and ensure that the correct exercise intensity 
had been identified from the previous incremental test. Participants performed a 2.5 
h exercise bout on the electronically braked cycle ergometer at an intensity of 15%  
(~ 55-60% 
2OV
 max). Expired gas was analysed during the 10th, 30th, 60th, 90th 
and 120th min of exercise. These timepoints were used to verify that the selected 
workrate did elicit the target intensity. Heart rate (HR) and RPE were monitored 
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every 15 min during the protocol using a telemetric device (Polar S610, Polar Electro 
Oy, Kempele, Finland) and Borg scale (Borg, 1982) respectively. These 
physiological responses were used throughout the familiarisation trial. A beverage in 
the form of diluted cordial (4 volumes of plain water to 1 volume of cordial) was 
provided at 2 mL∙kg-1 of BM every 15 min. The main outcomes of this trial were to 
habituate the participants with the physiological measurements (noted above) and 
the physical stress expected in the subsequent main trials as well as ensuring that 
the participant could main the required intensity for the duration of the trial (i.e. 2.5 
h). 
2.4 Blood analytical methods 
2.4.1 Blood collection and treatment  
Participants remained seated, performing minimal movement for 10 min prior to each 
blood sample with the exception of immediately post-exercise samples which were 
drawn within a few min of exercise cessation. All blood samples were collected by 
venepuncture (with a 21 gauge precision needle [Becton-Dickinson, Oxford, UK]) 
from an antecubital vein into the appropriate vacutainers (Becton-Dickinson, Oxford, 
UK); Study 1 and 2: K3EDTA and heparin pre-treated tubes; Study 3, 4 and 5: 
K3EDTA pre-treated and plain tubes. 
For all studies, aliquots of K3EDTA treated whole blood were used in haematological 
analysis. An aliquot of K3EDTA treated whole blood was set aside for determining in 
vitro stimulated neutrophil oxidative burst (Study 1, 2, and 3, see section 2.4.3.1). A 
1 mL aliquot and further aliquots of heparin treated whole blood were used for 
determination of in vitro stimulated neutrophil degranulation (see section 2.4.3.2) and 
haematological analysis (Study 1 and 2). The remaining blood in K3EDTA and 
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heparin treated tubes were centrifuged at 1500 g for 10 min at 4°C with subsequent 
plasma being stored at -80°C for later analysis (Study 1 and 2: glucose, lactate, 
unstimulated elastase) . Blood collected in the 6 mL plain vacutainers was allowed to 
clot at room temperature for 1 h 20 min. Following centrifugation (1300 g for 10 min 
at 4°C), serum was stored at -80°C for later analysis (see study 3 and 4).   
2.4.2 Haematological analysis 
Haemoglobin, total and differential leukocyte counts were measured in each of the 
K3EDTA tubes using an automated haematology analyser (Pentra 60 C+ 
Haematology analyser, HORIBA Medical, Montpellier, France). Determination of 
Haematocrit from an aliquot of heparin anti-coagulated whole blood (except Study 5 
– K3EDTA) by a standard microcentrifugation (using a Hawksley microcentrifuge) 
was used along with the previously attained haemoglobin concentration, to calculate 
changes in blood and plasma volume from pre- to post-exercise (Study 1, 2 and 5) 
as previously described (Dill and Costill, 1974). The measurement of blood/plasma 
lactate and glucose concentrations from aliquots of heparinised samples (Study 1 
and 2 only; Study 5 – K3EDTA) was performed using an automated analyser (YSI 
2300 Stat Plus, Yellow Springs, Ohio, USA).  Based on 10 repeated measurements 
of the same sample, intra assay CV for haemoglobin, haematocrit, leukocytes, 
lactate and glucose were 0.9%, 0.8%, 1.7%, 0.4% and 1.2% respectively. 
2.4.3 Measurements of neutrophil function 
2.4.3.1 In vitro stimulated oxidative burst activity 
A small volume of whole blood from the K3EDTA treated tubes was placed in a 
microcentrifuge tube and stored at room temperature (no longer than 2 h) prior to 
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measurement of in vitro stimulated neutrophil oxidative burst response to PMA 
and/or fMLP using a commercially available chemiluminescence (CL) kit (ABEL, 
Knight Scientific Ltd, Plymouth, UK) in accordance with Davison and Gleeson 
(2005). The sample was diluted as described below before (~ 5 min) commencing 
the assay. The CL per well was measured by a microplate luminometer (FLUOstar 
OPTIMA, BMG Labtech, Aylesbury, UK). The contents of each microplate well that 
contained a stimulated sample were as follows: 10 µL of diluted whole blood (blood 
and Hank’s balanced salt solution; HBSS, without calcium and magnesium, at ratio 
of 1:100), 90 µL assay buffer (HBSS with calcium and magnesium), 50 µL Pholasin 
and 20 μL adjuvant K (substance that enhances the luminescence of Pholasin during 
assays involving diluted whole blood).  
These mixtures were gently shaken and incubated at 37°C for 30 s in the 
luminometer, prior to the addition of 20 µL of PMA (5 µg mL-1) or 20 µL fMLP (10 μm) 
to provide an end total volume of 200 L per well, a 1:1010 final blood dilution and a 
PMA or fMLP concentration of 0.5 µg∙mL-1 or 1µM respectively. Although 
unstimulated samples in the PMA assay were also placed through similar mixing and 
incubation as the stimulated wells, 110 µL of HBSS was added to wells to ensure 
that the end volume of each well were standardised (replacing the combination of 90 
µL HBSS and PMA). In all samples which were stimulated by PMA, CL was recorded 
in duplicate as relative light units (RLU) at 20 s intervals for a duration of 30 min and 
the area under the CL curve was calculated. The area under the unstimulated CL 
curve for each sample was subtracted from the mean area of the duplicate 
stimulated sample to determine the PMA-stimulated CL.  
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When fMLP was the stimulant used, CL was recorded every second for 300 s. The 
unstimulated state in the fMLP was calculated as the mean CL of the well during the 
initial 2 s (Study 1 and 2) or 45 s (Study 3) (prior to addition of fMLP). The area 
above the stable unstimulated state was used to determine fMLP-stimulated CL. As 
fMLP binds to a cell receptor and does not penetrate the cell and trigger maximal 
stimulation (unlike PMA), neutrophils still have the capacity to respond to PMA 
stimulation following fMLP stimulation (see Figure 2.1 for activation of oxidative burst 
by these 2 agonists). In study 1 and 2, following the 300 s of the fMLP assay, 20 µL 
of PMA (5 µg·mL-1) was dispensed into the wells and CL recorded for a further 30 
min. The unstimulated state in this condition was calculated as the mean CL during 
the initial 40 s (following addition of PMA). The area above the stable unstimulated 
state (over 30 min) was used to determine the combined fMLP- and PMA-stimulated 
CL. 
To account for such responses on a per cell basis, as used previously it was 
assumed that the CL responses were attributable largely to the neutrophils within the 
samples (Morozov et al., 2003). Thus, PMA-stimulated, fMLP-stimulated and 
fMLP/PMA-stimulated area under the CL curve were divided by the number of 
neutrophils present in each well to give CL in RLU (i.e. oxidative burst response) per 
neutrophil. Whole blood (primarily via leukocytes) may contribute to exercise-induced 
increases in ROS and a state of oxidative stress (Nikolaidis and Jamurtas 2009; 
Powers and Jackson 2008). The unstimulated 30 min CL responses from the PMA 
oxidative burst assay were expressed per L of whole blood to provide a measure of 
spontaneous CL (a snapshot of the level of ROS) in accordance with Davison (2011) 
and Davison et al. (2012). This would allow for an investigation of the effect of COL 
on the antioxidant potential of whole blood. These unstimulated samples were also 
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expressed relative to neutrophils as a further indicator of any effect of COL on the 
basal level of CL (ROS). Based on 20 duplicated samples, intra assay CV for the 
fMLP, PMA and fMLP/PMA mix assay were 5.8%, 5.0% and 5.1% respectively. 
 
Figure 2.1. Receptor dependent (fMLP) and independent (PMA) stimulation of 
neutrophil oxidative burst. Attachment of fMLP to a seven transmembrane G-protein 
coupled receptor activates intracellular enzymes, kinases and secondary 
messengers (e.g. arachidonic acid, AA; calcium, Ca2+; diacylglycerol, DAG; inositol 
phosphatidic acid, PA; phosphatidylinositol (3,4,5) triphosphate, PIP3; 
biphosphatphosphatidylinositol (4,5) biphosphate, PIP2; phospholipase A2, PLA2; 
phospholipase C, PLC; phospholipase D, PLD. These components and/or 
intracellular kinases (e.g. protein kinase C, PKC) aid the phosphorylation of cytosolic 
components (p47phox, p67phox, and p40phox; phox: phagocyte oxidase) and 
mediate translocation to the plasma membrane where they associate with 
membrane-bound components gp91phox and p22phox known as the heterodimer, 
llavocytochrome b558. Rac2 (signalling G protein) also migrates to the membrane to 
interact with p67phox and flavocytochrome b558 resulting in activation of NADPH 
oxidase and release of superoxide ions (O2
-). In contrast to the rapid response of the 
intracellular transduction pathways to fMLP, PMA triggers a long lasting, strong 
stimulation via PKC which is independent of other messengers (e.g. Ca2+).PMA 
activates NADPH oxidase on the cell surface and other parts of the neutrophil where 
NADPH membrane components are present (e.g. on intracellular granules). 
Compiled from DeCoursey and Ligeti (2005); El- Benna et al. (2005, 2008); Kanaho 
et al. (2013); Nick et al. (1996); Peake (2002); Selvatici et al. (2006). 
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2.4.3.2 In vitro stimulated degranulation 
The neutrophil degranulation response was assessed in accordance with Davison 
and Gleeson (2005). The measurement of neutrophil degranulation involved adding 
1 mL of the heparinised blood sample to microcentrifuge tubes containing 50 L of 
bacterial stimulant (840-15, Sigma, Poole, UK). The tubes were initially mixed by 
gentle inversion before being incubated at 37°C for 1 h. All tubes were gently mixed 
halfway through the incubation period. Following incubation, the tubes were 
centrifuged for 2 min at 16,000 g, with the supernatant being immediately removed 
and stored at -80°C until further analysis. Upon thawing at room temperature, 
neutrophil degranulation response was based on measuring the amount of 
stimulated elastase release per neutrophil using an ELISA kit (Merck Calibiochem, 
Darmstadt, Germany). Bacterial-stimulated elastase release was based on 
subtracting elastase concentration of unstimulated samples (heparinised plasma at 
same timepoint) away from stimulated samples. The unstimulated samples were 
processed immediately to provide a ‘snapshot’ of the spontaneous elastase 
production at the specific timepoint (i.e. not incubated alongside stimulated 
samples). Based on 40 duplicated samples, intra assay CV was 5.3%. 
2.5 Saliva collection and treatment  
Participants remained seated, performing minimal movement for 10 min prior to each 
saliva sample with the exception of immediately post-exercise samples which were 
obtained within a few min of exercise cessation. For all saliva samples the mouth 
was rinsed with plain water at least 10 min before the collection period. The 
participant was requested to swallow in order to empty the mouth before each saliva 
sample. To obtain the sample, the participant remained seated with the head tilted 
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slightly forward and passively dribbling into a pre weighed 7 mL sterile bijou tube 
while keeping orofacial movement to a minimum. Following the 2 min, the tube was 
weighed again to allow for estimation of saliva flow rate when the density of saliva 
was assumed to be 1.0 g.ml-1 as used in previous studies (Chicharro et al., 1998; 
Davison et al., 2009). When there was an insufficient amount of saliva at the end of 2 
min, the process was repeated until an adequate amount was obtained. The final 
duration of collection was recorded to calculate saliva flow rate.  
After collection of saliva, samples were centrifuged for 5 min at 16,000 g to pellet 
debris leaving the remaining clear supernatant to be aliquoted and stored at – 80°C 
for later analysis. All saliva samples were thawed at room temperature only once 
prior to analysis. Following the thawing of saliva, samples were again centrifuged for 
5 min at 16,000 g to precipitate mucins and other debris and allow for the resulting 
clear supernatant to be analysed. With the use of a freezing point depression 
osmometer (Osmomat 030, Gonotec, GbBH, Berlin, Germany), saliva osmolality was 
determined to allow for concentration of salivary immunological parameters to be 
expressed relative to saliva osmolality. Based on 10 repeated measurements of the 
same sample, intra assay CV for osmolality was 1.6%.   
2.6 Salivary analysis 
2.6.1 Blood contamination 
Aliquots of saliva were screened for blood contamination by the determination of 
salivary transferrin concentration using an ELISA kit (Salivary blood contamination 
enzyme immunoassay kit, Salimetrics, State College, Pennsylvania, USA). If salivary 
transferrin concentration was greater than 1 mgdL-1, the sample was considered to 
be contaminated with blood and all other salivary data for that sample was excluded 
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(except SIgA due to assay being specific to the secretory component) from the 
study. Based on 20 duplicated samples, intra assay CV was 7.0%.   
2.6.2 Salivary secretory immunoglobulin A  
The concentration of salivary SIgA (mgL-1) was determined in accordance with the 
protocol of previous studies (e.g. Leicht et al., 2011). Saliva supernatants were 
analysed using a sandwich ELISA approach with flat-bottomed microtitration plates 
(Nunc-ImmunoPlate; Thermo Fisher Scientific, Roskilde, Denmark). The sandwich 
ELISA approach was slightly modified to include coating of plates with a capture 
antibody specific to the secretory component of human IgA (Mouse anti-human IgA 
secretory, Merck Millipore, Darmstadt, Germany) before plates were blocked with a 
solution of 2% bovine serum albumin in phosphate-buffered saline. Duplicates of 
serial diluted standard (Purified IgA from human colostrum, Sigma-Aldrich) and 
diluted samples (1:750) were applied to plates at a volume of 50 µL and incubated 
overnight at 4°C. Following washing of plates, a detection antibody, was added to 
plates and incubated at room temperature for 90 min. After the final washing 
procedure, a colouring substrate (OPD substrate, Dako, UK) and a stop solution (1M 
H2SO4) were applied in separate steps to all wells to allow for the absorbance of 
samples to be measured at 490 nm on a microplate reader (BioTek ELx808, BioTek 
Instruments, Winooski, USA). Based on 40 duplicated samples, Intra assay CV was 
2.2%.     
2.6.3 Salivary lactoferrin (sLac)  
The concentration of sLac was measured in saliva using a commercially available 
enzyme-linked immunoassay technique (Assaypro LLC, St-Louis, MO). Diluted  
saliva samples (1:1000 with phosphate buffered saline) and serially diluted human 
84 
 
lactoferrin standard were assayed in duplicate. Absorbance reading was performed 
for all wells at 450 nm using a microplate luminometer (FLUOstar OPTIMA, BMG 
Labtech, Aylesbury, UK). Based on 40 duplicated samples, intra-assay CV was 
2.2%. 
2.6.4 Salivary lysozyme (sLys)  
The concentration of sLys was measured in saliva using a commercially available 
enzyme-linked immunoassay technique (Assaypro LLC, St-Louis, MO). Absorbance 
of wells containing diluted saliva samples (1:8000 with phosphate buffered saline) 
and serially diluted human lysozyme standard were read on a microplate 
luminometer (FLUOstar OPTIMA, BMG Labtech, Aylesbury, UK). Based on 20 
duplicate samples, intra assay CV was 6.5% 
2.7 Monitoring of training volume 
On a weekly basis within the cross-sectional design of study 3 and 4 (Chapter 5 and 
6), participants were asked to complete a standard short-form International Physical 
Activity Questionnaire (IPAQ) (http://www.ipaq.ki.se/downloads.htm) to provide 
quantitative data of training loads in metabolic-equivalent (MET) hweek-1 (Craig et 
al., 2003). 
2.8 Monitoring of upper respiratory illness 
On a daily basis within the cross-sectional design of study 3 and 4, participants 
completed a health questionnaire (Gleeson et al., 2011, 2012a, see Appendix B). 
This involved participants indicating if they were suffering from any of the illness 
symptoms listed on the questionnaire: sore throat, catarrh in the throat, runny nose, 
cough, repetitive sneezing, fever, persistent muscle soreness, joint aches and pains, 
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weakness, headache, and loss of sleep. Upon reporting of any of the above 
symptoms, participants were asked to provide a subjective rating of the severity of 
symptoms (light, moderate, severe). As used previously (Fricker et al., 2005; 
Gleeson et al., 2011, 2012a), these ratings of light, moderate and severe were given 
numerical scores of 1, 2 and 3 respectively for data analysis. At any given point 
during the 12 weeks, a total symptom score of ≥12 was used to indicate that an URI 
was present. Participants were allowed unrestricted use of medication during 
episodes of URI but were asked to report such use.  
2.9 General statistical analysis 
Data shown in the text, tables and figures throughout this thesis are presented as 
mean values and/± standard deviation unless stated otherwise. Statistical analysis of 
all data was performed via the statistical computer software package SPSS (v20.00; 
SPSS Inc., Chicago, IL, USA). All data were checked for normal distribution by 
observations of skewness and kurtosis Z scores and using the Shapiro-Wilk test.  
Data not normally distributed were normalised with log or square root transformation 
before further analysis. Initially, either a two-factor repeated measures or a two factor 
mixed model ANOVA (trial × time) was carried out on all physiological and 
immunological measures to determine if the effect of time was different between 
COL and PLA (trial/group). Any significant main effects identified in the ANOVA, 
were further analysed by post hoc 1 tailed independent, paired t-tests or non-
parametric equivalents with Holm-Bonferoni correction due to the hypothesis that 
COL would enhance immune parameters compared to PLA. One way ANOVA on 
each trial was also performed when there was evidence of trial × time interaction. 
Statistical significance was accepted at p < 0.05. 
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Chapter 3. Study 1- Effect of acute bovine colostrum 
supplementation on blood neutrophil responses and mucosal 
immunity following prolonged exercise 
Abstract 
COL supplementation for periods of 4-8 weeks has been shown to reduce the 
magnitude of, or speed recovery from, exercise-induced immunodepression. The 
purpose of this study was to identify whether acute COL supplementation prior to a 
bout of prolonged exercise has any effect on neutrophil function and mucosal 
immunity. Sixteen healthy, recreationally active males (age 25 ± 6 years; BM 75.7 ± 
7.5 kg; height 178 ± 6 cm; 2OV

max 54.4 ± 9.3 ml·kg
-1·min-1; mean ± SD) participated 
in 2 main trials in a randomised order. Participants consumed either COL or PLA 1 h 
prior to 2.5 h of cycling at 15%  (~ 55-60% VO2 max) (30 g), immediately prior (5 g) 
and midway through the exercise (5 g). Venous blood and unstimulated saliva 
samples were obtained prior to consumption of the supplement (BAS), 1 h post-drink 
(immediately pre-exercise: PRE), immediately post-exercise (POST) and 1 h post-
exercise (1h POST). A greater fMLP-stimulated oxidative burst was observed in COL 
compared to PLA trial (trial, p < 0.05). There was an enhancement of sLys 
concentration and bacterial-stimulated neutrophil elastase release at POST and 1h 
POST respectively in COL trial compared with PLA trial (trial × time interaction, p < 
0.05).There was no effect of COL on leukocyte trafficking, PMA-stimulated neutrophil 
oxidative burst, salivary SIgA and sLac. This study supports proposals that COL may 
enhance human innate immunity by a direct and immediate mechanism. 
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3.1 Introduction 
Interest has grown in the use of COL within the area of exercise-induced immune 
dysfunction following findings that humans who participate in a period of 
supplementation (4 days – 12 weeks) benefit from enhanced prophylaxis and 
treatment of numerous illnesses including URI (Brinkworth and Buckley 2003; Patel 
and Rana, 2006; Sarker et al., 1998). Despite such findings, limited studies have 
investigated the effects of COL on cellular and/or innate immunity following 
prolonged exercise (Davison and Diment, 2010). Shing et al. (2007) when 
investigating leukocyte function during 8 weeks of COL supplementation, found a 
minor enhancement in expression of the receptor CD89 (binds IgA complexes to 
initiate phagocytosis and release of soluble mediators) on the surface of neutrophils 
during rest and following an exercise bout at end of the supplementation period. 
However, the value of such markers as a representation of a change in the functional 
capacity of leukocytes have been debated (Albers et al., 2005). Given the lack of 
significant neutrophilia following the performance tests during the 8 weeks of Shing 
et al. (2007), it can be suggested that the physical stress provided little scope to view 
more than modest effects of COL on neutrophil function. Previous work from our 
laboratory suggests that 4 weeks of COL supplementation can limit the 
immunodepressive effects of an acute prolonged physical stressor (2 h of cycling) by 
enhancing stimulated neutrophil degranulation post-exercise (Davison and Diment, 
2010).  
Although there is evidence to suggest that COL has an effect on the human immune 
system, the mechanism behind these modulations remains elusive. Recently, a 
shorter period of COL supplementation (10 days) was shown to have no effect on 
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leukocyte counts and plasma cortisol or cytokine concentrations (IL-6, IL-10, IL-1-
receptor agonist, and CRP) following a 1.5 h cycling trial which was performed after 
a glycogen depleting bout (Carol et al., 2011). The lack of effect of COL on leukocyte 
trafficking and cortisol concentration supports earlier data from our laboratory 
(Davison and Diment, 2010), however, as Carol et al. (2011) did not measure 
leukocyte function, the value of shorter periods of COL supplementation remain 
unclear.  
The findings of both animal studies and in vitro culture studies indicate that 
antimicrobial activities of neutrophils such as phagocytosis and oxidative burst are 
enhanced by COL (Benson et al., 2012; Sugisawa et al., 2001, 2002, 2003). The 
direct enhancement of functions by short term incubation with COL (~ 30 min) 
suggests that in the presence of COL, neutrophils are exposed to priming agents 
which can amplify their response upon subsequent activation. Sugisawa et al. (2003) 
proposed that the priming is mediated by low-molecular weight substances (< 10 
kDa) present in COL. This was supported by a recent investigation by Jensen et al. 
(2012) where the phagocytic activity of PMN cells from healthy humans was rapidly 
increased 1 h following a single oral dose of a low-molecular weight fraction of COL. 
In addition to the role of the neutrophils in the human body’s first line of defence, 
salivary SIgA is an immune parameter which has been related to risk of URI in 
exercising populations on numerous occasions (Gleeson and Walsh 2012). COL 
supplementation for 6-12 weeks has been shown to increase resting levels of 
salivary SIgA (Appukutty et al., 2010; Crooks et al., 2006). Previous evidence from 
our laboratory observed no benefits of 4 weeks supplementation at rest or following 
prolonged exercise (Davison and Diment, 2010). This may indicate that longer term 
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supplementation is required to observe beneficial effects on salivary SIgA. However, 
Mero et al. (2002) found a 33% increase in resting salivary IgA concentration 
following only 2 weeks of supplementation. The daily dose of COL in this study was 
split across the day which may suggest an alternative mechanism towards 
increasing resting salivary SIgA levels. The effects of shorter but yet higher doses of 
COL on salivary SIgA remain unclear. 
Although the importance of other salivary immune parameters (AMPs, e.g. sLys, 
sLac) for host defence has been recognised, they have received limited attention 
(West, 2006). The only study to date which has looked at the effects of COL on 
AMPs found a 4 week supplementation period prevented an exercise-induced 
decrease of sLys (Davison and Diment, 2010). This coincided with an improved 
recovery of neutrophil degranulation. Given the role of neutrophils as a source of 
AMPs (Travis et al., 2001), any acute, direct effects on neutrophil capacity may also 
lead to improvements in innate mucosal parameters (Davison et al., 2009). 
It is currently unknown whether the above mentioned priming and ‘immune-
enhancing’ ability will present with acute oral supplementation of COL in an exercise 
setting. Hence, the primary aim of this study was to determine the influence of acute 
oral COL supplementation on neutrophil function (degranulation and oxidative burst) 
following prolonged exercise. Secondly, this study also aimed to determine if COL 
had any effects on parameters of mucosal immunity. 
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3.2 Methods 
3.2.1 Pilot study 
Pilot work was carried out to determine a duration and dosage of COL that could 
potentially act as an acute intervention in human volunteers under conditions of 
exercise-induced immune dysfunction. Following an overnight fast, 3 males reported 
to the laboratory on 2 occasions separated by 7 days. On each occasion, 
participants either consumed 30 g of COL or 30 g of PLA (isoenergetic mixture of 
milk protein concentrate and skimmed milk powder) mixed in 300 mL water in a 
randomised double-blind manner. Solutions were also flavoured with vanilla 
flavouring (MP flavouring, My Protein, Northwich, UK) and were indistinguishable in 
flavour or appearance. Resting blood samples were taken from an antecubital vein 
immediately prior (PRE) to consumption of COL or PLA as well as 1 h and 3 h post-
consumption. Participants remained fasted until after the 3 h blood sample was 
taken. At each timepoint, PMA-stimulated oxidative burst and neutrophil count was 
assessed in whole blood collected from the K3EDTA vacutainer. This preliminary 
work suggested that COL may have a direct, acute effect on the functional capacity 
of blood neutrophils (Table 3.1). Compared to PLA, a greater increase in stimulated 
oxidative burst with COL was evident at 1 h post consumption which was maintained 
for a further 2 h later. A larger scale study was then completed to determine whether 
these benefits on neutrophil function are observed following acute COL 
supplementation under conditions of exercise-induced perturbations in innate 
immunity. 
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Table 3.1 Pilot study to assess acute effects of COL on neutrophil function at rest. 
Supplement PMA-stimulated CL per neutrophil 
(% of PRE) 
PRE 1 h 3 h 
COL 100 ± 0 133 ± 31 134 ± 29 
PLA 100 ± 0 92 ± 32 110 ± 38 
 
3.2.2 Participants  
Sixteen healthy, recreationally active males (age 25 ± 6 years; height 178 ± 6 cm; 
BM 75.7 ± 7.5 kg; 2OV

max  54.4 ± 9.3 ml·kg
-1· min-1) volunteered to participate in the 
present investigation. 
3.2.3 Preliminary visits 
A subset of participants (n = 7) were asked to attend the laboratory for 2 visits 
separated by 7 days. On each visit participants consumed either 30 g of COL or PLA 
(solutions prepared as above). K3EDTA anti-coagulated blood obtained 1 h following 
consumption of these solutions was immediately centrifuged at 1500 g for 10 min at 
4°C with subsequent plasma stored at -80°C for later use within experimental trials 
(plasma incubation experiments, see section below, 3.2.4). 
3.2.4 Experimental trials 
At least 7 days following the preliminary visits (see previous section and sections 
2.3) participants performed 2 trials separated by 7 days, in a double-blind 
randomised counterbalanced design. During the 48 h preceding each experimental 
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trial, participants were asked to refrain from heavy exercise and alcohol consumption 
while recording their food intake in food diaries in an effort to standardise their 
nutritional status in the 24 h before the first experimental trial. Participants were 
required to follow the same food intake during the 24 h prior to the second 
experimental trial. On the day of the main trial, they also completed a food frequency 
questionnaire relating to the previous 7 days. The dietary records were analysed 
using computer dietary analysis software (CompEat, Nutrition Systems, London, 
UK).  
On the morning of each trial, participants reported to the laboratory after an overnight 
fast of at least 10 h. The participants were asked to consume 500 mL of water 2 h 
before arrival to ensure euhydration. Upon arrival, participants were asked to remain 
seated for 10 min prior to collection of a resting baseline blood sample (BAS) from 
an antecubital vein and an unstimulated saliva sample. For one trial, participants 
then consumed 30 g of COL (prepared as above) while the other trial involved the 
consumption of 30 g of PLA (prepared as above). Participants undertook restful 
activities (i.e. reading) in the laboratory before collection of a venous blood sample 
and unstimulated saliva sample (PRE) 1 h post consumption of COL or PLA. 
Immediately prior to the exercise participants consumed a further 5 g of COL or PLA 
mixed in 50 mL of water and vanilla flavouring (see above).  
In each trial participants performed a 2.5 h of cycling at 15% . All participants also 
received a further 5 g of COL or PLA at 1 h 15 min into the exercise of the respective 
trial. With the exception of this time point, participants were permitted diluted cordial 
(four volumes of water to 1 volume of sugar-free cordial at 2 mL·kg-1 of BM) during 
the first trial with the pattern of intake and total volume consumed being replicated in 
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the second trial. Expired gas was analysed during the 30th, 60th, 90th and 120th min 
of exercise (Jaeger Oxycon Pro, Hoechberg, Germany). HR and RPE were 
monitored every 15 min during the protocol using a telemetric device (Polar S610, 
Polar Electro Oy, Kempele, Finland) and Borg rating scale (Borg, 1982) respectively. 
The mean of each of the physiological responses was used to determine if similar 
physical stress was imposed in each trial. A venous blood sample and an 
unstimulated saliva sample were collected immediately post-exercise (POST). 
Participants remained fasted until a further blood and saliva sample at 1 h post-
exercise (1h POST). To explore a proposed direct enhancement of neutrophil 
oxidative burst by components (Sugisawa et al., 2003) or metabolites of COL which 
become bioavailable following consumption, plasma obtained from the preliminary 
visits (section 3.2.3, i.e. 1 h following COL and PLA consumption) was thawed and 
incubated with whole blood (1:1 ratio, 100 l each) (same participants as section 
3.2.3) at BAS and POST in the PLA trial only. Following an incubation period of 30 
min at 37°C, blood was immediately analysed for fMLP oxidative burst as detailed in 
2.4.3.1.       
3.3 Results 
3.3.1 Nutrient intake 
In the 7 days prior to the 2 experimental trials, there was no significant difference in 
total energy (p = 0.443) and macronutrient intake of the participants (carbohydrate: p 
= 0.318; fat: 0.554; protein: p = 0.891). The mean daily macronutrient intake (as a 
percentage of total energy intake) prior the COL trial was carbohydrate 52.1 ± 5.9%, 
fat 32.3 ± 7.0% and protein 15.6 ± 3.9%. Prior to the PLA trial the mean daily 
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macronutrient intake was carbohydrate 50.9 ± 7.2%, fat  32.9 ± 6.3 % and protein 
15.8 ± 3.3%.  
3.3.2 Physiological variables 
There was no significant difference in oxygen uptake ( 2OV
 ) (p = 0.218; p = 0.138) 
between the COL (2336 ± 279 mL·min-1; 57.0 ± 4.2% 2OV
 max) and PLA trial (2297.8 
± 274.6 mL·min-1; 55.8 ± 4.5% 2OV
 max). The average HR (134 ± 15 bpm and 132 ± 
14 bpm during COL and PLA trials respectively) were not significantly different (p = 
0.209). There was no significant difference in average RPE (p = 0.174) between the 
COL (12.9 ± 1.3) and PLA (12.6 ± 0.8) trials. A similar pattern of plasma volume 
changes was observed from BAS between trials: COL; PRE (0.5 ± 4.3%); POST (-
3.7 ± 5.6%); 1h POST (-0.1 ± 4.5%) and PLA; PRE (-1.7± 2.1%); POST (-5.4 ± 
3.1%), 1h POST (-2.0 ± 5.6%). As there was no significant difference between trials 
(trial × time interaction; p = 0.915), it was deemed unnecessary to correct any 
haematological parameters for plasma volume changes.  
Although there was a significant change across time (p < 0.001), there was no 
significant trial (p = 0.073) or interaction effect (p = 0.694) on plasma glucose (Table 
3.2). Plasma glucose was significantly lower at PRE (p < 0.001), POST (p = 0.003) 
and 1h POST (p < 0.001) compared to BAS. There was also a significant change 
across time for plasma lactate (p < 0.001) but no effect of trial (p = 0.970) or 
interaction (p = 0.381) (Table 3.2). Plasma lactate significantly increased from BAS 
(p = 0.001) and PRE (p < 0.001) to POST before decreasing towards resting levels 
at 1h POST (p = 1.000).  
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 Table 3.2 Plasma glucose and lactate responses following acute COL or PLA 
consumption. 
 *Significant main effect of time (p < 0.001). 
3.3.3 Immune cell counts  
No significant trial or interaction effects were evident for total or differential leukocyte 
counts (Table 3.3). A main effect of time was observed in all leukocyte counts (Table 
3.3). There was a significant increase in total leukocytes, neutrophils, monocytes, 
neutrophil:lymphocyte ratio and large immature cells from BAS to POST and 1h 
POST (p ≤ 0.001). Total lymphocyte count at PRE was significantly lower than BAS 
(p < 0.01) and POST (p < 0.001). There was a significant increase in 
neutrophil:lymphocyte ratio (p < 0.001) and decrease in total lymphocytes and 
monocytes (p < 0.01) from POST to 1h POST (p < 0.01). 
  
 
 
 
Measure, mmolL-1 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
Plasma glucose     0.073 
COL 5.10 ± 0.39 4.39 ± 0.57 4.38 ± 0.42 4.25 ± 0.39 < 0.001* 
PLA 5.19 ± 0.51 4.43 ± 0.55 4.56 ± 0.53 4.35 ± 0.34 0.694 
Plasma lactate     0.970 
COL 1.50 ± 0.48 1.37 ± 0.29 2.04 ± 0.71 1.69 ± 0.66 < 0.001* 
PLA 1.49 ± 0.38 1.42 ± 0.26 1.97 ± 0.69 1.60 ± 0.43 0.381 
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Table 3.3 Immune cell counts following acute COL or PLA consumption. 
*Significant main effect of time (p < 0.001).  
  
 
 
 
Cell count, 10
9L-1 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
Total leukocytes   0.255 
COL 5.38 ± 1.46 5.51 ± 1.44 12.98 ± 5.01 12.15 ± 1.09 < 0.001* 
PLA 5.45 ± 1.33 5.17 ± 1.00 11.80 ± 3.43 11.43 ± 2.86 0.349 
Neutrophils   0.566 
COL 2.77 ± 1.15 3.23 ± 1.28 9.38 ± 4.19 9.54 ± 3.96 < 0.001* 
PLA 2.80 ± 0.79 2.98 ± 0.83 8.56 ± 2.96 8.86 ± 2.49 0.495 
Monocytes   0.820 
COL 0.50 ± 0.15 0.47 ± 0.13 0.90 ± 0.32 0.75 ± 0.23 < 0.001* 
PLA 0.53 ± 0.16 0.46 ± 0.12 0.82 ± 0.28 0.72 ± 0.19 0.211 
Total lymphocytes   0.073 
COL 1.86 ± 0.45 1.62 ± 0.39 2.41 ± 0.74 1.77 ± 0.27 < 0.001* 
PLA 1.89 ± 0.67 1.53 ± 0.33 2.16 ± 0.62 1.63 ± 0.39 0.176 
Neutrophil:lymphocyte   0.454 
COL 1.55 ± 0.67 2.13 ± 1.06 3.95 ± 1.36 5.49 ± 2.13 <0.001* 
PLA 1.59 ± 0.59 2.03 ± 0.78 4.27 ± 2.01 5.62 ± 1.68 0.962 
Large immature cells   0.870 
COL 0.04 ± 0.02 0.04 ± 0.02 0.20 ± 0.14 0.18 ± 0.13 < 0.001* 
PLA 0.05 ± 0.02 0.04 ± 0.02 0.17 ± 0.10 0.15 ± 0.06 0.402 
97 
 
3.3.4 Neutrophil responses 
A significant main effect time of time (p < 0.001) was observed for fMLP-stimulated 
CL per neutrophil (neutrophil oxidative burst) (Figure 3.1A). There was a significant 
decrease in fMLP-stimulated CL per neutrophil compared to BAS at PRE (p = 0.020), 
POST (p < 0.001) and 1h POST (p < 0.001). There was a main effect of trial for 
fMLP-stimulated CL per neutrophil (p = 0.024) but no trial ˣ time interaction (p = 
0.158 (Figure 3.1A).  
A significant main effect of time (p < 0.001) was observed for PMA-stimulated CL per 
neutrophil (neutrophil oxidative burst) (Figure 3.1B). There was a significant 
decrease in PMA-stimulated CL per neutrophil compared to BAS at POST (p = 
0.001) and 1h POST (p < 0.001). There was no main effect of trial (p = 0.449) or trial 
ˣ time interaction (p = 0.741) for PMA-stimulated CL per neutrophil (Figure 3.1B). 
Two-way ANOVA on PMA-stimulated CL per neutrophil following fMLP stimulation 
showed a main effect of time (p = 0.005) but no effect of trial (p = 0.335) or 
interaction (p = 0.344) (Table 3.4). Post hoc analyses could not reveal any significant 
differences between timepoints, only a trend for POST to be lower than BAS (p = 
0.094). 
A significant main effect of time (p < 0.001) was observed for unstimulated CL per 
neutrophil (basal ROS) (Table 3.4). There was a significant decrease in unstimulated 
CL per neutrophil compared to BAS at PRE (p = 0.008), POST (p < 0.001) and 1h 
POST (p = 0.001). There was no main effect of trial (p = 0.495) or trial ˣ time 
interaction (p = 0.655) for unstimulated CL per neutrophil (Table 3.4). There was no 
main effect of time (p = 0.426) trial (p = 0.785) or trial ˣ time interaction (p = 0.692) 
for spontaneous CLL-1 blood (Table 3.4). 
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There was no significant main effect of trial (p = 0.257) or time (p = 0.135) for 
stimulated elastase release per neutrophil (neutrophil degranulation) (Table 3.4). 
However, there was a significant difference within trials for exercise-induced 
changes in stimulated elastase release per neutrophil (trial ˣ time interaction, p = 
0.01) (Table 3.4). A one-way ANOVA on each trial showed a time effect in the PLA 
trial (p = 0.009) but not in COL trial (p = 0.547). Further post hoc analysis of PLA trial 
showed there was a significant decrease in stimulated elastase release from PRE to 
1h POST (p = 0.029). 
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Figure 3.1 fMLP (A) and PMA (B) stimulated chemiluminescence per neutrophil  
following acute COL or PLA consumption. Significant change from BAS (*p < 0.05, 
**p < 0.001). †Significant main effect of trial for fMLP-stimulated chemiluminescence 
per neutrophil (p < 0.05).  
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Table 3.4  Neutrophil responses following acute COL or PLA consumption.  
*Significant main effect of time (p < 0.001). †Significant main effect of interaction (p < 
0.05). 
3.3.5 Plasma incubations 
Two-way ANOVA analysis revealed a significant main effect of treatment for fMLP-
stimulated oxidative burst (p = 0.026) but no effect of time (p = 0.087) or treatment × 
time interaction (p = 0.293). The observed effects indicated an overall higher 
response to fMLP across both timepoints (BAS and POST) when whole blood (i.e. 
neutrophils) was pre-incubated with plasma obtained 1 h following COL consumption 
(Table 3.5). It is worthy to note that the main focus here was to observe the main 
effect of COL as the temporal pattern (i.e. interaction effect) may be confounded by 
enhancements with COL at both timepoints and a lack of statistical power compared 
to section 3.3.4 to identify an effect of time (i.e. exercise).  
 
 
 
Measure 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
PMA-stimulated CL following fMLP stimulation per neutrophil (% of BAS) 0.355 
COL 100 ± 0 93.0 ± 18.4 82.1 ± 34.6 92.9 ± 36.1 < 0.001* 
PLA 100 ± 0 96.3 ± 7.7 74.3 ± 33.6 73.7 ± 27.2 0.344 
Unstimulated CL per neutrophil (% of BAS)   0.495 
COL 100 ± 0 87.6 ± 28.5 33.8 ± 14.3 32.1 ± 13.8 < 0.001* 
PLA 100 ± 0 86.2. ± 16.5 39.2 ± 19.0 35.4 ± 22.4 0.665 
Spontaneous CLL-1 blood   0.785 
COL 964 ± 360 946 ± 323  1008 ± 307 960 ± 289 0.426 
PLA 1020 ± 394 943 ± 449 1106 ± 516 1084 ± 731 0.692 
Stimulated elastase release per neutrophil (fgcell-1)                                                                    0.257 
COL  401 ± 168 366 ± 143 396 ± 191  0.135 
PLA  467 ± 179 418 ± 105 356 ± 119†   0.010 
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Table 3.5 CL (oxidative burst) responses following pre-incubation of whole blood 
from PLA main trial with plasma collected following COL or PLA consumption.  
*Significant main effect of trial (p < 0.05) 
3.4 Saliva SIgA and antimicrobial peptide responses 
There was no significant main effect of trial (p = 0.604) or interaction (p = 0.518) for 
salivary SIgA concentration (Table 3.6). There was a significant main time effect (p = 
0.002) with post hoc analysis showing that salivary SIgA concentration was lower at 
PRE compared to BAS (p = 0.006) and POST (p = 0.039). Two-way ANOVA 
revealed no significant main effects of time (p = 0.315), trial (p = 0.384) or interaction 
(p = 0.220) for salivary SIgA secretion rate (Table 3.6). There was no main effect of 
trial (p = 0.205) or interaction (p = 0.150) for saliva SIgA:osmolality (Table 3.6). 
There was, however, a main effect of time (p < 0.001 ) with post hoc analysis 
showing a significant decrease in SIgA: osmolality from BAS to POST (p < 0.001) 
while decreases from BAS to PRE (p = 0.057) and increases from POST to 1h POST 
(p = 0.071 ) approached significance. 
There was no significant main effect of trial (p = 0.602) or interaction (p = 0.327) for 
sLac concentration (Table 3.6). There was a significant main time effect (p = 0.001) 
with post hoc analysis showing that sLac concentration was increased at POST 
compared to BAS (p = 0.033) and PRE (p = 0.039). ANOVA also revealed a main 
 
 
fMLP- stimulated CL per neutrophil 
(RLUs-1 cell-1) 
 
 
 
COL 
 
 
 
PLA 
p values 
trial 
time 
interaction 
     0.026* 
BAS 32.8 ± 12.1 25.3 ± 13.7 0.087 
POST 24.0 ± 10.7 21.0 ± 9.1 0.293 
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effect of time for sLac secretion rate (p = 0.044) but post hoc analysis could not 
identify any specific differences between time points (Table 3.6). There was no effect 
of trial (p = 0.549) or interaction (p = 0.813) on sLac secretion rate. There was a 
main effect of time (p = 0.022) with sLac:osmolality but post hoc analysis could not 
identify specific differences between timepoints (Table 3.6). There was no main 
effect of trial (p = 0.855) or interaction (p = 0.067) for sLac:osmolality. 
 Two-way ANOVA showed a significant interaction (trial × time) for sLys 
concentration (p = 0.018) (Figure 3.2). Paired t-tests showed there was a higher sLys 
concentration at POST in the COL trial compared to PLA trial (p = 0.007). This was 
supported by a one-way ANOVA on each trial showing a main effect of time (0.026) 
with significantly greater sLys concentration at POST compared to PRE in COL trial 
(p = 0.031) while there was no significant change across time for sLys concentration 
in PLA trial (p = 0.766). There was no main effect of time (p = 0.333) but the effect of 
trial approached significance (p = 0.059). There was a trend (p = 0.061) for an 
interaction (trial ×time) for sLys secretion rate but no effect of trial (p = 0.254) or time 
(p = 0.528) (Table 3.6). Two-way ANOVA showed a significant interaction (trial × 
time) for sLys:osmolality (p = 0.042) (Figure 3.3). Paired t-tests showed there was a 
higher sLys:osmolality at POST in the COL trial compared to PLA trial (p = 0.013). 
One-way ANOVA on each trial revealed no significant main effects of time in COL (p 
= 0.093) or PLA trial (p = 0.312). No significant main effects of trial (0.226) or time 
(0.356) were reported for sLys:osmolality. 
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Table 3.6 Changes in salivary SIgA and AMPs with acute COL or PLA 
supplementation.  
Significant main effect of time (* p < 0.05, ** p < 0.001). 
 
 
 
Immune measure 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p value 
trial 
time 
interaction 
SIgA concentration (mgL-1 )    0.604 
COL 364 ± 177 317 ± 201 359 ± 350 350 ± 191   0.002* 
PLA 385 ± 183 301 ± 151 352 ± 175 374 ± 162  0.518 
SIgA secretion rate (gmin-1 )  0.384 
COL 160 ± 95  196 ± 116 179 ± 119 191 ± 105 0.315 
PLA 161 ± 106 159 ± 94 179 ± 132 194 ± 131 0.220 
SIgA: osmolality (mgmosmol-1 )   0.205 
COL 5.3 ± 1.8 4.8 ± 2.6 4.1 ± 1.2 4.5 ± 1.8 < 0.001** 
PLA 5.4 ± 1.8 4.6 ± 1.7 4.2 ± 1.3 5.2 ± 1.6 0.150 
sLac concentration (mgL-1)   0.602 
COL 3.9 ± 0.8 4.0 ± 0.9 4.9 ± 1.0 4.3 ± 1.1   0.001* 
PLA 3.7 ± 1.0 4.3 ± 1.0 4.9 ± 0.9 4.5 ± 1.1  0.327 
sLac secretion rate (gmin-1 )   0.549 
COL 2.3 ± 1.5 3.2 ± 2.0 2.9 ± 1.7 3.1 ± 1.8   0.044* 
PLA 2.0 ± 1.7 3.1 ± 1.9 2.8 ± 1.5 2.7 ± 1.3  0.813 
sLac: osmolality (mgmosmol-1 )   0.855 
COL 0.06 ± 0.01 0.06 ± 0.01 0.05 ± 0.02 0.06 ± 0.02   0.022* 
PLA 0.05 ± 0.02 0.06 ± 0.01 0.06 ± 0.01 0.06 ± 0.02  0.067 
sLys secretion rate (gmin-1 )   0.528 
COL 10.0 ± 7.3 12.9 ± 7.1 17.2 ± 13.4 12.6 ± 12.0  0.254 
PLA 9.8 ± 11.5 11.9 ± 8.2 8.8 ± 6.7 11.4 ± 8.2  0.061 
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Figure 3.2 The response of sLys concentration following acute COL or PLA 
supplementation. *Significant difference between trials (p < 0.05). 
  
 
 
 
 
 
 
 
Figure 3.3 The response of sLys:osmolality following acute COL or PLA 
supplementation. *Significant difference between trials (p < 0.05). 
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3.5 Discussion 
The main finding(s) of this study was that acute consumption of COL resulted in a 
greater fMLP-stimulated oxidative burst compared to PLA and an enhancement of 
bacterial-stimulated neutrophil degranulation and salivary lysozyme in the recovery 
period following prolonged exercise. This supports previously mentioned benefits of 
COL on the human innate immune system following prolonged exercise (Davison 
and Diment, 2010) but it is the first study to demonstrate such effects with acute COL 
supplementation.  
Only one earlier study had investigated a brief period (10 days) of COL 
supplementation on leukocyte responses to prolonged exercise. Carol et al. (2011) 
suggested no role of COL supplementation in preventing exercise-induced immune 
dysfunction despite lacking any measurements of leukocyte function. Similar to 
previous research a significant immunological stress was observed in response to 
prolonged exercise during the COL and PLA trials with increases in leukocytes, 
neutrophils, lymphocytes (followed by lymphocytopenia), neutrophil:lymphocyte ratio, 
monocytes and large immature cells (Davison and Diment, 2010; Lancaster et al., 
2003; Li and Gleeson, 2004, 2005; McCarthy and Dale, 1988; Nieman, 1998). 
The evidence of a greater fMLP-stimulated oxidative burst in the COL trial and 
greater recovery of neutrophil degranulation at 1 h post-exercise compared to PLA 
suggest that acute COL supplementation may have similar benefits to chronic 
supplementation (Davison and Diment, 2010). Similar to previous studies on COL 
supplementation there was no apparent effect of COL on exercise-induced 
leukocytosis (Carol et al., 2011); supporting proposals from in vitro evidence that 
COL may have direct effects on leukocyte function (Davison and Diment, 2010; 
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Sugisawa et al., 2003). The fact that PMA-stimulated oxidative burst was unaffected 
by COL may provide a novel insight into how COL modulates neutrophil activity 
following exercise-induced immune dysfunction. Evidence from numerous in vitro 
studies suggest that short pre-term incubation with COL primes the response of 
neutrophils to subsequent stimulation (Benson et al., 2012; Sugisawa et al., 2001, 
2002, 2003). Neutrophil priming has been demonstrated with a range of certain 
cytokines (GM-CSF, G-CSF, IL-8, TNF, (Elbim et al., 1994; You et al., 1991; 
Khwaja et al., 1992). The exact intracellular events that occur with these priming 
agents depend on the subsequent activating agonist of neutrophil stimulation but it 
seems that priming involves phosphorylation of cytosolic proteins that are crucial in 
the assembly of NADPH oxidase on the plasma membrane (Dang et al., 1999; 
Dewas et al., 2003). In line with changes of in vitro neutrophil activation observed in 
this study, some of these pro-inflammatory cytokines (e.g. TNF) can prime the 
receptor-mediated stimulation (degranulation and oxidative burst) of neutrophils by 
bacterial products but not affect receptor-independent responses to synthetic stimuli 
(e.g. PMA) (Bajaj et al., 1992).  
Despite the reported effects in vitro, the priming agent within COL remains unclear. 
Sugisawa et al. (2003) proposed that priming effects are due to low molecular weight 
components such as proteose peptones following findings that a COL fraction 
containing substances less than 10 kDa enhanced responses to Staphylococcus 
aureus whereas fractions containing constituent cytokines (IL-1, IL-6, TNF) of COL 
did not have any effects. Of note to the present study was that the priming nature of 
this low molecular weight fraction in Sugisawa et al. (2003) was lost when 
neutrophils were stimulated with PMA. Benson et al. (2012) observed enhancement 
of ex vivo neutrophil phagocytosis 1 h and 2 h following consumption of a low 
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molecular weight fraction of COL in healthy males. As any priming components 
remain unclear, the direct or indirect effects of COL on cytokines in vivo cannot be 
excluded due to the molecular mass of some cytokines with mediating effects on 
neutrophils being < 10 kDa (e.g. IL-8) (Lin et al., 2004; Mikami et al., 1998). 
Furthermore, COL is considered to be a precursor of numerous potential biologically 
active peptides (Jorgensen et al., 2010). Although IgG within non-digested COL is 
unlikely to pass into circulation, the digestion of its Fc heavy chain may release other 
metabolites (e.g. Tuftsin) which have been shown to modulate neutrophil oxidative 
burst (Najjar and Nishioka, 1980; Siemion and Kluczyk, 1999; Werner et al., 1986; 
Wu et al., 2012). Such mechanism(s) triggered by metabolites of COL would 
challenge hypotheses proposed by others (Sugisawa et al., 2001, 2002, 2003) that 
the component is present within whole COL. Nevertheless, this study expands on 
previous in vitro co-culture evidence by suggesting that these ‘priming’ and/or 
immune- enhancing components become biologically available to affect neutrophil 
function upon oral consumption of COL within a model of exercise-induced immune 
dysfunction. These findings are further supported by the enhancement of neutrophil 
oxidative burst when neutrophils are pre-incubated with plasma collected following 
acute COL consumption. It can be suggested from the findings presented here that 
the mechanism(s) of acute COL supplementation are not due to a modulation of 
antioxidant capacity or basal ROS production due to a lack of effect on unstimulated 
or spontaneous oxidative burst. Based on the available evidence, it can be 
speculated that the enhancement of neutrophil function by COL is mediated by 
changes proximal to surface receptors and/or intracellular signal transduction 
pathways that are independent of PKC as responses to PMA-stimulated (strong PKC 
agonist, Sheppard et al., 2005) were unaffected.  
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This hypothesis, however, would not explain the observed enhancement of PMA-
stimulated oxidative burst 1-3 h following COL consumption in resting males in the 
pilot study. However, it must be recognised that previous in vitro work by others has 
suggested that priming effects of COL on PMA-stimulated oxidative burst responses 
are absent (Sugisawa et al., 2003) or mild and substantially lower (Sugisawa et al., 
2002) compared to responses to bacterial (Staphylococcus aureus) stimulation. 
Physiological stimuli like fMLP can stimulate neutrophils multiple times while PMA is 
considered a maximal stimulus which migrates into the cell and stimulates ROS 
production via all intracellular sources (Sheppard et al., 2005). In the experimental 
trial of this study, there was no beneficial effect of COL on PMA-stimulated oxidative 
burst 1 h post consumption of COL or in post exercise measures. There was also no 
effect of COL on PMA-stimulation when neutrophils had previously been activated by 
fMLP. However, as measurement of response to PMA following fMLP stimulation 
was only carried out on a small subset of participants (n = 8) and potentially limited 
by a lack of statistical power, further investigation is warranted. Taken together, it 
can be suggested that components of COL and/or its metabolites may possess the 
ability to prime neutrophil responses by mediating various pathways of signal 
transduction but the functional significance of these may be influenced by exercise.  
The importance of mucosal immune parameters such as AMPs towards host 
defence have been recognised (West et al., 2006). In accordance with Davison and 
Diment (2010), COL compared with PLA enhanced sLys concentration immediately-
post exercise, before the parameter returned to pre-exercise levels in both trials after 
1 h of recovery. The effects occurred despite the lack of exercise-induced decrease 
in sLys in the present study that was observed in Davison and Diment (2010). Such 
findings may provide further evidence to the aforementioned proposal regarding COL 
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and the effector responses of neutrophils. In addition to circulating netrophilia, it has 
been suggested that there is an increase in the number of neutrophils in mucosal 
secretions following prolonged exercise (Muns, 1994). As neutrophils are considered 
an important source of sLys (Travis et al., 2001), it is plausible that the increased 
concentrations post-exercise are due to the migration of ‘primed’ neutrophils into the 
oral cavity. sLys along with sLac are the most abundant AMPs within saliva (Singh et 
al., 2000). In contrast to sLys, there was increased sLac concentration post-exercise 
in both the COL and PLA trials. These exercise-induced changes, however, are in 
agreement with other investigations of sLac or other AMPs that have similar sources 
(e.g. LL37) (submucosal glands and epithelial cells) (Davison et al., 2009; Gillum et 
al., 2013). The functional significance of these increases is unclear at present but it 
may reflect an inflammatory response to exercise-induced damage to mucosal 
surfaces. Given the suggested synergistic effects of these AMPs on host defence 
within the oral cavity, further research is required to elucidate any influence by COL.  
There was also no apparent effect of COL on salivary SIgA in this study. Within this 
study design, benefits to salivary SIgA may have been via a modulation of responses 
to exercise or an elevation in pre-exercise levels. Similar to a 4 week 
supplementation period in Davison and Diment (2010), none of these effects were 
seen with acute COL intake. Based on evidence from studies that have observed 
increases in resting salivary SIgA with COL (Crooks et al., 2006; Mero et al., 2002), 
longer term supplementation (e.g. 12 weeks) and/or splitting the dose across the day 
may be required. In accordance with others (Allgrove et al., 2009; Davison et al., 
2009), there was a decrease in saliva SIgA:osmolality post-exercise which highlights 
the potential perturbations on mucosal immunity following prolonged exertion. 
However, the lack of simultaneous decreases in salivary SIgA concentration or 
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secretion rate reiterates the variance and/or discrepancies with salivary SIgA 
expression methods (Bishop and Gleeson, 2009).   
A possible limitation to the present study was that there was a lack of or minimal 
exercise-induced immune dysfunction in some parameters (e.g. salivary SIgA) 
providing little scope for benefit via a nutritional countermeasure (i.e. COL). Despite 
significant falls with in vitro fMLP- and PMA-stimulated neutrophil oxidative burst 
supporting previous findings (e.g. Davison and Gleeson, 2005; Henson et al., 2008), 
the lack of simultaneous decrease in bacterial-stimulated degranulation immediately 
post-exercise is somewhat surprising and dissimilar to many previous findings (e.g. 
Davison and Gleeson, 2005, 2006; Laing et al., 2005, 2008). It is likely that the 
cumulative intensity and duration of the current exercise protocol was not strenuous 
enough in the study population to trigger decreases in neutrophil degranulation. 
Indeed, evidence suggests that decreases in neutrophil capacity are associated with 
increasing neutrophilia (i.e. greater physiological stress) (Li and Cheng, 2007; Li and 
Gleeson, 2006). Exercise-induced changes in plasma hormones (adrenaline, 
cortisol, GH) and inflammatory mediators (IL-6, C5a) have been proposed to explain 
the decreases in neutrophil degranulation following prolonged exercise but the exact 
mechanisms remain unclear (Bishop et al., 2003; Henson et al., 1978; Laing et al., 
2008; Pyne, 1994; Robson et al., 1999b; Yamada et al., 2002). The lack of 
measurement of these factors limits the discussion of the findings of the present 
study to previous studies. 
To conclude, this is first to study to demonstrate that acute COL supplementation 
can enhance components of the innate immune system following prolonged 
exercise. It is proposed that this is primarily due to priming agents that become 
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bioavailable upon COL consumption. Further research is required to confirm this and 
identify whether a longer period of supplementation (to allow for greater absorption 
of priming components) has further benefits. 
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Chapter 4. Study 2 - Effect of 4 weeks of bovine colostrum 
supplementation on blood neutrophil responses and mucosal 
immunity following prolonged exercise 
Abstract 
Acute COL supplementation enhances neutrophil function and sLys concentration 
within a model of exercise-induced immune dysfunction. The aims of this study were 
to identify the effects of 4 weeks of COL supplementation on neutrophil responses 
and mucosal immunity following prolonged exercise. Participants were randomly 
assigned to 20 g per day of COL (n = 10, age: 28.8 ± 7.6 years, BM: 79 ± 8 kg, 
height: 183 ± 6 cm, 2OV
  max 54.3 ± 8.6 mL·kg-1·min-1) or PLA (n = 10, age: 27 ± 9 
years, BM: 78.0 ± 7.7 kg, height: 180 ± 7 cm, 2OV
  max 55.7 ± 8.8 mL kg-1·min-1) for 
4 weeks. Venous blood and unstimulated saliva samples were obtained before and 
after 2.5 h of cycling at 15%  (~ 55-60% VO2 max). A significantly greater fMLP-
stimulated oxidative burst was observed in COL group compared with PLA group (p 
< 0.05) and a trend toward a trial × time interaction (p = 0.06). However, there was 
no effect of COL on leukocyte trafficking, PMA-stimulated oxidative burst, bacterial-
stimulated neutrophil degranulation, salivary SIgA, sLac or sLys (p > 0.05). These 
findings provide further evidence of the beneficial effects of COL on receptor-
mediated stimulation of neutrophil oxidative burst in a model of exercise-induced 
immune dysfunction. 
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4.1 Introduction 
Study 1 demonstrated that acute consumption of COL resulted in a greater fMLP-
stimulated neutrophil oxidative burst and enhanced bacterial-stimulated neutrophil 
degranulation following prolonged exercise. This supported previous evidence from 
in vitro studies where short term co-culture with COL enhances oxidative burst 
activity of neutrophils. Sugisawa et al. (2003) proposed that in the presence of COL, 
PMN cells (i.e. neutrophils) become primed for subsequent activation by low-
molecular weight substances (< 10 kDa) (such as protease peptones). Study 1 
suggested that upon digestion of COL, these bioactive components or yet to be 
identified metabolites of COL become biologically available to prime the activity of 
neutrophils in vivo. 
The magnitude of effects of COL on post-exercise stimulated-elastase release per 
neutrophil was similar to that reported in a 4 week study by Davison and Diment 
(2010). As neutrophil oxidative burst was not investigated in this 4 week study, the 
effects of longer term COL supplementation on this immune parameter in a 
prolonged exercise model remains unclear. If the above proposed mechanism is 
partly responsible for the effects of COL on immune function it may be hypothesised 
that 4 weeks of COL supplementation (longer period to allow for full absorption of 
COL and exposure to priming agents) would lead to a greater enhancement of 
oxidative burst. 
In a similar way to blood neutrophil function, acute supplementation of COL showed 
beneficial effects on sLys (component of neutrophil granules) concentration post-
exercise. There was, however, no effect of acute COL supplementation on sLac and 
salivary SIgA. Davison and Diment (2010) reported beneficial effects of 4 weeks of 
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COL supplementation on sLys concentration and secretion following prolonged 
exercise but observed no improvements in salivary SIgA. As sLac along with sLys 
are the most abundant AMPs in saliva, recognised to be important mediators of host 
defence (West et al., 2006, 2010), investigation into the effects of longer term 
supplementation on sLac is warranted.  Davison and Diment (2010) suggested that 
longer term supplementation (e.g. 12 weeks) of COL or shorter durations (2 weeks) 
in multiple dosages across the day may lead to changes in resting concentrations of 
salivary SIgA. Enhancement of mucosal defences at rest (Crooks et al., 2006; Mero 
et al., 2002) or following exercise (Davison and Diment, 2010) could reduce the 
magnitude of any immunodepressive effects and the susceptibility to URI at the sites 
where most pathogens enter the body (Macpherson et al., 2012). Therefore, the 
aims of this study were to identify the effects of 4 weeks of COL supplementation on 
neutrophil responses and mucosal immunity following a similar prolonged exercise 
bout of study 1. 
4.2 Methods 
4.2.1 Participants 
Twenty healthy, recreationally active males (age 28 ± 8 years; BM 78.6 ± 7.0 kg; 
height 182 ± 6 cm; 2OV
  max  55.0 ± 8.5 mL·kg-1·min-1) volunteered to participate in 
this investigation. 
4.2.2 Supplementation 
Participants were randomly assigned to a COL group (n = 10, age: 28.8 ± 7.6 years, 
BM: 79 ± 8 kg, height: 183 ± 6 cm, 2OV
  max 54.3 ± 8.6 mL·kg-1·min-1) or a PLA 
group (n = 10, age: 27 ± 9 years, BM: 78.0 ± 7.7 kg, height: 180 ± 7 cm, 2OV
  max 
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55.7 ± 8.8 mL kg-1·min-1). In a double blind manner, participants were asked to 
consume 20 g per day (split into a morning and evening 10 g dose on an empty 
stomach) of COL or an isoenergetic/isomacronutrient PLA for 4 weeks. 
4.2.3 Experimental trials 
Participants reported to the laboratory (following an overnight fast of at least 10 h) for 
the collection of a blood and saliva sample (BAS) prior to commencing the above 
supplementation. Following preliminary measurements ( 2OV
 max determination and 
familiarisation on day 8 and 15 of supplementation respectively) and 4 weeks of 
supplementation (28 days), participants completed the main experimental trial. 
During the 48 h preceding the experimental trial, participants were asked to refrain 
from heavy exercise and alcohol consumption. 
On the morning of the experimental trial, participants reported to the laboratory after 
an overnight fast of at least 10 h and at the same time of day as their BAS visit. The 
participants were asked to consume 500 mL of water 2 h before arrival to encourage 
euhydration. Participants were asked to remain seated for 10 min prior to collection 
of a resting blood sample (PRE) from an antecubital vein and an unstimulated saliva 
sample. Following collection of samples, participants immediately commenced 2.5 h 
of cycling at 15% . All participants were permitted diluted cordial (four volumes of 
water to 1 volume of sugar-free cordial at 2 mL·min-1 kg of BM) every 15 min during 
the exercise but not at end of the exercise.  
Expired gas was analysed during the 30th, 60th, 90th and 120th min of exercise 
(Jaeger Oxycon Pro, Hoechberg, Germany). HR and RPE was monitored every 15 
min during the protocol using a telemetric device (Polar S610, Polar Electro Oy, 
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Kempele, Finland) and Borg rating scale (Borg, 1982) respectively. The mean of 
each of the physiological responses were used to determine if similar physical stress 
was imposed in each trial.  A venous blood sample and an unstimulated saliva 
sample were collected immediately post-exercise (POST). Participants remained 
fasted until a further blood and saliva sample was obtained at 1 h post-exercise (1h 
POST).  
4.3 Results 
4.3.1 Physiological variables 
There was no significant difference in 2OV
  (p = 0.479; p = 0.445) between the COL 
(2406 ± 187 mL·min-1; 56.7 ± 3.8 % 2OV
  max) and PLA trial (2497 ± 351 mL·min-1; 
58.0 ± 3.8 % 2OV
 max). Mean HR of 129 ± 6 bpm and 137 ± 9 bpm during COL and 
PLA trials respectively, were significantly different (p = 0.03). There was no 
difference (p = 0.989) when HR was compared between COL (73 ± 2%) and PLA (74 
± 3%) trials as a proportion of peak HR obtained during 2OV
 max determination. 
There was no significant difference in RPE (p = 0.158) between the COL (12.4 ± 1.9) 
and PLA (13.5 ± 1.2) trial.  
Similar pattern of plasma volume changes were observed from PRE between trials: 
COL; POST (-6.4 ± 4.8%); 1h POST (-3.1 ± 6.0) and PLA; POST (-4.5 ± 2.7%), 1h 
POST (-1.7 ± 3.3%). As there was no significant difference between trials (trial ˣ time 
interaction; p = 0.697), it was deemed unnecessary to correct any haematological 
parameters for plasma volume changes. Although there was a significant change 
across time (p = 0.004), there was no significant trial (p = 0.937) or interaction effect 
(p = 0.771) on plasma glucose (Table 4.1). Post hoc analysis revealed a significantly 
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lower plasma glucose at 1h POST compared to both PRE (p < 0.001) and POST (p 
= 0.031). There was also a significant change across time for plasma lactate (p = 
0.002) but no effect of trial (p = 0.796) or interaction (p = 0.751) (Table 4.1). Plasma 
lactate significantly increased from PRE (p 0.014) to POST before decreasing 
towards resting levels at 1h POST (p = 1.000). 
Table 4.1 Plasma glucose and lactate responses following 4 weeks of COL or PLA.  
 
 
 
 
 
*Significant main effect of time (p < 0.01). 
  
 
 
 
Measure, mmolL-1 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
Plasma glucose    0.937 
COL 4.87 ± 0.34 4.54 ± 0.86 4.29 ± 0.46  0.004* 
PLA 4.79 ± 0.31 4.59 ± 0.52 4.28 ± 0.33 0.771 
Plasma lactate    0.796 
COL 1.36 ± 0.28 1.93 ± 0.67 1.54 ± 0.56  0.002* 
PLA 1.49 ± 0.46 2.01 ± 0.73 1.46 ± 0.28 0.751 
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4.3.2 Immune cell counts 
No significant trial or interaction effects were evident for total or differential leukocyte 
counts (Table 4.2). A main effect of time (p < 0.001) was observed in all leukocyte 
counts (Table 4.2). There was a significant increase in total leukocytes, neutrophils, 
monocytes, neutrophil:lymphocyte ratio and large immature cells from timepoints 
pre-exercise (BAS and PRE) to POST (p ≤ 0.01) with all of these counts also 
showing significant increases from BAS and PRE to 1h POST (p < 0.01). Total 
lymphocyte count significantly increased from BAS to POST (p = 0.022). There was 
a significant increase in neutrophils, neutrophil:lymphocyte ratio (p < 0.001) and 
decrease in total lymphocytes (p < 0.001) and monocytes (p = 0.036) from POST to 
1h POST.   
119 
 
Table 4.2 Immune cell counts following 4 weeks of COL or PLA.  
*Significant main effect of time (p < 0.001). 
  
 
 
 
Cell count, 10
9L-1 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
Total leukocytes    0.528 
COL 4.91 ± 1.10 5.14 ± 1.07 11.46 ± 5.73 11.13 ± 4.47 < 0.001* 
PLA 5.33 ± 1.60 5.62 ± 1.37 11.95 ± 4.39 11.51 ± 3.62 0.965 
Neutrophils    0.611 
COL 2.57 ± 0.81 2.50 ± 1.28 7.84 ± 4.14 8.32 ± 3.81 < 0.001* 
PLA 2.48 ± 0.79 2.78 ± 0.83 8.45 ± 3.74 8.78 ± 3.36 0.679 
Monocytes    0.899 
COL 0.43 ± 0.15 0.52 ± 0.12 0.95 ± 0.58 0.84 ± 0.43 < 0.001* 
PLA 0.50 ± 0.23 0.54 ± 0.12 0.79 ± 0.22 0.72 ± 0.21 0.336 
Total lymphocytes    0.622 
COL 1.65 ± 0.46 1.90 ± 0.71 2.41 ± 1.12 1.77 ± 0.46 0.001* 
PLA 2.02 ± 0.68 2.02 ± 0.58 2.32 ± 0.57 1.69 ± 0.33 0.278 
Neutrophil:lymphocyte    0.883 
COL 1.61 ± 0.61 1.45 ± 0.72 3.36 ± 1.21 4.74 ± 1.90 < 0.001* 
PLA 1.32 ± 0.48 1.45 ± 0.50 3.70 ± 1.46 5.35 ± 2.33 0.176 
Large immature cells    0.679 
COL 0.03 ± 0.02 0.04 ± 0.01 0.20 ± 0.23 0.19 ± 0.17 < 0.001* 
PLA 0.04 ± 0.03 0.05 ± 0.02 0.16 ± 0.09 0.15 ± 0.05 0.598 
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4.3.3 Neutrophil responses 
A significant main effect time of time (p < 0.001) was observed for fMLP-stimulated 
CL per neutrophil (neutrophil oxidative burst) (Figure 4.1A). There was a significant 
decrease in fMLP-stimulated CL per neutrophil compared with PRE at POST (p = 
0.001) and 1h POST (p < 0.001). There was a main effect of trial for fMLP-stimulated 
CL per neutrophil (p = 0.049) and an interaction effect (trial ˣ time) which approached 
significance (p = 0.060, Figure 4.1A).  
A significant main effect of time (p < 0.001) was observed for PMA-stimulated CL per 
neutrophil (neutrophil oxidative burst) (Figure 4.1B). There was a significant 
decrease in PMA-stimulated CL per neutrophil compared with PRE at POST (p < 
0.001) and 1h POST (p = 0.001). There was a significant increase in PMA-stimulated 
CL per neutrophil from POST to 1h POST (p = 0.014). There was no main effect of 
trial (p = 0.395) or trial ˣ time interaction (p = 0.464) for PMA-stimulated CL per 
neutrophil (Figure 4.1B). Two-way ANOVA on PMA-stimulated CL per neutrophil 
following fMLP stimulation showed a main effect of time (p = 0.001) but no effect of 
trial (p = 0.152) or interaction (p = 0.135) (Table 4.3). There was a significant 
decrease in PMA-stimulated CL per neutrophil following fMLP compared to PRE at 
POST (p < 0.001) and 1h POST (p < 0.001) with an increase towards resting levels 
from POST to 1h POST (p < 0.001). 
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A significant main effect of time (p < 0.001) was observed for unstimulated CL per 
neutrophil (basal ROS) (Table 4.3). There was a significant decrease in unstimulated 
CL per neutrophil compared to PRE at POST (p < 0.001) and 1h POST (p = 0.001). 
There was a significant decrease in unstimulated CL per neutrophil from POST to 1h 
POST (p = 0.004). There was no main effect of trial (p = 0.842) or trial ˣ time 
interaction (p = 0.940) for unstimulated CL per neutrophil (Table 4.3). A significant 
main effect of time (p < 0.001) was observed for CLL-1 blood (Table 4.3). There was 
a significant increase in spontaneous CLL-1 blood compared to PRE at POST (p < 
0.001) and 1h POST (p = 0.001). Spontaneous CLL-1 blood significantly decreased 
from POST to 1h POST (p = 0.014). There was no main effect of trial (p = 0.071) or 
trial ˣ time interaction (p = 0.539) for spontaneous CLL-1 blood (Table 4.3). There 
was no significant main effect of time (p = 0.629) trial (p = 0.538) or trial ˣ time 
interaction (p = 0.687) for stimulated elastase release per neutrophil (neutrophil 
degranulation) (Table 4.3).  
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Figure 4.1 fMLP (A) and PMA (B) stimulated chemiluminescence per neutrophil 
following 4 weeks of COL or PLA. Significant change from PRE: *p = 0.001, **p < 
0.001. #Significant change from POST (p < 0.05). †Significant main effect of trial for 
fMLP-stimulated chemiluminescence per neutrophil (p < 0.05). 
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Table 4.3 Neutrophil degranulation and oxidative responses following 4 weeks of 
COL or PLA..  
Significant main effect of time (*p < 0.01, **p < 0.001). 
4.3.4 Saliva responses 
There was no significant main effect of time (p =0.903), trial (p = 0.801) or interaction 
(p = 0.773) for salivary SIgA concentration (Table 4.4). Two-way ANOVA revealed 
no significant main effect of time (p = 0.430) trial (p = 0.845) or interaction (p = 
0.159) for salivary SIgA secretion rate (Table 4.4). There was no main effect of trial 
(p = 0.865) or interaction (p = 0.550) for saliva SIgA:osmolality (Table 4.4). There 
was, however, a main effect of time (p < 0.001 ) with post hoc analysis showing a 
significantly decreased saliva SIgA:osmolality from BAS and PRE to POST (p < 
0.001) and an increase towards resting levels from POST to 1h POST (p = 0.022). 
  
 
 
 
Measure 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p values 
trial 
time 
interaction 
PMA-stimulated CL (oxidative burst) following fMLP stimulation (% of PRE) 0.152 
COL 100 ± 0 61.9 ± 16.9 71.6 ± 16.2  0.001* 
PLA 100 ± 0 51.6 ± 18.3 58.6 ± 16.2 0.135 
Unstimulated CL per neutrophil (% of PRE)    0.842. 
COL 100 ± 0 69.0 ± 45.9 57.2 ± 36.9 < 0.001** 
PLA 100 ± 0 63.1. ± 31.9 54.0 ± 29.2 0.940 
Spontaneous CLL-1 blood   0.071 
COL 813 ± 193 1110 ±  323 1042 ± 326         < 0.001** 
PLA 1114 ± 335 1502 ± 537     1309 ± 467 0.539 
Stimulated elastase release per neutrophil (fgcell-1) 0.538 
COL 369 ± 85 428 ± 310 374 ± 159 0.629 
PLA 444 ± 144 396 ± 166 447 ± 233 0.687 
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Table 4.4 Salivary SIgA responses following 4 weeks of COL or PLA.  
*Significant main effect of time (p < 0.001). 
There was no main effect or trial (p = 0.195) or interaction (p = 0.244) for sLac 
concentration (Table 4.5). There was a significant main time effect (p < 0.001) with 
post hoc analysis showing that sLac concentration was increased at POST 
compared to BAS (p < 0.001) and PRE (p = 0.002) followed by a decrease from 
POST to 1 h (p = 0.005). Two way ANOVA also revealed a main effect of time for 
sLac secretion rate (p < 0.001) (Table 4.5). Post hoc analysis identified greater sLys 
secretion rate at POST (p < 0.001) and 1h POST (p = 0.030) compared to BAS as 
well as an increase from PRE to POST (p =0.026). Results for sLac:osmolality 
showed no effect of time (p = 0.405), trial (p = 0.448) or interaction (p = 0.711) (Table 
4.5).  
Two-way ANOVA showed a significant main effect of time for sLys concentration (p = 
0.003) but no effect of trial (p = 0. 359) or interaction (p = 0.386) (Table 4.5). Post 
 
 
 
Immune measure 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p value 
trial 
time 
interaction 
SIgA concentration (mgL-1)    0.933 
COL 336 ± 91 318 ± 91 321 ± 104 323 ± 100 0.801 
PLA 325 ± 101 339 ± 115 345 ± 85 332 ± 94 0.773 
SIgA secretion rate (gmin-1)    0.845 
COL 169 ± 77 141 ± 69 163 ± 97 186 ± 102  0.430 
PLA 155 ± 99 180 ± 96 179 ± 92 174 ± 91 0.159 
SIgA:osmolality (mgmosmol-1)    0.865 
COL 5.1 ± 1.0 5.1 ± 1.2 3.9 ± 1.2 4.7 ± 1.7 < 0.001* 
PLA 5.6 ± 1.7 5.4 ± 1.0 3.9 ± 1.3 5.0 ± 1.3 0.550 
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hoc analysis revealed an increase in sLys concentration from BAS to POST (p = 
0.012). There was a main effect of time (p = 0.009) for sLys secretion rate but no 
effect of trial (p = 0. 514) or interaction (p = 0.117) (Table 4.5). Post hoc analysis 
revealed an increase in sLys secretion rate from BAS to 1h POST (p = 0.023). Two-
way ANOVA showed no effect of time (p = 0.127), trial (p = 0.392) or interaction (p = 
0.663) for sLys:osmolality (Table 4.5). 
Table 4.5 The responses of sLac and sLys following 4 weeks of COL or PLA. 
Significant main effect of time (*p < 0.01,** p < 0.001)  
 
 
 
Immune measure 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
 
 
 
1h POST 
p value 
trial 
time 
interaction 
sLac concentration (mgL-1 )    0.195 
COL 3.9 ± 1.2 4.5 ± 5.3 5.3 ± 0.7 4.3 ± 0.5  < 0.001** 
PLA 4.0 ± 1.2 4.7 ± 1.0 5.8 ± 1.0 5.2 ± 1.0  0.244 
sLac secretion rate (gmin-1 )    0.186 
COL 2.1 ± 1.2 2.0 ± 1.3 2.7 ± 1.5 2.4 ± 0.8  < 0.001** 
PLA 2.4 ± 1.3 3.0 ± 1.6 3.6 ± 1.6 3.4 ± 1.4 0.256 
sLac:osmolality (mgmosmol-1 )    0.448 
COL 0.03 ± 0.02 0.03 ± 0.03 0.03 ± 0.02 0.04 ± 0.02 0.405 
PLA 0.04 ± 0.02 0.05 ± 0.02 0.05± 0.02 0.05 ± 0.02 0.711 
sLys concentration (mgL-1 )    0.368 
COL 13.7 ± 6.0 18.8 ± 14.7 21.5 ± 11.6 22.2 ± 13.6   0.003* 
PLA 13.5 ± 5.4 20.4 ± 10.6 32.5 ± 12.6 23.7 ± 6.2  0.359 
sLys secretion rate (gmin-1 )     0.514 
COL 6.6 ± 4.8 6.8 ± 5.8 11.3 ± 7.6 10.3 ± 3.2   0.009* 
PLA 6.9 ± 6.2 12.7 ± 11.0 20.0 ± 11.3 15.5 ± 6.1 0.117 
sLys:osmolality (mgmosmol-1 )    0.392 
COL 0.23 ± 0.13 0.33 ± 0.29 0.27 ± 0.14 0.35 ± 0.25 0.127 
PLA 0.26 ± 0.14 0.40 ± 0.26 0.42 ± 0.14 0.37 ± 0.09 0.663 
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4.4 Discussion 
The present study demonstrated that 4 weeks of COL supplementation results in 
greater fMLP-oxidative burst responses compared to PLA. Although these findings 
expand on the beneficial effect observed on fMLP-stimulated responses with acute 
COL supplementation (Study 1), previously reported effects of 4 weeks COL 
supplementation on other innate and mucosal parameters could not be replicated in 
this study (i.e. stimulated-elastase release, sLys enhancement) (Davison and 
Diment, 2010). 
Similar to study 1 and other investigations of prolonged exercise, there were 
significant increases in leukocytes, neutrophils, lymphocytes, neutrophil:lymphocyte, 
monocytes and immature cells (Davison and Diment, 2010; Davison et al., 2012; 
Lancaster et al., 2003; Li and Gleeson, 2004, 2005; McCarthy and Dale, 1988; 
Nieman, 1998). As shown previously (Carol et al., 2011; Davison and Diment, 2010; 
Study 1), there were no differences between the COL and PLA groups for leukocyte 
trafficking. Taken together, evidence suggests that is likely the effects of COL on 
immune function within a stress model of prolonged exercise are not related to the 
attenuation of the perturbations in leukocytes that occur as a result of increases in 
catecholamine or HPA activation (e.g. leukocytosis) (McCarthy and Dale, 1988). 
The findings of in vitro culture demonstrate that COL possesses the ability to prime 
neutrophil function (Benson et al., 2012; Sugisawa et al., 2001, 2002, 2003). 
Neutrophils can be primed by a range of cytokines (GM-CSF, G-CSF, IL-8, TNF) 
which amplify responses to subsequent stimulation (Elbim et al., 1994; Khwaja et al., 
1992; Mikami et al., 1998; You et al., 1991). Sugisawa et al. (2003) proposed that 
‘priming’ induced by COL are due to low molecular weight proteins (e.g. proteose 
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peptones) other than cytokines. Although investigations into the role of cytokines in 
the effects of COL on human immune function are limited, the findings here and 
within study 1 suggest that consumption of COL does increase the bioavailability of 
components which enhance neutrophil oxidative activity to physiological agonists 
(fMLP). It is currently unclear how long any priming effect of COL lasts but it is 
becoming apparent that the effects occur with receptor-mediated stimulation of 
neutrophils. It has previously been reported that enhanced oxidative burst responses 
to fMLP can last at least 24 h following exposure to priming agents (e.g. G-CSF) 
(Ichinose et al., 1990). It is worthy to note that the findings from this study, and those 
of study 1, suggest that the mechanisms underlying the effects of COL are not 
related to up-regulation of antioxidant capacity or modulation of basal ROS 
production following exercise.  
This study showed no attenuation of exercise-induced decreases in PMA-stimulated 
oxidative burst with or without prior fMLP stimulation, supporting evidence gathered 
from study 1. It may be suggested that COL may not exert effects on neutrophil 
responses via PKC and/or does not affect the maximal capacity of neutrophils 
following prolonged exercise. Although the activation of PKC has been shown to 
occur following stimulation by some physiological agonists (Peake, 2002), PMA is 
not encountered in vivo and hence considered as an artificial stimulus (Sheppard et 
al., 2005). Due to the irreversible nature of PMA stimulation, it differs substantially to 
physiological agonists (e.g. fMLP) (DeCoursey and Ligeti, 2005).The effectiveness of 
PMA to stimulate pathways for ROS production in vitro has perhaps masked the 
irrelevancy of the agonist towards in vivo neutrophil function (Sheppard et al., 2005). 
In contrast, production of formylated proteins (e.g. fMLP) is attributed to bacteria and 
mitochondria, where a receptor (FPR1) on the cell surface of neutrophils recognises 
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the microbial moieties and tissue damage (Jaillon et al., 2013; Zhang et al., 2010). 
Therefore, the potential in vivo significance of enhanced fMLP-induced oxidative 
burst by acute and longer term COL supplementation may be enhanced responses 
toward infectious and/or inflammatory challenge (Carp, 1982; Marasco et al., 1984; 
Tennenberg and Solomkin, 1990).  
Despite the exercise-induced fall in neutrophil oxidative burst, there was no effect of 
prolonged exercise on neutrophil stimulated-elastase release. This is in contrast to 
findings reported by numerous investigators (Davison and Gleeson, 2005, 2006, 
2006; Davison et al., 2007, 2012; Laing et al., 2005, 2008) but supports others (Li 
and Gleeson, 2005). It has been proposed that increasing neutrophilia following 
prolonged exercise may be associated with decreases in neutrophil function (Li and 
Cheng, 2007; Li and Gleeson, 2006). In general, neutrophilia observed in the studies 
where stimulated-elastase release was unaffected by exercise have not been to the 
same extent as where exercise-induced decreases have been found. Based on the 
available evidence, it is hypothetical to suggest that the exercise stress, in particular 
the exercise intensity in this study was not sufficient to induce decrements in 
neutrophil degranulation within the study population. The comparison of this study to 
others is limited by the lack of measurement in potential mediators but it is likely that 
the exercise intensity was not of an adequate strenuous nature to induce the 
elevations in circulating concentrations of adrenaline (with subsequent increases in 
intracellular cyclic adenosine monophosphate) cortisol, growth hormone, IL-6, and/or 
C5a to levels where perturbations in mobilisation and degranulation of neutrophils 
were seen previously (Bishop et al., 2003; Henson et al., 1978; Laing et al., 2008; 
Peake, 2002; Pyne, 1994; Robson et al., 1999b; Yamada et al., 2002). Nevertheless 
the findings of this study and our previous study (Study 1) may support the 
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hypothesis that oxidative burst capacity may be more susceptible to the duration 
rather than exercise intensity per se (Peake, 2002; Peake et al., 2004; Pyne et al., 
2000; Robson et al., 1999b). 
The absence of a fall in neutrophil degranulation (bacterial-stimulated elastase) in 
this study (hence a reduced scope for nutritional intervention) may also explain why 
there was a discrepancy to effects observed with 4 weeks of supplementation in 
Davison and Diment (2010). The azurophilic granules of neutrophils are also 
abundant in AMPs e.g. lysozyme (Amulic et al., 2012). In contrast, to Davison and 
Diment (2010) and study 1, there was also no enhancement in sLys within the 
present study. The two aforementioned studies observed a decline in neutrophil 
degranulation in the PLA groups during the recovery period. Although further 
research is required to ascertain the role of oral neutrophils in exercise-induced 
immune depression, changes in sLys (as other AMPs) may reflect the activity of 
circulating neutrophils (Davison et al., 2009). The large variability in sLys in the PLA 
group in this study is in accordance with others (Hopkins, 2000; West et al., 2010) 
who have recognised the variance as a source of limitation for detection of 
intervention induced-changes in mucosal parameters.  
As shown previously (Gillum et al., 2013; Study 1), there was an increased 
availability of sLac following prolonged exercise in both COL and PLA trials. The 
reason for this increase remains unclear but may be indicative of an inflammatory 
response induced by damaged epithelial cells (Davison et al., 2009; Usui et al., 
2011). Given that longitudinal studies of sLac have observed lower levels in athletes 
compared to resting controls (West et al., 2010), further investigations are required 
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to determine whether responses to prolonged exercise on a regular basis leads to a 
depletion of sLac availability. 
Reduced mobilisation of salivary SIgA has been advocated as a marker of 
dysfunctional mucosal immunity following prolonged exercise (Walsh et al., 2011b). 
Despite no change in concentration or secretion, there was an exercise-induced 
decrease in saliva SIgA:osmolality. This reduction was unaltered by COL 
supplementation. COL has previously been shown to increase resting salivary SIgA 
concentrations (Crooks et al., 2006; Mero et al., 2002), but this was not evident in 
the present study. Based on Crooks et al. (2006) and Mero et al. (2002), Davison 
and Diment (2010) proposed that the dosage of COL may need to be split across the 
day or taken over longer periods to stimulate changes in resting salivary SIgA 
production. Although not separated into four doses (5 g) as Mero et al. (2002), the 
present study did split the COL dosage into a morning and evening dose of 10 g. 
The variance in results may be explained by the composition of the COL and the 
assay used in the determination of IgA. Further evidence is required to confirm the 
findings of Crooks et al. (2006) that significant changes in salivary SIgA are only 
evident after 12 weeks of supplementation. 
In conclusion, the primary finding of the study was that COL supplementation leads 
to a greater fMLP-oxidative burst than a PLA group. There was, however, no effect 
of COL on all other parameters of innate and mucosal immunity. Further research is 
required to elucidate the mechanisms underlying COL supplementation and whether 
beneficial effects of COL may become apparent at rest when consumed over longer 
periods.  
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Chapter 5. Study 3 - Effects of bovine colostrum supplementation 
on upper respiratory illness in active males 
Abstract 
COL has been advocated as a nutritional countermeasure to exercise-induced 
immune dysfunction and increased risk of URI in athletic populations, however, the 
mechanisms remain unclear. During winter months, under double-blind procedures, 
53 males (mean training load ± SD, 50.5 ± 28.9 MET-h week-1) were randomized to 
daily supplementation of 20 g of COL (n = 25) or an isoenergetic/isomacronutrient 
PLA (n = 28) for 12 weeks. Venous blood was collected at baseline and at 12 weeks 
and unstimulated saliva samples at 4 weeks intervals. There was a significantly 
lower proportion of URI days and number of URI episodes with COL compared to 
PLA over the 12 weeks (p < 0.05). There was no effect of COL on in vitro neutrophil 
oxidative burst, salivary SIgA or AMPs (p > 0.05), which does not support previously 
suggested mechanisms. In a subset of participants (COL = 14, PLA = 17), real-time 
quantitative PCR, targeting the 16S rRNA gene showed there was an increase in 
salivary bacterial load over the 12 weeks period with PLA (p < 0.05) which was not 
as evident with COL. Discriminant function analysis of outputs received from serum 
metabolomics showed changes across time but not between groups. This is the first 
study to demonstrate that COL limits the increased salivary bacterial load in 
physically active males during the winter months which may provide a novel 
mechanism of immune-modulation with COL and a relevant marker of in vivo (innate) 
immunity and risk of URI. 
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5.1 Introduction 
It is now well established that exercise of a strenuous and/or prolonged nature can 
lead to significant transient perturbations of immune function (commonly referred to 
as immunodepression) which includes, but is not limited to, decreases in both cell-
mediated and mucosal parameters (Nieman, 2007). This may result in an ‘open 
window’ during which risk of illness is increased (Nieman, 2000). Hence, if such 
exercise is performed on a regular basis, as with endurance athletes, and particularly 
in combination with other life stressors (e.g. inadequate nutrition, psychological 
stress) the overall risk can be substantially higher (Gleeson, 2007).  The increase in 
the frequency and severity of symptoms of URI in athletes (e.g. sore throat, runny 
nose) has been attributed to such periods of heavy exertion (Walsh et al., 2011b). 
COL may be effective at alleviating recurrent URI in situations of immune deficiency 
(Patel and Rana, 2006). Previous evidence has shown that 8-10 weeks of COL 
supplementation can reduce the incidence of URI in physically active populations but 
the mechanism(s) behind such effects remains unclear (Brinkworth and Buckley, 
2003; Crooks et al., 2010). Animal and in vitro culture studies demonstrate that COL 
has a mediating effect on cell-mediated immunity by influencing the production of 
cytokines (Biswas et al., 2007; Shing et al., 2009b). Increasing concentrations of 
COL, in vitro, has been shown to modulate cytokine production in peripheral blood 
mononuclear cells from resting, healthy individuals, to promote a  Th1 profile (cell-
mediated immunity) (Shing et al., 2009b), which may suppress the binding of 
pathogens (e.g. rhinovirus) (Sethi et al., 1997). Direct effects of COL on leukocyte 
capacity are also supported by evidence of an enhancement of phagocytosis and 
oxidative burst of PMN cells (i.e. neutrophils) following short term culture with COL 
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(Sugisawa et al., 2001, 2002, 2003). Sugisawa et al. (2003) proposed that in the 
presence of COL leukocytes become primed for subsequent activation by low-
molecular weight substances (< 10 kDa) such as protease peptones. 
Given the aforementioned effects of COL within inflammatory in vitro culture 
conditions, it may be expected that COL can act as a nutritional countermeasure to 
exercise-induced immunodepression. Our previous work suggests that 4 weeks of 
COL (20 gday-1) supplementation can limit the immunodepressive effects of an 
acute physical stressor (2 h of cycling) by enhancing neutrophil function (stimulated 
degranulation/elastase release) post-exercise (Davison and Diment, 2010). Within 
the study the modulatory effects of COL also extended to innate mucosal immunity 
by preventing the exercise-induced decrease of sLys concentration and secretion.  
Study 1 also demonstrated the immune enhancing potential of acute COL 
supplementation on innate immunity (stimulated degranulation, fMLP-stimulated 
oxidative burst; sLys concentration). Such findings may provide support to proposed 
mechanisms that some of the immune-modulatory effects of COL are due to 
bioactive components that become biologically available upon digestion of COL and 
prime leukocyte capacity (Davison, 2013). It is currently unclear whether longer term 
supplementation of COL and exposure to these priming agents or metabolites also 
leads to changes in innate markers in athletes at rest. Crooks et al. (2006) 
demonstrated that longer periods of COL supplementation (i.e. 12 weeks) may be 
associated with significant increases in resting concentrations of salivary SIgA, which 
is the only immune measure to date that has been consistently related to risk of URI 
in exercising populations (Walsh et al., 2011b). Other studies have also seen 
improvements in resting salivary SIgA concentrations with COL supplementation but 
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have not monitored URI (Appukutty et al., 2010; Mero et al., 2002). To date, the 
majority of both longitudinal and cross-sectional exercise training studies have 
focused on changes in salivary SIgA (Walsh et al., 2011b). Although the importance 
of other salivary AMPs (e.g. lysozyme, lactoferrin) for host defense have been 
recognised, they have received limited attention (West, 2006).  
In addition to the presence of inducible factors such as AMPs at mucosal surfaces, 
protection from invading microorganisms is also provided by the diverse community 
of commensal microbes which colonise the upper respiratory tract (Blaser and 
Falkow, 2009; Bosch et al., 2013).  Subsequently, disturbance of this respiratory 
microbial community can contribute to acquisition of new pathogens which may 
result in respiratory illness, particularly if host immunity is compromised (Murphy et 
al., 2009). However, the effects of exercise and nutritional interventions on changes 
in the salivary microbiome have not previously been investigated.  
The aims of this study were to investigate the effects of 12 weeks of COL 
supplementation on innate and mucosal immunity as well as the salivary microbiome 
in a population of males who engage in exercise training during the winter months. 
The study also aimed to determine whether any effects of COL on these parameters 
would also lead to a change in the incidence of URI. Given the potential involvement 
of a diverse array of biological pathways, we also undertook a metabolomic profiling 
approach on serum in an attempt to gain a more detailed understanding of any 
modulation of the immune system by COL.  
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5.2 Methods 
5.2.1 Participants 
Fifty seven males, completing at least 3 h of moderate-vigorous endurance exercise 
a week and free of influenza vaccinations in the previous 12 months, volunteered to 
participate in the present investigation.  
5.2.2 Supplementation 
All 57 participants were randomly allocated into COL or PLA groups with stratification 
by age and type of exercise training only. In a double blind manner, participants were 
asked to consume 20 gday-1 (10 g prior to morning and evening meal) of COL or an 
isoenergetic/isomacronutrient PLA for 12 weeks. Four participants (COL = 3, PLA = 
1) were lost due to lack of compliance with the study protocol (e.g. lack of training or 
supplement consumption due to injury, family bereavement or air travel). All 
participants who successfully completed the study (COL group, n = 25, age: 30.5 ± 
13.8 years, BM: 77.2 ± 8.9 kg, height: 179.9 ± 6.4 cm); PLA group, n = 28, age: 31.5 
± 13.2 years, BM 74.5 ± 8.7 kg, height 178.4 ± 6.6 cm) commenced the study 
between September and December. 
5.2.3 Serum Metabolomics 
Blood samples were collected at baseline and at 12 weeks following COL or PLA 
supplementation. Serum obtained from all samples were analysed using Direct 
Injection Electrospray Ionisation Mass-Spectrometry (DI-ESI-MS) by colleagues (see 
acknowledgements section) at the Institute of Biological, Environmental and Rural 
Sciences. To remove proteins before mass spectrometry, 20 µL of each serum 
sample was mixed with 30 µL of ice-cold ultrapure water and vortexed. 50 µL of ice-
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cold HPLC grade acetone (Fisher Scientific UK Ltd, Loughborough, UK) was then 
added and the mixture vortexed. Samples were left on ice for 30 min to allow protein 
precipitation, after which, they were centrifuged at 16000 g for 10 min in a micro-
centrifuge. After centrifugation, 50 µL of the supernatant was removed and 
transferred to a glass insert placed in a glass auto-sampling vial, to which 250 µL of 
ice-cold 70% (v/v) methanol (made up using HPLC grade methanol (Fisher Scientific 
UK Ltd) and ultrapure water) was added. Seven control serum samples, from human 
male AB plasma (Sigma-Aldrich, Dorset, UK), were run simultaneously using the 
same protocol to act as machine and protocol controls. 
Analysis (DI-ESI-MS) was carried out using on a Micromass LCT mass-spectrometer 
(Micromass/Waters Ltd., UK) in negative ionisation mode where metabolites are 
singly ionised by the loss of H+. The polar extracts were reconstituted in 0.25 mL 
30% [v/v] methanol: H2O and 50 μL added to 200 μL inserts in 2 mL (Waters Ltd. 
UK) and introduced by direct-infusion (DI) at a flow rate of 0.05 mL min-1 in 30% [v/v] 
methanol: H2O running solvent. Data were acquired over the m/z range 100-1400 Th 
and were imported into MATLAB, binned to unit mass and then normalised to 
percentage total ion as stated in Johnson et al. (2007). Tentative identification of 
metabolites of interest was achieved through interrogation of the HMDB Serum 
Metabolome database (Psychogios et al., 2011).  
 
5.2.4 Saliva sampling 
Participants reported to the laboratory for a saliva sample at baseline and 4 weeks, 8 
weeks and 12 weeks following supplementation. All participants avoided strenuous 
exercise 24 h prior to each visit and arrived at the laboratory after an overnight fast 
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of at least 10 h. Following centrifugation of saliva samples at baseline, 4 weeks, 8 
weeks and 12 weeks, saliva supernatants (following centrifugation) were analysed 
for salivary SIgA and AMPs (detailed in sections 2.6.2 – 2.6.4). At baseline and at 12 
weeks in 31 participants (COL = 14, PLA = 17), the saliva pellets (from saliva 
centrifugation) were used for DNA extraction. 
5.2.5 Extraction of microbial DNA 
Microbial DNA was extracted from 200 µL of the salivary pellet at baseline and 12 
weeks of 31 participants who all commenced the study late September/early October 
and completed the study late December/early January. Extraction was performed 
using a FastDNA SPIN Kit (MP Biomedical, Santa Ana, USA) following the 
manufacturer’s guidelines, except that bead beating was carried out using a 
FastPrep24 (MP Biomedical) machine with three cycles at speed setting 6.0 for 30 s, 
with cooling on ice for 60 s between each cycle. Extracted DNA was quantified using 
Epoch (BioTek, Winooski, USA) spectrophotometry. All extractions were confirmed 
to have a 260/280 nm ratio of between 1.8 and 2.0 for quality control purposes. 
5.2.6 16S rRNA Gene Terminal Restriction Fragment Length Polymorphisms 
(T-RFLP) 
Amplification of the 16S rRNA gene was accomplished through PCR using primers 
27f (5’-AGA GTT TGA TCC TGG CTC AG-3’ with FAM labelled on 5’ end) and 1389r 
(5’-ACG GGC GGT GTG TAC AAG-3’) as described by Huws et al. (2011). All PCR 
products were verified using a 1.0% agarose gel. Triplicate reactions for each 
sample were pooled and purified using a QIAquick PCR purification kit (Qiagen, 
West Sussex, UK) following the manufacturer’s guidelines. 25 ng of purified PCR 
product for each sample was digested for 5 h at 37°C with restriction enzymes HaeIII 
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and MspI (Promega, Madison, USA), in separate reactions. Restriction products 
were separated through size using an ABI PRISM1 377 Automated DNA Sequencer 
(Applied Biosystems, Warrington, UK). As there was an inability to sequence the 16S 
rRNA genes at one of the timepoints for 2 participants, peak profiles and Shannon 
Diversity Indexes were determined on 29 participants only (COL = 12, PLA = 17). 
Peak profiles were examined using Genemapper software (Version 3.7, Applied 
Biosystems). Those peaks with an estimated fragment size below 50 nucleotides 
were removed and the remaining data were modelled using FingerPrinting II 
software (BioRad, Hercules, USA). Shannon Diversity Indexes were determined 
using Fingerprint Analysis with Missing Data software (Version 1.2) (Schluter and 
Harris, 2006). 
5.2.7 16S rRNA Gene Quantitative PCR 
Quantitative PCR was carried out on neat extracted DNA against standards created 
by amplifying the 16S rRNA gene of 5 randomly selected baseline samples. This 
used 1 µL of each sample in a PCR reaction using 27f and 1389r primers, as 
detailed above, except that the 27f primer did not have FAM on the 5’ end, to amplify 
the gene. The resulting PCR product was purified and quantified, as previously 
detailed, to estimate the total number of 16S rRNA gene copies and serial dilutions 
made to a 10-10 level. Serial dilutions of 10-0, 10-2, 10-4, 10-6, 10-8, and 10-10 were 
used in subsequent qPCR reactions using a C100 thermal cycler (BioRad) and 
CFX96 optical detector (BioRad), with data captured using CFX Manager software 
(BioRad). qPCR reactions were completed in 25 µL volumes consisting of 1X SYBR 
Green Mastermix (Applied Biosystems), 400 nM of each of the EubF forward (5’-
GTG STG CAY GGT TGT CGT CA-3’) and EubR reverse (5’-ACG TCR TCC MCA 
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CCT TCC TC-3’) primers, as detailed by Kim et al. (2008) and 3 µL of neat DNA. The 
final volume was made up with PCR grade water (Roche, Hertfordshire, UK). 
5.2.8 Microbial Growth Curve Analysis 
To ascertain the antimicrobial properties of each supplement, 10 µL of a 50 gL-1 
(w/v) solution of COL or PLA (made using autoclaved ultrapure water), were cultured 
with 200 µL of artificial saliva medium and 10 µL of a salivary microbial culture as 
previously described by McBain et al. (2003). In addition, 10 µL of the COL and PLA 
solutions were incubated with 200 µL of artificial saliva medium, without the addition 
of the salivary microbial culture, to determine the level of microbial load for each 
solution. These cultures, alongside appropriate positive and negative growth 
controls, were incubated in a CellStar tissue culture 96 well plate with flat bottom and 
lid (Greiner Bio-one, Nürtingen, Germany) in a BioTek ELx808 microplate reader 
(BioTek Instruments, Winooski, USA) set at 37°C for 72 h. An optical density reading 
was taken every 20 min at a 630 nm wavelength, before which, the plate was shaken 
for 5 s. 
Kinetic read data was exported from the Gen5 software package (BioTek 
Instruments) and corrected to a baseline (the first reading taken for each of the 96 
wells). To allow for log transformation of the raw data, all data points, after baseline 
correction, were added to 10. The Log10 value for each data point was then 
calculated. After 3 replicate 96 well plates were completed, the mean and standard 
deviation for each growth condition, across all 3 plates, was calculated 
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5.2.9 Statistical analysis 
Initially, a 2 factor mixed model ANOVA (group × time) was carried out on all 
immunological measures,16S rRNA (salivary bacterial load) and total peak number 
for HaeIII and MspI (salivary bacterial diversity) to determine if the effect of time was 
different between COL or PLA groups. Any significant main effects identified in the 
ANOVA were further analysed by post hoc paired t-tests with Holm-Bonferroni 
correction. Independent t-tests were used to determine differences between groups 
at baseline and 12 weeks in Shannon Diversity Indexes for TFRLP (HaeIII and 
MspI). Data for the proportion of reported URI days and proportion of participants 
who suffered URI over the 12 weeks between the COL and PLA groups were 
assessed by chi-squared test. To also examine the time-course of any effect of COL, 
chi-squared analyses of URI at 4 week intervals were performed, in accordance with 
the timing of saliva collections in the current study and the methods of Crooks et al. 
(2006, 2010). Chi-squared analysis was also used to assess proportion of 
participants within COL or PLA who reported use of medication during URI episodes. 
Comparisons between COL and PLA groups for mean number of self-reported URI 
episodes, mean duration of URI, mean severity of URI and mean weekly training 
loads were performed with an independent t-test. Metabolite data was analysed 
through multivariate statistics, including principal component analysis and 
discriminant function analysis (DFA), using PyChem software (Jarvis et al., 2006) 
and following accepted Metabolomics Standard Initiative procedures (Sansone et al., 
2007). Those whole mass unit bins which had a DFA loading of more than 2 
standard deviations from the mean were selected for tentative identification. 
Determination of change from baseline for each whole mass unit bins was 
determined using 1-way ANOVA. 
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5.3 Results 
5.3.1 Training loads 
Analysis of IPAQ questionnaires showed no significant differences between COL 
(53.1 ± 6.0 MET-h·week-1) and PLA (48.2 ± 5.4 MET-h·week-1) groups for weekly 
training volume at moderate-vigorous intensity (p = 0.546).  
5.3.2 Upper respiratory illness 
Chi-squared analysis showed a significantly lower proportion of days with URI during 
the 12 weeks in the COL group (5%) compared to the PLA group (9%) (p < 0.001). 
Further chi-squared analyses of URI at 4 week intervals showed a significantly lower 
proportion of days with URI in the COL group at 1-4 weeks (COL = 6%, PLA = 8%;  p 
= 0.021) and 5-8 weeks (COL = 2%, PLA = 13%; p < 0.001) but not 9-12 weeks 
(COL = 6%, PLA = 7%; p = 0.348) (Figure 5.1). Independent t-test showed a 
significantly lower mean number of URI episodes in the COL group compared to PLA 
group over the 12 weeks (COL, 0.4 ± 0.7; PLA, 0.8 ± 0.7; p = 0.033). The proportion 
of participants who reported URI during the study period (all 12 weeks combined) 
was not lower in the COL group (40%) than PLA group (64%) (p = 0.067). There 
were, however, a significantly lower proportion of participants who reported URI in 
the COL group (12%) compared to PLA (36%) at 5-8 weeks (p = 0.044) which was 
not evident at 1-4 weeks (COL = 16 %, PLA = 25%; p = 0.322) or 9-12 weeks (COL 
= 20%, PLA = 18%; p = 0.559) (Figure 5.1). When URI episodes were reported by 
participants, the severity (COL, 35.3 ± 26.9; PLA, 42.0 ± 27.4; p = 0.250) and 
duration of symptoms (COL, 7.9 ± 4.4 days; PLA, 9.9 ± 5.6 days; p = 0.159) were 
similar between groups. During episodes of URI, there were no differences between 
groups for the proportion of participants who used medication (COL = 50%, PLA = 
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78%; p = 0.139). All of the above patterns/effects were similar in the subset of 
participants used for microbiome analysis (see section 5.25). 
 
Figure 5.1 URI during 4 week intervals in COL and PLA groups. Columns reflect 
proportion of participants in each group who report URI. Line and symbol represent 
proportion of URI days in each group during 4 week intervals. **Significantly lower 
proportion of URI days in COL group at 1-4 weeks and 5-8 weeks (p < 0.05). 
*Significantly lower proportion of participants in the COL group who report URI at 5-8 
weeks (p < 0.05). 
 
5.3.3 Salivary SIgA and AMPs 
The analyses of salivary AMPs across the 12 week period are shown in Table 5.1 
and 5.2. One participant was removed from SIgA analysis due to a lack of clear 
supernatant upon centrifugation of saliva samples. Final comparison for salivary 
SIgA was conducted on 52 participants (COL = 25, PLA = 27). This participant had 
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been excluded from sLac and sLys for contamination purposes as previously 
mentioned (see above). There were no significant differences between groups in 
salivary measures during the 12 weeks (p > 0.05) (Table 5.1 and 5.2). 
 
Table 5.1 Salivary SIgA before, during and at the end of 12 weeks of COL and PLA. 
  
Immune measure Baseline 4 weeks 8 weeks 12 weeks p trial 
p time 
p  interaction 
SIgA concentration (mgL-1)   0.286 
COL 267 ± 127 253± 120 256 ± 143 272 ± 153 0.569 
PLA 260 ± 203 217 ± 124 230 ± 132 215 ± 99 0.841 
SIgA secretion rate (gmin-1)  0.733 
COL 117 ± 89 126 ± 106 130 ± 90 144 ± 97 0.065 
PLA  121 ± 126 105 ± 52 114 ± 63 108 ± 57 0.192 
SIgA:osmolality (mgmOsmol-1)   0.280 
COL 3.8 ± 1.5 3.6 ± 1.4 3.5 ± 1.4 3.8 ± 1.8 0.409 
PLA     3.6 ± 2.0 3.19 ± 1.4 3.4 ± 1.5 3.1 ± 1.2 0.595 
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Table 5.2 sLac and sLys before, during and at end of 12 weeks of COL and PLA  
 Main effect of time indicated by * p < 0.05. Post hoc analysis could not reveal any 
significant differences between timepoints for sLac concentration. There was a 
significant increase in sLac secretion rate (at 8 and 12 weeks) and sLys secretion 
rate (at 8 weeks) from baseline (p < 0.05). 
 
  
Immune measure 
 
BAS 
 
4 weeks 
 
8 weeks 
 
12 weeks 
 
p trial 
p time 
p interaction 
sLac concentration (mgL-1)    0.431 
COL 3.3 ± 0.8 3.7 ± 0.8 3.8 ± 0.8 3.8 ± 0.8  0.032* 
PLA 3.8 ± 1.2 3.8 ± 1.0 4.0 ± 1.0 3.8 ± 1.0 0.198 
sLac secretion rate (gmin-1)     0.365 
COL 1.6 ± 1.0 1.9 ± 1.2 2.0 ± 0.9 2.1 ± 0.8    0.001** 
PLA 1.9 ± 1.0 2.1 ± 1.2 2.3 ± 1.4 2.3 ± 1.3 0.829 
sLac: osmolality (mgmOsmol-1)    0.549 
COL 0.05 ± 0.02 0.06 ± 0.02 0.06 ± 0.02 0.06 ± 0.02 0.111 
PLA 0.06 ± 0.02 0.06 ± 0.02 0.06 ± 0.02 0.06 ± 0.02 0.282 
sLys concentration (mgL-1)    0.837 
COL 21.5 ± 13.3 23.0 ± 13.5 22.2 ± 12.6 20.1 ± 12.7 0.636 
PLA 22.0 ± 14.6 20.1 ± 12.1 21.7 ± 11.5 21.1 ± 12.1 0.295 
sLys secretion rate (gmin-1)    0.764 
COL 9.9 ± 8.3 10.5 ± 6.5 11.4 ± 8.4 10.0 ± 5.1 0.037* 
PLA 10.8 ± 8.8 10.7 ± 8.4 11.7 ± 7.4 11.6 ± 8.8 0.627 
sLys:osmolality (mgmOsmol-1)    0.941 
COL 0.3 ± 0.2 0.4 ± 0.3 0.3 ± 0.2 0.3 ± 0.2 0.622 
PLA 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.3 ± 0.2 0.420 
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5.3.4 Salivary bacterial load and diversity 
The ANOVA to analyse log of estimated copy number of 16S rRNA gene revealed a 
significant time (p < 0.001) and interaction effect (p = 0.035) but no group effect (p = 
0.602) (Figure 5.2). Post hoc analysis of interaction revealed a significant increase in 
bacterial load over the 12 weeks in the PLA group (p < .001) that was not present in 
COL group (p = 0.386) (Figure 5.2). ANOVA on total TRFLP peak number obtained 
from the restriction enzyme MspI revealed a main time effect (p < 0.001), with 
decreased bacterial diversity at 12 weeks, but no interaction (p = 0.515) or group 
effect (p = 0.917). However, analysis of total TRFLP peak number using HaeIII 
revealed no time (p = 0.123), interaction (p = 0.912) or group effects (p = 0.866). 
Analysis of Shannon Diversity Indexes for TFRLP using MspI showed no differences 
between groups at baseline (p = 0.789) or at 12 weeks (p = 0.746). There were also 
no differences at baseline (p = 0.683) or 12 weeks (p = 0.823) in Shannon Diversity 
Indexes for TFRLP using HaeIII. Microbial growth analysis, showed no indication of a 
direct antimicrobial effect of either the COL or PLA supplement (see Appendix C). 
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Figure 5.2 Salivary bacterial load in COL/ PLA groups. Standard deviation as error 
bars. *Significant increase in salivary bacterial load from baseline to 12 weeks in 
PLA group (p < 0.001). 
 
 
 
5.3.5 Immune cell counts and neutrophil responses 
Results for total and differential leukocyte counts, and stimulated neutrophil oxidative 
burst, at baseline and 12 weeks following supplementation in COL and PLA groups 
are shown in Table 5.3.  
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Table 5.3 Blood leukocytes and neutrophil function in COL and PLA groups.  
Significant difference between baseline and 12 week measures (main effect of time) 
indicated by * p < 0.05. 
  
Immune measure 
 
 
Baseline 
 
 
12 weeks 
 
 
p trial 
p time 
p interaction 
Total leukocytes (cells ×10
9L-1)  0.382 
COL 4.74 ± 1.02 4.90 ± 1.01 0.193 
PLA 5.20 ± 1.68 5.27 ± 1.63 0.687 
Neutrophils  (cells ×10
9L-1)  0.268 
COL 2.31 ± 0.61 2.31 ± 0.59 0.359 
PLA 2.58 ± 1.18 2.74 ± 1.28 0.480 
Monocytes (cells ×10
9L-1)   0.766 
COL 0..46 ± 0.11 0.46 ± 0.12 0.567 
PLA 0.46 ± 0.13 0.47 ± 0.20 0.431 
Total lymphocytes  (cells ×10
9L-1)  0.970 
COL 1.77 ± 0.50 1.91 ± 0.67 0.619 
PLA 1.90 ± 0.61 1.79 ± 0.47 0.079 
Large immature cells (cells ×10
9L-1)   0.305 
COL 0.03 ± 0.01 0.03 ± 0.02 0.832 
PLA 0.05 ± 0.04 0.04 ± 0.03 0.605 
fMLP-stimulated CL per neutrophil  (RLUs-1cell-1)                                                         0.413 
COL 43.7 ± 27.4 54.0 ± 26.5  0.025* 
PLA 42.8 ± 25.6 44.5 ± 24.9 0.365 
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5.3.6 Serum metabolomics 
Sugisawa et al. (2003) have suggested that low molecular weight (< 10 kDa) 
substances may be responsible for the immunological effects of COL. We therefore 
used a metabolomics approach to determine whether COL increased the 
concentration of compounds at the lower end of this range (< 1.4 kDa) with the 
expectation that any such effects would be due to bioactive metabolites. Thus, 
metabolite profiles of serum derived using DI-ESI-MS were analysed using 
multivariate approaches. DFA of serum profiles at baseline and at 12 weeks (Figure 
5.3), showed no separation, at either time point, between the COL and PLA groups. 
However, there was clear separation between the two timepoints. Interrogation of the 
loading vectors selected by the algorithm to derive DF1 suggested that 13 m/z were 
calculated to be the major sources of variation. Interrogation of the HMDB Serum 
Metabolome database allowed the tentative identification of these 13 metabolites 
(Table 5.4). Within the tentative identifications, there are several possibilities for each 
m/z but no particular biochemical pathways or immunological metabolite markers 
appeared to have been targeted. 
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Figure 5.3 Discriminant Function analysis (DFA) plot of metabolomic profiles before 
and at end of 12 weeks of COL and PLA supplementation. ■ - COL group at 
baseline; ● - PLA group at baseline; ■ - COL group at 12 weeks; ● - PLA group at 12 
weeks. A satisfactory separation was obtained between time points but not groups. 
Rings on figure display 95% confidence intervals for DFA separation. 
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Table 5.3 Tentative identifications of metabolites which may be responsible for the 
separation between the 2 timepoints visible in DF1 of Figure 5.3.  
MW Tentative ID 
Change from 
Baseline 
p  
108 Cresol Decrease 0.002 
154 
Gentisic acid 
Decrease < 0.001 
2-Pyrocatechuic acid 
Protocatechuic acid 
Hydroxytyrosol 
155 L-Histidine Increase < 0.001 
157 Unknown Increase < 0.001 
168 
Uric acid 
Decrease < 0.001 
Homogentisic acid 
3-Hydroxymandelic acid 
3,4-Dihydroxybenzeneacetic 
acid 
Pyridoxamine 
169 
Norepinephrine 
Increase < 0.001 
Pyridoxine 
3-Methylhistidine 
D-Glyceraldehyde 3-phosphate 
Dihydroxyacetone phosphate 
170 
Gallic acid 
Increase < 0.001 3,4-Dihydroxyphenylglycol 
cis-4-Decenoic acid 
172 
Glycerol 3-phosphate 
Decrease < 0.001 
Glycylproline 
173 
2-Oxoarginine 
Increase < 0.001 
Pyrophosphate 
174 
Dehydroascorbic acid 
Increase < 0.001 
Suberic acid 
N-Acetylornithine 
L-Arginine 
186 
2-Phosphoglyceric acid 
Decrease < 0.001 
3-Phosphoglyceric acid 
285 Unknown Increase < 0.001 
325 10-Nitrolinoleic acid Decrease < 0.001 
For some of the whole number molecular weight bins there are multiple tentative IDs 
which may or may not contribute to the DF1 loading. Change from the baseline and 
subsequent ANOVA p values are detailed alongside the tentative IDs.  
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5.4 Discussion 
This study aimed to determine the effects of COL on innate and mucosal markers of 
immunity and the subsequent incidence of URI in regularly exercising males. 
Compared to the PLA group, there was a significantly lower number of URI episodes 
and subsequently less proportion of URI days in the COL group over the 12 weeks. 
This supports previous evidence in studies of both active and immune-deficient 
populations (Brinkworth and Buckley, 2003; Crooks et al., 2010; Patel and Rana, 
2006). Beneficial effects of COL were most evident during periods of greater 
prevalence of URI within the study population by reducing the proportion of 
participants who report URI (hence a greater scope for intervention). As not all 
participants commenced the study at the same time of year, it is important to 
recognise that these findings reflect the effects of COL within the timeframe and the 
incidence of illness in participants of the current study rather than proposing a 
specific seasonal window where COL affects URI. There was, however, no effect of 
COL on severity and duration of URI episodes, which supports some previous 
studies (Brinkworth and Buckley, 2003; Crooks et al., 2006, 2010) but not the 
beneficial effects reported by Patiroglu and Kondolot (2013). 
In contrast to the effect of COL on URI, there was no significant effect of COL on 
salivary SIgA and AMPs or fMLP-stimulated blood neutrophil oxidative burst. The 
lack of effect on immune parameters despite differences in URI is in accordance with 
previous evidence (Crooks et al., 2006; Shing et al., 2007). Although previous 
studies have found beneficial effects in mucosal protection (salivary SIgA and AMPs) 
following COL supplementation, either a blunting of the exercise-induced immune 
dysfunction (Davison and Diment, 2010) or increased resting salivary SIgA (Crooks 
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et al., 2006), they did not measure URI (Davison and Diment, 2010) or failed to see 
simultaneous effects of COL on URI (Crooks et al., 2006). This has led to proposals 
that the effect of COL occurs through a combination of mechanisms (Shing et al., 
2007). In the current study we proposed the use of a novel in vivo marker (salivary 
microbiome) that may have greater sensitivity to changes in innate mucosal defense 
following an intervention. This study shows for the first time that during regular 
training in the winter months, COL limits the increase in salivary bacterial load that 
was observed in the PLA group. However, it is currently unclear whether the 
significant increase in bacterial load in the PLA group played a role in the greater 
episodes of URI observed in this group or whether the increased bacterial load 
occurred as result of a greater number of illnesses, or compromised immunity (due 
to training and/or seasonal effects). Future studies should investigate salivary 
bacterial load at the taxonomic level with next generation sequencing methods to 
determine whether changes reflect predisposed interactions with viruses which are 
the common cause of URI (Bosch et al., 2013).  
Evidence from respiratory health research has suggested that bacterial colonisation 
of tissues contiguous to the oral cavity (e.g. airway) can trigger an increase in the 
frequency of disease exacerbations (Wedzicha and Donaldson, 2003). Furthermore, 
the interaction between viruses and bacteria which colonise the upper respiratory 
tract has been highlighted to affect the risk of illness (Bosch et al., 2013). Of 
relevance to this study are suggestions that the balance of microbes involved in 
colonisation can be perturbed when host immunity is compromised (Murphy et al., 
2009). It is apparent that the magnitude of change in immunity immediately following 
each bout of strenuous exercise may have more clinical significance than training-
induced alterations in resting immunity (Abbasi et al., 2013; Nieman et al., 1994; 
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Pedersen and Bruunsgaard, 1995). It is reasonable to suggest that over the course 
of the 12 weeks the COL group suffered fewer incidences of transient immune 
perturbations, and/or smaller or shorter disturbance, (in response to training and/or 
seasonal variation) which may have limited conditions for changes in the salivary 
microbiome to occur. COL has been shown to prevent exercise-induced decreases 
in salivary AMPs and improve recovery of the capacity of neutrophils (a source of 
AMPs) following strenuous exercise (Davison and Diment, 2010). Deficiencies or 
decreases in AMPs expressed in mucosal secretions have been shown to be related 
to greater bacterial invasion and/or cases of infection (Bals et al., 1998, 1999; Daele 
and Zicot, 2000; Smith et al., 1996b; Goldman et al., 1997). It is worthy to note, 
however, that the present study has only investigated a narrow range of AMPs that 
are present in mucosal secretions. Therefore, the effects of COL on the resting 
concentrations of other AMPs such as cathelicidins, which have broad 
antibactericidal effects (Bals, 2000) remain unclear and cannot be excluded. In 
addition, there were no apparent effects of COL on in vitro microbial culture in this 
study which supports that the aforementioned effects on bacterial load are not due to 
components of COL having direct antimicrobial effects in the oral cavity during 
consumption. 
Of particular note was the lack of simultaneous increase in bacterial diversity within 
the PLA group during the study. This suggests that it was not the acquisition of new 
bacteria that caused the significant increase in bacterial load in the PLA group but 
rather amplification of bacteria resident at baseline. The oral cavity is exposed to a 
constant array of exogenous and endogenous factors, thus measurement via saliva 
has been recognised to provide a ‘fingerprint’ of the whole oral microbiota (Boutaga 
et al., 2007; Dewhirst et al., 2010; Fabian et al., 2008; Li et al., 2005;). We propose 
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that, rather than causing URI per se, an increase in bacterial load is indicative of 
compromised innate immune status, and as such is a relevant marker of in vivo 
(innate) immune status. Furthermore, if COL supplementation does limit increases in 
salivary bacterial load, it will be important to determine whether this is a general 
reduction in bacteria, or whether it is biased towards certain bacterial taxonomies.  
A further aim of this study was to determine any metabolomic changes as a result of 
COL supplementation. Metabolomics provides an unbiased biochemical “snap shot” 
of samples which due to the use of high resolution mass spectrometry-based (as 
here) or nuclear magnetic resonance-based approaches simultaneously and 
accurately measure hundreds of metabolites. Exercise immunologists view that high 
throughput laboratory methods such as metabolomics will provide greater 
understanding of the mechanisms behind modulations of the immune system with 
exercise and/or nutrition (Walsh et al., 2011b). Crucially, in this study, we did not 
observe any changes in serum metabolome linked to COL supplementation, 
indicating that either no major changes were occurring or that these were occurring 
below the detection limits of the Mass Spectrometer (< 10-12 mol, Sumner et al., 
2003). There was, however, a clear separation of metabolome profiles obtained at 
baseline and at the 12 week timepoint of the study. The timepoint effect could reflect 
a combination of a seasonal effect and accumulation of training stress. As seasonal 
and/or exercise effects alone on the immune system were not a primary aim of the 
study, future studies should investigate whether changes in metabolome are 
involved in the greater incidence of URI seen in the winter months. Confirmatory 
identifications of the 13 m/z which appear to be responsible for the majority of the 
temporal separation were not accomplished as changes in the serum metabolome 
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were not as a result of COL supplementation and thus fell outside of the scope of 
this project. 
Previous in vitro culture studies suggested that low molecular weight (≤ 10 kDa) 
components of COL (e.g. proteose peptones) rather than larger growth factors or 
cytokines may be responsible for the effects on human immune function (e.g. 
neutrophil oxidative burst) (Sugiswa et al., 2003). Given that our metabolomics 
approach provides data on (< 1.4 kDa) metabolites involved in biological pathways 
(Holmes et al., 2008), it may have been expected to identify traces of such bioactive 
metabolites in the circulation following 12 weeks of supplementation. Future studies 
could additionally examine components between 1.4 - 10 kDA to identify whether the 
above mentioned components of COL investigated within in vitro culture become 
bioavailable to affect human immune function following periods of supplementation. 
Such studies will help identify the bioactive components and eradicate discrepancies 
found between studies of COL that are due to the source/quality of the supplement 
(Davison, 2013). It is plausible, however, to suggest that in the present study the 
proposed priming effects may have been localised to immune parameters in the 
mucosae rather than having systemic effects. Another proposed mechanism behind 
the effects on URI is the ability of COL to truncate the increase in gut permeability 
following strenuous exercise (Marchbank et al., 2011). This effect on intestinal 
integrity may prevent additional stress on the immune system via the translocation of 
luminal bacteria into systemic circulation. This hypothesis, however, requires further 
study in relation to episodes of URI. 
Although previous studies have shown inconsistencies in isolated immune markers 
at rest, the present study suggests that the effects of COL are apparent when an 
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integrated and interactive holistic immune marker is taken (e.g. salivary bacterial 
load). It should be noted that participants in this study were not limited in their use, 
either before or during the study, of mouthwash. This could be considered a potential 
limitation of the study and an important consideration for future studies using the 
salivary bacterial load as an in vivo marker. Given the presence of null findings in the 
present study compared to previous studies of investigated immune parameters (e.g. 
salivary SIgA), it is important to acknowledge methodological limitations not yet 
considered. The present study involved participants who were involved in a range of 
sports training. Although these were all endurance based activities, previous studies 
have reported that effects of COL on salivary SIgA may not be universal in all groups 
of regular exercisers (Crooks et al., 2010). In addition, it is unclear whether the use 
of participants who had a higher mean weekly training load and hence potentially a 
greater number of immunodepressive bouts would have produced different findings 
for these measures. Indeed, when highly trained cyclists completed 5 consecutive 
days of high-intensity training, COL supplementation was found to prevent the 
decreases in cytotoxic/suppressor T cells observed at the end and in the recovery 
period from the training in the PLA group (Shing et al., 2007).  
In summary, we have shown for the first time that COL supplementation can limit 
microbial changes in the oral cavity during the winter months. This may be due to 
COL acting as a nutritional countermeasure to seasonal effects on salivary 
microbiome or immune perturbations following acute exercise. The clinical 
implications of this may be a reduction in the number of URI episodes. Future 
research should include responses to acute training during the monitoring period to 
determine the effects on the salivary microbiome and whether COL influences these 
(and other, e.g. AMPs) responses.  
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Chapter 6. Study 4 - The effects of bovine colostrum on symptoms 
of upper respiratory illness in EBV seronegative and seropositive 
active males 
Abstract 
Previous infection with EBV has been proposed as a possible risk factor for more 
frequent illness in those involved in intense training. The aims of this study were to 
investigate the effects of EBV serostatus on episodes of URI and the total number of 
URS days across a 12 week period and whether such outcomes would be influenced 
by COL supplementation. Serum collected from the 53 males of Study 3 (Chapter 5) 
at baseline and following 12 weeks of COL or PLA supplementation was assayed for 
IgG antibodies to EBV VCA. There was no difference in the number of URI and URS 
days or incidence, duration and severity of URI episodes based on EBV serostatus 
alone (p < 0.05). Similar findings were also observed when comparing EBV 
seropositive and seronegative participants in the PLA group (p < 0.05). There was a 
significant difference in proportion of URI days (p < 0.05) and a trend for a lower 
duration of URI episodes (p = 0.07) in seropositive participants of the COL group 
compared to their seronegative counterparts receiving COL. This study indicated no 
clear effect of EBV serostatus on URI but within participants who underwent COL 
supplementation, seropositive males suffered fewer URI days than those who have 
not previously suffered EBV infection. Further investigations are warranted to 
determine the role of prior infection with herpesviruses in URI of athletes and how 
nutritional interventions may mediate the risk.  
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6.1 Introduction 
Exposure of athletes to a greater strain of exercise training (through exceeding 
individual training thresholds) in combination with other stressors (e.g. inadequate 
nutrition, psychological) can increase the risk of URI (Foster et al., 1998; Gleeson et 
al., 2007; Pyne and Gleeson, 1998). For such reasons, athletes tend to report URI 
either during the high intensity and tapering period prior to competition (e.g. 
swimming, team sports) or in the period following competition (e.g. long distance 
running) (Walsh et al., 2011b). Despite such observations, even when significant 
immune perturbations have been observed in athletes participating in strenuous 
exercise, investigators have had limited success in identifying such measures that 
influence alterations in rates of URI (Gleeson et al., 1999; Mackinnon et al., 1993; 
Nieman, 2000; Nieman et al., 1990b, 2000; 2007). 
Previous evidence has shown the benefits of COL supplementation (8-10 weeks) 
towards reducing the incidence of URI in physically active and in immune deficient 
populations (Brinkworth and Buckley, 2003; Crooks et al., 2010; Patel and Rana, 
2006). This was supported by study 3 (Chapter 5) where following 4 weeks of 
supplementation there was a lower proportion of days and participants in the COL 
group who reported URI. Within this study, an increase in bacterial load over the 12 
week winter period within the PLA group was limited with COL supplementation. We 
proposed that, rather than causing URI per se, an increase in saliva bacterial load is 
indicative of compromised innate immune status, and as such is a relevant marker of 
in vivo (innate) immune status.  
There is a considerable interest in identifying risk factors which may determine the 
susceptibility of athletes to URI. Previous infection (i.e. seropositive) with viruses of 
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the herpes family (e.g. EBV) have been proposed as possible risk factors for more 
frequent illness in those involved in intense training (He et a., 2013b). EBV typically 
infects humans early on in life, with up to 90% of the world’s population infected by 
adulthood (Gleeson et al., 2002; Sarid et al., 2001). Gleeson et al. (2002) found a 
significant correlation between previous EBV infection and URI, while all 
seronegative swimmers reported no URI during a 1 month period of intensive 
training. It is worthy to note that this study did include a relatively small sample size 
and was undertaken over a short window which may not provide sufficient 
opportunity to provide a valid indicator of an enhanced risk to frequent URI. Indeed, 
other investigations conducted over a longer period (i.e. 4 months) and included 
larger sample sizes have found no differences in URI based on EBV serostatus (He 
et al., 2013b). Others have suggested that prior infection with herpesviruses may 
provide a symbiotic rather than a deleterious effect on risk of acute illness with other 
pathogens (Barton et al., 2007; Sandalova et al., 2010). Latent EBV infection may 
promote immunosurveillance through inducing prolonged elevation of cytokines (e.g. 
IFN) and systemic activation of macrophages (Barton et al., 2007). Furthermore, 
positive EBV serostatus has been suggested to confer heterologous immunity 
whereby EBV specific CD8+cells augment the population of T cells which proliferate 
during acute viral infection (Sandalova et al., 2010).  
EBV infects epithelial cells and B cells of the orpharynx where it establishes lifelong 
persistence in the former (Cruchley et al., 1997; Sixbey et al., 1984). This EBV 
infected B cell population is tightly-regulated by Tc cells (Rickinson and Moss, 1997). 
Periods of physical and/or psychological stress have been shown to reduce the 
effectiveness of EBV specific Tc cells (Glaser, et al., 1999). Such disturbance within 
certain parameters of the immune system which usually keep the virus dormant can 
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lead to reactivation of EBV (Mehta et al., 2000a). EBV can replicate continuously or 
intermittently from the orpharynx and it has been suggested that athletes have 
greater levels of detectable EBV-DNA compared with non-exercising controls 
(Faulkner et al., 2000; Hoffmann et al., 2010; Nadal et al., 2002). Therefore, an 
alternative hypothesis to the proposal that EBV serostatus may affect susceptibility 
to URI is that the cell damage and inflammation which occurs within the orpharynx 
during an EBV reactivation may itself induce URS (Cox et al., 2004). This may 
provide an explanation to the minor, short lasting symptomatology that is commonly 
found within athletes alongside persistent fatigue as a result of the stress of chronic 
training (Reid et al., 2004). It may also partly explain the low proportion (30%) of 
identified pathogens in reported illness (Spence et al., 2007), particularly within EBV 
seropositive athletes. However, if the appearance of symptoms occur as a result of 
dysregulated immunity, it is possible that EBV seropositive athletes would benefit 
from a nutritional countermeasure (e.g. COL) to maintain the integrity of immune 
parameters which control the latency of EBV.  
Further investigation is warranted to determine whether positive EBV serostatus 
increases the incidence of minor URS or whether it influences susceptibility to 
episodes of conventional URI. An understanding of the clinical relevance of EBV 
serostatus may highlight possible prevention and treatment strategies. Numerous 
studies have investigated the use of nutritional interventions to prevent the risk of 
URI in athletes but none have explored such effects in relation to latent 
herpesviruses. 
The aims of this study were to investigate the effects of EBV serostatus on the 
proportion of URI episodes and the total number of URS days (which may include 
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short-lasting symptomatology related to previous EBV infection) across a 12 week 
period and whether such outcomes would be influenced by COL supplementation.   
6.2 Methods 
6.2.1 Participants  
Fifty three males, completing at least 3 h of moderate-vigorous endurance exercise a 
week, volunteered to participate in the present investigation.  
6.2.2 Supplementation 
Participants were randomly allocated into COL or PLA groups with stratification by 
age and type of exercise training only. Participant characteristics of each group (COL 
= 25, PLA = 28) are detailed in a companion study (Study 3). In a double blind 
manner, participants were asked to consume 20 gday-1 (10 g prior to morning and 
evening meal) of COL (Neovite UK, London) or an isoenergetic/isomacronutrient 
PLA (as used in study 3) for 12 weeks.  
6.2.3 EBV serology 
Serum collected from participants at baseline and following 12 weeks of 
supplementation was assayed for IgG antibodies to EBV viral capsid antigen (VCA) 
using a commercially available ELISA kit (DRG Diagnostics, Marburg, Germany) 
according to the manufacturer’s instructions. EBV VCA IgG has been recognised to 
diagnose both previous and current EBV infection (Hess et al., 2004). 
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6.2.4 Monitoring of upper respiratory symptoms  
Participants completed a health questionnaire (Gleeson et al., 2011, 2012a) on a 
daily basis to indicate any URI (detailed in section 2.8). Participants were also asked 
to report how their training was affected by the URI (1 – training maintained, 2- 
training reduced, 3 – training discontinued). Separately to the monitoring of URI 
(episodes with a total symptom score ≥12), any reported URS, regardless of duration 
and/or severity, were included in the total URS days for all groups. This was deemed 
suitable in the present investigation as EBV reactivation has been shown to fluctuate 
on a daily basis (Gleeson et al., 2002; Yamauchi et al., 2011) and thus would provide 
a better indication of whether EBV serostatus affects reporting of symptoms. 
6.2.5 Statistical analysis 
The analysis below was completed in accordance with the methods of He et al 
(2013b) to determine the influence of EBV serostatus on URI and/or total URS days 
in the study cohort but with the additional attempt to identify whether any effects 
would be similar in PLA or COL groups. Data for the proportion of reported URI days 
and proportion of participants who suffered URI over the 12 weeks between 
participants who were EBV
+
 and EBV
-
 were assessed by chi-squared test. This was 
replicated for 2 other comparisons: COL
+
 vs. COL
-
; PLA
+
 vs. PLA
-
. Chi-squared 
analysis was also used to assess proportion of participants who reported use of 
medication or a negative effect on training load (reduced or discontinued) during URI 
episodes and proportion of total URS days within the previously mentioned 
comparative groups. Differences between the comparative groups for mean duration 
of URI, mean severity of URI and mean weekly training loads were performed with 
an independent t-test.   
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6.3 Results 
6.3.1 EBV serostatus 
Analysis of EBV VCA IgG levels demonstrated that 75% of the PLA group (n = 21) 
and 60% of the COL group (n = 15) were seropositive (EBV+). All participants were 
EBV+ or seronegative (EBV
-
) at both baseline and at 12 weeks, indicating no 
incidence of acute EBV infection during the study period. 
6.3.2 Baseline characteristics and training loads 
Baseline characteristics of the subgroups from all 53 participants are provided in 
table 6.1.  
Table 6.1 Baseline characteristics. 
Group N Age Body mass Height 
EBV+ 36 32.8 ± 14.1 77.4 ± 8.9 179.1 ± 6.7 
EBV- 17 27.2 ± 11.3 72.3 ± 7.7 179.0 ± 6.3 
COL+ 15 33.5 ± 15.1 80.0 ± 9.3 180.3 ± 6.5 
COL- 10 25.9 ± 10.8 72.9 ± 6.3 179.3 ± 6.5 
PLA+ 21 32.2 ± 13.6 75.5 ± 8.3 178.3 ± 6.9 
PLA- 7 29.1 ± 12.7 71.4 ± 9.9 178.5 ± 6.5 
 
Mean weekly training volume at moderate-vigorous intensity for the 53 participants 
across the 12 weeks was 50.5 ± 28.9 MET-h·week-1. There were no significant 
differences between groups in weekly training loads (p < 0.05) (Table 6.2). 
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Table 6.2 Weekly training loads of moderate-vigorous intensity.  
Weekly training load (MET-h·week-1) p 
EBV+ EBV-  
50.9 ± 27.7 49.7 ± 32.2 0.885 
COL+ COL-  
53.0 ± 24.3 53.2 ± 38.0 0.911 
PLA+ PLA-  
49.4 ± 30.4 44.7 ± 23.3 0.710 
P values are provided for the independent t-tests performed on comparative groups. 
6.3.3 Upper respiratory illness and total daily symptoms 
There was no significant difference in proportion of URI days (p = 0.457) or total 
URS days (p = 0.454) between EBV
+
 (7% and 11% respectively) and EBV
-
 groups 
(7% and 11% respectively). There was also no differences between groups for 
proportion of participants to report URI (EBV
+
: 53%; EBV
-
:
 
53%; p = 0.612), use of 
medication (EBV
+
: 74%; EBV
-
: 56%; p = 0.337) and/or negative effect on training 
during URI episodes (EBV
+
:47%: ;EBV
-
: 44%; p = 0.885) or the mean number 
(EBV
+
:0.6 ± 0.7; EBV
-
: 0.7 ± 0.7; p = 0.968), duration (EBV+:9.3 ± 5.7 days; EBV-: 
9.4 ± 4.0 days; p = 0.976) and severity (EBV+:41.4 ± 27.5; EBV-: 35.9 ± 26.8; p = 
0.589) of URI episodes.  
There was a significant difference in proportion of URI days (p = 0.001) between 
COL
+
 (3%) and COL
-
 (6%). There was, however, no differences between groups for 
total URS days (COL
+
: 8%; COL
-
:
 
9%; p = 0.138), proportion of participants to report 
URI (COL
+
: 40%; COL
-
:
 
40%; p = 1.000), use of medication (COL+: 50%; COL-: 
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50%; p = 1.000) and/or negative effect on training during URI episodes URI (COL+: 
50%; COL
-
:
 
75%; p = 0.429) or the mean number (COL+: 0.5 ± 0.6; COL-: 0.5 ± 0.7; 
p = 0.904), duration (COL
+
: 6.0 ± 2.1 days; COL
-
: 10.6 ± 5.7 days; p = 0.074) and 
severity (COL
+
: 28.4 ± 17.7; COL
-
: 45.0 ± 36.3; p = 0.313) of URI episodes.  
There was no significant difference in proportion of URI days (p = 0.426) or total 
URS days (p = 0.209) between PLA
+
 (13% and 10%, respectively) and PLA
-
 (13% 
and 9%, respectively). There was also no differences between groups for proportion 
of participants to report URI (PLA
+
: 62%; PLA
-
:
 
71%; p = 0.649), use of medication 
(PLA
+
: 85%; PLA
-
:
 
60%; p = 0.261) and/or negative effect on training during URI 
episodes (PLA
+
: 46%; PLA
-
:
 
17%; p = 0.216) or the mean number (PLA+:0.8 ± 0.7; 
PLA
-
: 0.9 ± 0.7; p = 0.976), duration (PLA+:10.8 ± 6.2 days; PLA-: 8.3 ± 1.8 days; p = 
0.174) and severity (PLA
+
:47.1 ± 29.5; PLA
-
: 28.3 ± 15.0; p = 0.157) of URI 
episodes.  
6.3.4 Total and differential leukocyte counts 
Analysis of leukocyte changes from baseline to 12 weeks indicated a significant 
difference between EBV
+
 and EBV
-
 groups across time in monocyte counts (2 way  
ANOVA group × time interaction, p = 0.037). Post hoc analysis could only reveal a 
trend for a decrease across time in EBV
- 
(p = 0.052). There were no main effects of 
time or group in monocyte counts (p > 0.05). Results for total leukocytes, neutrophils, 
total lymphocytes, neutrophil:lymphocyte, revealed no main effects of time, group, or 
group × time interaction (p > 0.05) (Table 6.3).  
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Table 6.3 Total and differential leukocyte counts at baseline and 12 weeks 
timepoints in EBV+ and EBV- participants.  
 
 
 
 
 
 
 
 
 
 
 
Analysis of total and differential leukocyte counts between COL
+
 and COL
-
 at 
baseline and 12 weeks timepoints revealed no main effects of group, time or group × 
time interaction (p > 0.05) (Table 6.4). There was a significant difference in total 
leukocyte changes across time between PLA
+
 and PLA
-
 groups (2 way ANOVA 
group × time interaction, p = 0.046) (Table 6.4). Post hoc analysis of timepoints 
could not reveal significant differences within groups.  All other leukocytes counts 
revealed no main effects (p > 0.05), although a trend did emerge for group × time 
interaction in monocyte counts (p = 0.068) (Table 6.4). 
 
 
 
Cell count, 10
9L-1 
 
 
 
     Baseline 
 
 
 
12 weeks 
Total leukocytes   
EBV+ 5.02 ± 1.49 5.24 ± 1.46 
EBV- 4.91 ± 1.28 4.79 ± 1.15 
Neutrophils   
EBV+ 2.47 ± 1.05 2.64 ± 1.14 
EBV- 2.42 ± 0.75 2.31 ± 0.73 
Monocytes   
EBV+ 0.45 ± 0.12 0.48 ± 0.17 
EBV- 0.47 ± 0.12 0.44 ± 0.14 
Total lymphocytes   
EBV+ 1.86 ± 0.54 1.86 ± 0.58 
EBV- 1.79 ± 0.60 1.82 ± 0.56 
Neutrophil:lymphocyte   
EBV+ 1.40 ± 0.62 1.51 ± 0.69 
EBV- 1.44 ± 0.53 1.36 ± 0.62 
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Table 6.4 Immune cell counts at baseline and 12 weeks following COL or PLA 
supplementation in EBV+ and EBV- participants.  
  
 
 
 
Cell count, 10
9·L-1 
                  COL 
 
 
      Baseline         12 weeks 
PLA 
 
 
      Baseline              12 weeks 
Total leukocytes     
EBV
+
 4.66 ± 0.81 4.82 ± 0.92 5.28 ± 1.80 5.53 ± 1.71 
EBV
-
 4.87 ± 1.31 5.02 ± 1.18 4.96 ± 1.35 4.47 ± 1.12 
Neutrophils     
EBV
+
 2.21 ± 0.39 2.24 ± 0.34 2.66 ± 1.32 2.93 ± 1.40 
EBV
-
 2.46 ± 0.85 2.41 ± 0.85 2.37 ± 0.65 2.16 ± 0.55 
Monocytes     
EBV
+
 0.45 ± 0.15 0.46 ± 0.12 0.46 ± 0.14 0.49 ± 0.22 
EBV
-
 0.50 ± 0.23 0.54 ± 0.12 0.46 ± 0.12 0.40 ± 0.10 
Total lymphocytes     
EBV
+
 1.79 ± 0.43 1.90 ± 0.73 1.90 ± 0.62 1.84 ± 0.47 
EBV
-
 1.73 ± 0.60 1.92 ± 0.61 1.88 ± 0.64 1.67 ± 0.48 
Neutrophil:lymphocyte     
EBV
+
 1.27 ± 0.28 1.28 ± 0.31 1.49 ± 0.77 1.67 ± 0.84 
EBV
-
 1.50 ± 0.56 1.37 ± 0.78 1.36 ± 0.51 1.34 ± 0.30 
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6.4 Discussion 
The aims of this study were to determine the influence of prior EBV infection on 
susceptibility to episodes of URI or short-lasting URS and identify whether the 
likelihood of such outcomes would be influenced by COL supplementation. The 
present study suggests that EBV serostatus alone does not affect the number of 
URI/URS days or the duration and severity of URI episodes. This is in support of the 
evidence from the recent study by He et al. (2013b) but not the findings of Gleeson 
et al. (2002). In line with He et al. (2013b) the present study involved monitoring a 
larger cohort of participants from a range of endurance sports compared to the small 
numbers of elite swimmers in Gleeson et al. (2002). More investigations are 
warranted to clarify whether susceptibility to URI due to EBV serostatus may be 
specific to certain athletes/sport settings (e.g. swimmers) undergoing intensified 
training.  
It is worthy to note there was a modest (3%) difference in the proportion of URI days 
between COL
+
 and COL
-
. The reasons for this and the biological significance are still 
unclear but may purely reflect certain pathogens involved in the illnesses of each 
group as there were similar trends for URI duration and no effect on number of URI 
episodes. Prior EBV infection has been shown to alter populations of CD8+ T cells 
which may produce antiviral cytokines. He et al. (2013b) observed fewer URI 
episodes and days and greater total lymphocyte count at rest in athletes who had 
prior CMV and EBV infection compared with athletes who were seronegative for both 
herpes viruses. This was contrary to their original hypothesis, but as there were also 
differences in URI days between positive CMV and negative CMV athletes it appears 
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that previous CMV infection may be an important factor in promoting 
immunosurveillance.  
As only EBV serostatus was assessed in the present study, the role of CMV in 
differences between COL subgroups can not to be dismissed, particularly as being 
EBV
+
 is more common with positive CMV serostatus (Bigley et al., 2012). This would 
not explain why there were no such differences in URI between PLA
+
 and PLA
- of 
this study. Furthermore, in the present study there were no apparent differences in 
leukocyte counts between COL
+
 and COL
-
 to be suggesting any higher level of 
immunosurveillance. CMV serostatus has been shown to amplify memory CD8+ T 
cells to acute exercise (Turner et al., 2010). In contrast, others have reported 
blunting of NK cell mobilisation following exercise in CMV positive participants 
(Bigley et al., 2012), or found no effect of CMV serostatus on responses of 
granulocytes and monocytes (LaVoy et al., 2013). At present, the effect of EBV 
serostatus on response to acute exercise is understudied; further research is 
required to clarify the role of prior infection with CMV/EBV on acute response to 
exercise and whether use of a nutritional intervention (e.g. COL) can have additive 
effects on any immunosurveillance. 
Although EBV serostatus was not assessed in Yamauchi et al. (2011), salivary 
expression of EBV-DNA tended to occur during reporting of URS (cough, sore 
throat) in rugby players involved in an intensive period of training. The present study 
design did not allow for the exploration of any direct role of EBV reactivation in 
causing URS. Notwithstanding, the lack of differences in total URS days between 
groups based on EBV serostatus may provide indirect evidence to suggests that 
being EBV
+ does not increase the incidence of URS. The appearance of EBV in 
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saliva may be random, an epiphenomenon to URS incidence, with no clinical 
significance per se on athlete’s health (Gleeson et al., 2002). However, the lack of 
investigation of EBV expression during URS in the present study must be considered 
a limitation as determining the relationship between total URS with EBV serostatus 
alone may be masked by other non-infectious inflammatory stimuli (Bermon, 2007).  
It is unclear whether the use of participants who had a higher mean weekly training 
load and/or of similar status to previous studies (e.g. elite, Gleeson et al., 2002), 
hence with the potential for a greater risk of EBV reactivation, would have produced 
different findings in total URS. There is reasonable evidence to suggest that EBV 
reactivation during intensified periods of training may be a marker of compromised 
mucosal and/or cellular immunity rather than contributing towards a risk for URI 
(Gleeson et al., 2002: Mehta et al., 2000a).  Such perturbations in the Tc population 
may explain why decrements in mucosal protection (i.e. secretory IgA) have also 
been found in conjunction with increased EBV expression (Gleeson et al., 2002; 
Yamauchi et al., 2011). Further evidence to support proposals of salivary EBV 
expression as an in vivo marker of immunodepression only are findings of 
administration of antiviral (specific to herpes viruses) agents reducing detectable 
EBV but yet not influencing the incidence of URI in endurance runners (Cox et al., 
2004).    
The importance of detecting novel indicators of immune dysfunction and risk factors 
for illness is highlighted in the present study by the negative effect on training volume 
in ~ 46% (both groups combined) of URI episodes. Regardless of any role in 
symptomatology, as increased EBV expression has been shown to coincide with 
immune perturbations during physiological and/or psychological stressors (Mehta et 
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al., 2000a, 2000b), it may provide a useful in vivo marker of the effects of training on 
the immune system of athletes. Although EBV seroprevalence was somewhat lower 
in the present cohort (~ 68%) compared to previous reports in the general population 
(80-90%), the high proportion of seropositve in the adult population reiterates the 
need for further research on this latent virus.  
In summary, the current study indicated that there was no clear effect of EBV 
serostatus on URI but within participants who underwent COL supplementation, 
EBV+ suffered fewer URI days than their EBV- counterparts. This study contributes to 
on-going research exploring the role of latent viruses towards the risk of URI. Further 
investigations are warranted to determine the role of prior EBV infection towards 
responses to acute endurance exercise and/or duration of URI and whether 
nutritional interventions influence the significance of any changes.    
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Chapter 7. Study 5 - The effects of bovine colostrum 
supplementation on in vivo T-cell-mediated responses within a 
contact hypersensitivity model following prolonged exercise 
Abstract 
Prolonged exercise significantly reduces both the induction and elicitation of in vivo 
cell-mediated immune responses. The aim of this study was to investigate the effects 
of COL supplementation on the in vivo cell-mediated responses to a topical 
sensitiser (Diphenylcyclopropenone, DPCP) following prolonged exercise. In a 
double-blind design, 28 male participants were randomly assigned to either a COL 
(20 g a day) (n = 14, age: 24 ± 5 years, BM: 75.6 ± 9.5 kg, height: 181 ± 6 cm, 
2OV

max: 57.1 ± 5.2 mL∙kg-1∙min-1) or PLA (n =14, age: 25 ± 6 years, BM: 74.1 ± 8.6 kg, 
height 179 ± 8 cm, 
2OV
 max: 58.4 ± 8.2 mL∙kg-1∙min-1 ) group for 87 days following 
stratification for age and aerobic fitness only. Exactly 28 days into supplementation, 
participants took part in 2 h of running at 60% of 
2OV
 max. Within 20 min of exercise 
completion, all participants were sensitised to DPCP using a single patch applied to 
the mid-lower back for 48 h. Following the induction of immune-specific memory 
(sensitisation), participants reported to the laboratory 28 days later for a dose series 
of DPCP patches to be applied in a randomly allocated order to the volar aspect of 
their right upper arm for 6 h. Participants returned to the laboratory 24 h and 48 h 
following the application of patches for skin responses (oedema) to be measured at 
each DPCP patch site using modified skinfold callipers. There was no difference in 
total oedema responses (sum of all skinfold sites) between COL and PLA (p > 0.05). 
Analysis of the dose response curves allowed for the minimum dose (threshold) for a 
positive response in each group to be determined (i.e. sensitivity). The minimum 
dose for PLA was 2.0 and 2.1 fold greater than COL at 24 h and 48 h respectively 
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(i.e. greater sensitivity in COL). There was a greater response in COL at 24 h for the 
lowest DPCP dose (p < 0.05), but not at 48 h or with other doses at either timepoint 
(p > 0.05). There were no apparent effects of COL supplementation on the 
magnitude of cutaneous immune responses (summed skinfold responses) at recall 
(4 weeks following initial sensitisation to DPCP). The study does, however, suggest 
that COL enhances sensitivity of the recall of antigen-specific memory. This may 
support previous evidence from our laboratory where COL has been shown to act as 
a nutritional countermeasure to prolonged exercise and decrease susceptibility to 
illness. 
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7.1 Introduction 
Numerous studies have shown significant decreases in circulating and mucosal 
immune function in individuals undergoing heavy physical exertion (Nieman, 2007). 
The majority of these studies have investigated this via animal studies or in vitro 
measures (Walsh et al., 2011b). The relevance of animal studies to human immune 
function comes under constant scrutiny while clinical relevance of investigations 
using in vitro measures have been questioned, particularly if cells have been isolated 
from their normal environment (Vumanovic-Stejic et al., 2006). The importance of in 
vivo measures of immunity to determine the clinical relevance of an intervention 
have been recognised (Albers et al., 2005). The few human studies which have used 
these measures have investigated the in vivo response to novel or previously 
encountered antigens (Harper-Smith et al., 2011).  
Bruunsgaard et al. (1997) found that the DTH skin response to an intra-dermal 
injection of seven previously encountered antigens (Mérieux CMI Multitest®) was 
significantly decreased in endurance athletes after prolonged exercise in comparison 
with rested controls. This technique, however, is limited by the investigation of pre-
existing immunological memory (elicitation) and therefore provides no indication of 
the effects of exercise on the primary (induction) T-cell-mediated response to a novel 
antigen (Harper-Smith et al., 2011).  
Topical skin exposure to novel chemicals (contact sensitisation) such as DPCP 
allows for the effects of systemic stressors on the induction and elicitation phases of 
in vivo T-cell-mediated immune response to be quantified by oedema and erythema 
(Albers et al., 2005; Friedmann, 2007; Palmer and Friedmann, 2004). By use of this 
model of experimental contact sensitisation, Harper-Smith et al. (2011) 
175 
 
demonstrated that participation in a single bout of prolonged (2 h) moderate exercise 
compared to rest significantly reduced both the induction as well as the elicitation of 
in vivo cell-mediated immunity. Interestingly, in this study the impairment in cell-
mediated immunity by a prolonged exercise bout was greater in the induction phase 
(53%) compared to the elicitation phase (19%). Nevertheless, this supports evidence 
from other investigations, to date, which indicates that prolonged exercise reduces in 
vivo cell mediated immune response in humans (Bruunsgaard et al., 1997; Dhabhar 
and Viswanathan, 2005; Edwards et al., 2006; Walsh et al., 2011b). 
Several nutritional interventions have been proposed as countermeasures to 
exercise-induced immune dysfunction. Despite recognition of DTH responses as 
sensitive in vivo indicators of the ability of nutritional interventions to influence cell-
mediated immune responses (Bogden et al., 1994; Fuller et al. 1992; Herraiz et al., 
1998; Meydani et al., 1990; Pallast et al., 1999), none have explored the use of 
previously mentioned human in vivo model to investigate the effects of nutritional 
countermeasures to exercise-induced immune dysfunction. Animal and in vitro 
culture studies demonstrate that COL has a mediating effect on cell-mediated 
immunity by influencing the production of cytokines (Biswas et al., 2007; Shing et al. 
2009b). Although some have demonstrated alterations in the balance of Th1/Th2 
cytokines towards a profile which promotes cell-mediated immunity (Shing et al., 
2009b), this may depend on the nature of the stimulus. Biswas et al. (2007) indicated 
that COL enhanced IFNproduction by PBMC under weak antigenic stimulation but 
inhibited IFN with strong antigenic stimulation (Biswas et al., 2007).  
Despite findings of a reduced incidence of URI with COL supplementation in study 3, 
any effect on immune parameters (at rest) appeared to have been localised to the 
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oral cavity. Previous investigations (Study 1, 2; Davison and Diment, 2010) suggest 
that COL can have a beneficial effect on fMLP-stimulated oxidative burst and 
bacterial-stimulated elastase release of neutrophils within a model of exercise-
induced immune dysfunction. It may be hypothesised that the immunomodulatory 
and immunoprotective effects of COL are more apparent in the immediate period 
following acute, heavy exertion. Although Albers et al. (2005) suggested that the 
measure of neutrophil oxidative burst does provide sufficiently reliable and sensitive 
investigation of a human intervention, it is difficult to conclude with any degree of 
certainty that increases in one component of immune function is responsible for the 
alteration observed in an individual’s susceptibility to URI with COL supplementation 
(Brinkworth and Buckley, 2003; Crooks et al., 2010; Patel and Rana; 2006; Patiroglu 
and Kondolot, 2013; Study 3). To date, most exercise studies (Study 1, 2; Davison 
and Diment, 2010) have focused on the influence of COL supplementation on innate 
immunity. The effects of COL on the in vivo response to a novel antigen involving a 
multi-cellular response remain unclear. Therefore, the aim of this study was to 
investigate the effects of COL supplementation on the induction of a cell-mediated 
response to DPCP following prolonged exercise. 
7.2 Methods 
7.2.1 Participants 
Twenty eight, healthy, recreational active males, (age 24 ± 5 years; BM 74.9 ± 8.9 
kg; height 180 ± 7 cm; 
2OV
 max 57.8 ± 6.8 mL∙ kg-1∙min-1) volunteered to participate 
in the present investigation. 
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7.2.2 Supplementation 
In a cross sectional design, 28 male participants were randomly assigned to either 
the COL group (n = 14, age: 24 ± 5 years, height: 181 ± 6 cm, BM: 75.6 ± 9.5 kg; 
2OV
 max 57.1 ± 5.2 mL∙ kg-1∙ min-1 ) or a PLA group (n =14, age: 25 ± 6 years, height 
179 ± 8 cm, body mass 74.1 ± 8.6 kg; 
2OV
 max 58.4 ± 8.2 mL∙kg-1∙min-1 ) following 
stratification for age and aerobic fitness only. In a double blind manner, participants 
were asked to consume 20 g a day (split into a morning and evening 10 g dose) of 
COL or an isoenergetic/isomacronutrient PLA for ~ 8 weeks (87 days). 
7.2.3 Preliminary visits 
To control for aerobic fitness prior to group allocation (above), each participant 
performed a continuous incremental test (1 kmh-1 ramp rate every 1 min following 3 
min at a speed of 7 kmh-1) to volitional exhaustion on a treadmill with a 1% grade 
(PPS 55med, Woodway GmbH, Weil am Rhein, Germany). Throughout the duration 
of the incremental test, expired gas was analysed by the use of an online breath-by-
breath gas analysis system (Jaeger Oxycon Pro, Hoechberg, Germany). Upon 
volitional exhaustion, participants supported their weight with their hands and moved 
their feet to the sides of the treadmill. Strong verbal encouragement was provided in 
the later stages of the test to encourage maximal effort. For each participant, 
2OV
  
max was determined by the highest 30 s average during the test.  
At least 48 h following the incremental test and after an overnight fast (from 
midnight), participants reported to the laboratory at 10:30 for a blood sample (BAS) 
prior to commencing the above supplementation. Fourteen days into the 
supplementation period, 
2OV
 max of participants was determined as detailed 
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previously. The objective of this second incremental test was to estimate a speed 
equivalent to 60% 
2OV
 max for each participant. Seven days later, participants 
performed a familiarisation trial consisting of a 1 h run at 60% 
2OV
 max. The main 
objectives of this visit were to habituate participants with procedures of the main 
experimental trial (on day 28) and to verify that the speed set from the incremental 
test corresponded to 60% 
2OV
 max. 
7.2.4 Experimental trials  
For the 24 h prior to the main experimental trial, participants were provided a 
standardised diet of 60% (energy from) carbohydrate: ~5.4 gkg-1 BM; 25% fat: ~1.0 
gkg-1 BM; 15% protein: ~1.3 gkg-1 BM and water: 35 mLkg-1 BM (Todorovic and 
Micklewright, 2004). This diet matched the estimated daily energy expenditure 
requirements for each participant which was calculated by the equation of Harris and 
Benedict (1918) multiplied by a physical activity factor of 1.5 (note: relative rest was 
required on this day). In addition to controlling for the quantity of food, all participants 
were given the same types of food. This diet did not include any caffeine or alcohol 
and participants were also asked to avoid any exercise during this period. On day of 
the main trial, participants reported to the laboratory at 07:30 for a standardised 
breakfast (total energy: 7.5 kcalkg-1 BM, carbohydrate: ~1 gkg-1 BM [60%], fat: ~ 0.2 
gkg-1 BM [25%] and protein: ~0.2 gkg-1 BM [15%]).  
Subsequently, all participants had a ~ 3 h period in the laboratory where they 
completed light activity (e.g. reading, writing, watching TV). Participants were 
provided a bolus of water equivalent to 5 mLkg-1 BM during this period. A blood 
sample (PRE) was collected (10:45) prior to participants commencing (11:00) a 2 h 
running bout at 60% 
2OV
 max. All participants were permitted diluted cordial (four 
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volumes of water to 1 volume of sugar-free cordial at 2 mL per kg of BM) every 15 
min during the exercise but not at end of the exercise. Expired gas was analysed 
during the 30th, 60th and 90th minute of exercise (Jaeger Oxycon Pro, Hoechberg, 
Germany). HR and RPE were monitored and recorded every 15 min during the 
protocol using a telemetric device (Polar S610, Polar Electro Oy, Kempele, Finland) 
and the Borg rating scale (Borg, 1982) respectively. A venous blood sample was 
collected immediately post-exercise (POST). Participants showered and returned to 
the laboratory within 20 min of exercise completion.  
At the same time of day (13:20), participants were sensitised to DPCP using a single 
patch (comprising of a12 mm aluminium Finn chamber, on Scanpor hypoallergenic 
tape, containing a 10 mm paper disc) applied to the mid-lower back. The patch had 
22.8 µL of 0.125% DPCP in acetone applied (30 µg·cm-2 DPCP). This was allowed 
to dry before application. Following application, the patch remained in place for 
exactly 48 h. Participants were instructed to avoid alcohol and exercise during this 
period. Prior to leaving the laboratory on the day of the experimental trial, 
participants were given a standardised meal (carbohydrate: 0.62 gkg-1 BM (50%), 
fat: 0.2 gkg-1 BM (34%) and protein: 0.2 gkg-1 BM (16%)). Upon removal of the 
DPCP patch (48 h later), sensitisation to the novel antigen was assessed (i.e. red 
mark present at patch site). As used previously (Harper-Smith et al., 2011), 
participants were contacted 14 days later by telephone to confirm sensitisation.  
Exactly 28 days following the induction of immune-specific memory (sensitisation), 
participants reported to the laboratory for a dose series of DPCP patches to be 
applied to the volar aspect of their right upper arm (10 µL of DPCP: 0.0048%, 1.239 
µg·cm-2; 0.0076%, 1.982 µg·cm-2; 0.0122%, 3.172 µg·cm-2; 0.01953%, 5.075 µg·cm-
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2; 0.03125%, 8.120 µg·cm-2 and 10 µL of 100% acetone control patch [i.e. 0% 
DPCP] for background subtraction) at the same time that the initial sensitisation 
patch was placed on the mid/lower back (13:20). Each individual patch comprised of 
an 8 mm aluminium Finn chamber mounted on Scanpor hypoallergenic tape 
containing a 7 mm filter paper disc. To minimise anatomical variability these patches 
were applied in a randomly allocated order. Following 6 h of application, participants 
were asked to return to the laboratory for removal of the patches. Participants 
returned to the laboratory 24 and 48 h following the application of patches for skin 
responses (oedema) to be measured. Mean skin fold thickness (oedema) was 
determined from triplicate measurements (to the nearest 0.1 mm) at each DPCP 
patch site using modified skin fold callipers (Baty, West Sussex, UK). Mean 
background values were determined from triplicate measurements at the control 
(0%) patch site, for oedema. All measurements were made by the same investigator 
to minimise variability in the measurements. Increases in thickness were determined 
by subtracting the control site value from each DPCP site value. Summed increases 
in skinfold thickness were determined by adding values over all doses. In the 24 h 
prior to application of these patches and until measurement of skin responses were 
complete, participants were requested to avoid any exercise and alcohol.   
7.3 Results 
7.3.1 Physiological responses 
 There was no significant difference in 
2OV
  (p = 0.692; p = 0.578) between the COL 
(2656 ± 262 ml∙min-1; 61.4 ± 2.3% 
2OV
  max) and PLA trials (2702 ± 322 ml∙min-1; 
62.0.0 ± 3.5% 
2OV
 max). Mean HR of 149 ± 14 bpm and 149 ± 11 bpm during COL 
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and PLA trials respectively, was not significantly different (p = 0.968). There was no 
significant difference in RPE (p = 0.994) between the COL (12.7 ± 1.0) and PLA 
(12.7 ± 1.2) trials. There was no significant time (p = 0.571), trial (p = 0.092) or 
interaction effect (p = 0.838) on blood glucose (Table 7.1). There was a significant 
time effect for blood lactate (p < 0.001) with a significant increase from PRE (p < 
0.001) to POST but there was no trial (p = 0.338) or interaction effect (p = 0.105) 
(Table 7.1).  
Table 7.1 Blood glucose and lactate responses in the main experimental trial.  
 
 
 
 
 
*Significant main effect of time (p < 0.001). 
7.3.2 Immune cell counts 
No significant trial or interaction effects were evident for total or differential leukocyte 
counts (Table 7.2). A main effect of time was observed in all leukocyte counts (Table 
7.2). There was a significant increase in total leukocytes, neutrophils, monocytes, 
lymphocytes, neutrophil:lymphocyte ratio and large immature cells from timepoints 
pre-exercise (BAS and PRE) to POST (p < 0.05). There was no significant change in 
leukocytes from BAS to PRE except for an increase in neutrophil count (p = 0.026).   
 
 
 
Measure, mmol∙L
-1
 
 
 
 
PRE 
 
 
 
POST 
p values 
trial 
time 
interaction 
Blood glucose   0.092 
COL 4.13 ± 0.40 4.21 ± 0.50 0.571 
PLA 3.91 ± 0.39 3.95 ± 0.49 0.838 
Blood lactate   0.338 
COL 0.59 ± 0.14 0.71 ± 0.19  < 0.001* 
PLA 0.57 ± 0.13 0.84 ± 0.22  0.105 
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Table 7.2 Immune cell counts prior to and following prolonged running.  
*Significant main effect of time (p < 0.001). 
  
 
 
 
Cell count, 10
9
∙L
-1
 
 
 
 
BAS 
 
 
 
PRE 
 
 
 
POST 
p values 
trial 
time 
interaction 
Total leukocytes    0.537 
COL 5.49 ± 1.75 5.65 ± 1.33 11.10 ± 3.96 < 0.001* 
PLA 4.80 ± 1.23 5.18 ± 0.94 11.76 ± 5.71 0.435 
Neutrophils    0.533 
COL 2.98 ± 1.69 3.21 ± 1.27 8.07 ± 4.33 < 0.001* 
PLA 2.36 ± 0.81 2.85 ± 0.78 8.24 ± 5.09 0.484 
Monocytes    0.622 
COL 0.55 ± 0.17 0.53 ± 0.12 0.83 ± 0.32 < 0.001* 
PLA 0.47 ± 0.12 0.51 ± 0.13 0.89 ± 0.40 0.275 
Total lymphocytes    0.653 
COL 1.72 ± 0.35 1.59 ± 0.35 2.24 ± 0.67 0.001* 
PLA 1.77 ± 0.68 1.62 ± 0.58 2.36 ± 0.57 0.866 
Neutrophil:lymphocyte    0.434 
COL 1.91 ± 1.69 2.13 ± 1.01 3.71± 1.66 < 0.001* 
PLA 1.37 ± 0.40 1.82 ± 0.54 3.51 ± 1.93 0.640 
Large immature cells    0.771 
COL 0.05 ± 0.04 0.05 ± 0.03 0.15 ± 0.10 < 0.001* 
PLA 0.04 ± 0.02 0.04 ± 0.01 0.20 ± 0.17 0.485 
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7.3.3 Contact Hypersensitivity responses 
Two way ANOVA revealed there was a significant increase in summed skinfold 
responses from 24 h to 48 h (< 0.001) (Figure 7.1). However, there was no effect of 
trial (p = 0.519) or trial × time interaction (p = 0.943). Data for individual doses could 
not be normalised for 2-way ANOVA analysis. As the main purpose of the study was 
to assess the potential effects of COL on in vivo responses to a range of DPCP 
doses and due to apparent differences in sensitivity between groups (see below), 
individual doses were investigated by non-parametric (Mann Whitney-U) tests 
(Figure 7.2). At 24 h for the lowest dose of DPCP, there was a significantly greater 
response in COL compared to PLA (p = 0.039). There were no other differences 
between the COL and PLA group at 24 h or 48 h for any of the other doses of DPCP 
(p > 0.05).  
In accordance with Harper-Smith et al. (2011), further analysis of the dose response 
curves (Figure 7.2) would allow the minimum dose (threshold, x-intercept when y = 
0) for a positive response in each group to be determined. Analysis revealed at 24 h, 
the threshold was 0.63 µg·cm-2 and 1.22 µg·cm-2 for COL and PLA groups 
respectively, indicating a dose 1.95 fold greater was required to elicit a positive 
response in the PLA group. At 48 h, the threshold was 0.51 µg·cm-2 and 1.06 µg·cm-2 
for COL and PLA groups respectively, indicating a dose 2.09 fold greater was 
required to elicit a positive response in the PLA group.  
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Figure 7.1 Skin responses to DPCP following the completion of exercise prior to 
induction of contact sensitivity with DPCP in COL and PLA groups. Columns are the 
means of summed responses to the five doses of DPCP with error bars displaying 
standard deviation. * Significant main effect of time (increases in summed skinfold 
thickness from 24 to 48 h) (p < 0.001).   
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Figure 7.2 Mean skin responses at each of the DPCP doses at 24 h (A) and 48 h (B). 
Error bars represent standard deviation. *Significant difference between groups at 
dose (p < 0.05). 
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7.4 Discussion 
The aim of this study was to investigate the effects of COL supplementation on the 
induction of a cell-mediated response to DPCP following prolonged exercise. 
Previous evidence suggests that completion of prolonged exercise prior to 
sensitisation to the novel sensitising chemical, DPCP, can impair the induction of 
antigen-specific memory (Harper-Smith et al., 2011). This provides a robust method 
to evaluate the effects of purported nutritional countermeasures on exercise-induced 
immune dysfunction which in this model is assumed to primarily involve T-cell-
mediated immunity. In the present study, there was no apparent effects of COL 
supplementation on the magnitude of cutaneous immune responses (summed 
skinfold responses) recalled 4 weeks following initial sensitisation to DPCP. This lack 
of effect in overall reactivity to DPCP (Cooper et al., 1992; Palmer and Friedmann, 
2004) was evident at 24 h and 48 h following the recall of antigen-specific memory. 
Harper-Smith et al. (2011) also indicated that participation in prolonged exercise 
prior to primary sensitisation increased the minimum dose (threshold) required to 
elicit a positive response to DPCP 48 h following the recall challenge. Essentially, 
the exercise group who suffered the exercise-induced impairment in cell mediated 
immunity required a DPCP dose of 2.58 fold greater (i.e. lower sensitivity) than the 
control group to evoke a positive response (i.e. increase in skin oedema). Within the 
present study, at the same timepoint, a dose of 2.09 greater was required to elicit a 
positive response in the PLA group compared to COL. Furthermore, these 
thresholds for positive responses as a dose per unit area (COL: 0.51µg·cm-2; PLA: 
1.06µg·cm-2) at 48 h for COL and PLA groups are comparable to the control (resting) 
and exercise groups of Harper Smith et al. (2011) (control: 0.53 µg·cm-2; exercise: 
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1.38µg·cm-2). Taken together, this may suggest that COL acts as nutritional 
countermeasure to prolonged exercise by preventing decrements in the sensitivity of 
the recall of antigen-specific memory. Such interpretation should be viewed with 
caution considering that here and within the data of Harper-Smith et al. (2011) the 
data for minimum thresholds are not exposed to statistical analysis as they must be 
derived from pooled group data. However, the greater responses to the lowest dose 
of DPCP at 24 h in the COL group would provide support to a lower threshold with 
COL supplementation.  
There is unequivocal evidence that a threshold effect exists for cutaneous 
sensitisation (Kimber et al., 1999). It has been substantiated with a number of 
allergens and contact sensitisers such as nickel and 2-4-dinitrochlorobenzene 
(Allenby and Basketter, 1993; Friedmann and Moss, 1985). Indeed, with 
experimental contact dermatitis, there are threshold doses where an allergic state is 
not clinically elicited despite prior sensitisation (Hostynek and Maibach, 2004). 
Currently there is no available evidence to suggest that differences in responses to 
DPCP translate to change in the resistance to other novel antigens (e.g. viruses) in 
athletes. In other words, clinical relevance of the lower threshold for positive 
response in COL and greater responses at the lowest DPCP dose (at 24 h) 
compared to PLA but a  lack of effect of COL on the summed oedema responses in 
the present study is unknown. It is reasonable to suggest that greater immune 
responses by the host during exposure to a low dose of pathogen would be 
beneficial for limiting the spread of the infectious agent. Indeed, a major goal of 
vaccines is to sensitise the host for future exposure to the pathogen (Constant and 
Bottomly, 1997). It is beyond the scope of the findings of this study to suggest that T-
cell mediated responses at lower doses of DPCP are of greater biological 
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significance than summed responses. Previous studies, however,  have 
demonstrated that COL does reduce the incidence of URI in athletic and immune-
deficient populations but generally has no effect on the duration and severity of 
episodes (Brinkworth and Buckley, 2003; Study 3; Crooks et al., 2010; Patel and 
Rana, 2006). 
It must be acknowledged that the present study design does not allow us to fully 
establish whether the potential effect of COL on the immune system occurred during 
the induction and/or the elicitation of cell-mediated immune responses. Within the 
field of contact sensitisation, the main factor considered to determine the extent of 
elicitation is the strength of the induction (Hostynek and Maibach, 2004). In addition, 
the stronger the degree of induction, the lower the dose that sensitised individuals 
will react to upon any recall challenge (Friedmann, 2007). Given the extent of 
depression in the induction phase of T cell memory following prolonged exercise 
(Harper-Smith et al., 2011), it is reasonable to suggest that this is the period that 
would have benefited most from a nutritional countermeasure such as COL. 
Evidence to date (Davison and Diment, 2010; Study 1, 3) suggests that the effects of 
COL may be more apparent in the early recovery period following prolonged 
exercise. The immunoprotective effects of COL within a model of exercise-induced 
immune dysfunction thus far in humans have only been demonstrated within 
measures of neutrophil function. Biswas et al. (2007) did, however, demonstrate that 
COL can differentially affect in vitro stimulation of human PBMC by enhancing IFN 
production during weak antigenic stimulation but inhibiting IFN response during 
strong antigen stimulation. Whether such findings provide and explanation to the 
findings of our study remains speculative at present.  
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Although T cell infiltration plays a central role in the orchestration of the DTH 
response, this is initiated by the non-specific ‘sensitivity’ of other local (dendritic, 
Langherhans) cells that respond to perturbations induced by the antigen (Friedmann 
et al., 1993). In addition to the induction phase, recent evidence suggests that the 
recruitment of antigen-primed CD8+T cells into the elicitation site may also depend 
on the infiltration and chemoattractants released by inflammatory cells (e.g. 
neutrophils) (Engeman et al., 2004; Kish et al., 2012). The lack of measurement of 
circulating cytokines within this study limits any discussion on the effects of COL on 
signals that may have triggered the migration and maturation of these innate cells. 
Such findings may have reflected possible tissue priming effects that resulted in 
enhanced immunosurveillance and explain the greater responses at lower 
concentrations of DPCP in the COL group. Future studies should explore any effects 
of COL supplementation on immune parameters prior to induction and elicitation 
separately in order to determine potential mechanisms. It also would be prudent for 
investigators to measure oedema prior to the 24 h timepoint if an intervention is 
proposed to improve the sensitivity of responses.   
The mechanisms underpinning the effects of prolonged exercise on responses to 
DPCP are still unclear. The present study observed no effects of COL on the 
magnitude of skin oedema following recall of antigen memory. Harper-Smith et al. 
(2011) suggested that reductions in both induction and elicitation of such responses 
may be due to stimulation of the sympathetic nervous system and HPA axis (Dhabar, 
2002; Dhabar and McEwen, 1999). The increase in total and differential leukocytes 
within the present study is in line with such prolonged exertion where changes are 
well recognised to be due to increases in circulating concentrations of 
catecholamines and cortisol (Anane et al., 2009; Atanackoviv et al., 2006; McCarthy 
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and Dale, 1988; Nieman, 2001). The similar leukocyte trafficking between groups 
suggests that they were exposed to a matched physiological stressor and provides 
further evidence that COL does not mediate immune responses to exercise via such 
mechanisms. Given that carbohydrate supplementation during prolonged exercise 
has been shown to attenuate perturbations in stress hormones and/or in vitro 
measures of immune function (Davison and Gleeson, 2005; Lancaster et al., 2005a; 
Scharhag et al., 2002), use within the current experimental model warrants 
investigation.  
In summary, COL may affect the sensitivity of the in vivo response to a novel antigen 
but it has no effect on the overall magnitude of such responses. Further research is 
required to determine the clinical implications of such effects and whether they may 
provide further mechanistic explanations of the decrease in the incidence of URI 
during COL supplementation within athletic and immune deficient populations.  
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Chapter 8. General Discussion 
The series of studies presented in thesis (Study 1-5) were aimed to determine the 
effects of COL supplementation on the human immune system and risk of URI. The 
primary focus of the initial studies (Study 1 and 2) were to examine the influence of 
COL on neutrophil responses to a physical stress model (2.5 h of prolonged cycling) 
expected to result in exercise-induced immune dysfunction. These involved either 
consumption of COL on the day of exercise (1 h and immediately pre-exercise and 
mid-way through exercise) or supplementation for 28 days prior to the exercise trials. 
The secondary outcomes of these studies were also to investigate the effects of COL 
on mucosal immune responses to the prolonged cycling. This allowed for the 
independent investigation of acute and longer term supplementation of COL. 
As it was anticipated that any effects of COL were likely to be related to the 
absorption of bioactive components/derivatives which become bioavailable following 
digestion, a further study was designed with a chronic supplementation period (12 
weeks) to identify whether immune-enhancing properties would become apparent at 
rest. Given the opportunity of a sufficient window to identify differences in incidence 
of illness, the primary outcome in this study was incidence of URI. Due to the nature 
of the previous studies, a group of participants who performed regular endurance 
training were chosen as it was considered that they would expose themselves, 
regularly, to similar stressors imposed in our physical stress models and hence 
provide greater scope for an intervention with a nutritional countermeasure.  
The aetiology of URI in athletes is an on-going investigation with infectious and non-
infectious causes being explored. One such risk factor is latent herpes viruses. 
Therefore, in the same cohort as study 3, study 4 investigated whether susceptibility 
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to URI in seropositive or seronegative to EBV was affected by COL supplementation. 
To reflect a ‘normal situation’, minimal efforts were taken to modify the diet of 
participants. The common approach across all of these studies was to request for 
participants to arrive fasted to the laboratory on the day of all visits which involved 
measurement of immune parameters. Due to the crossover design of study 1, this 
study also involved a replication of diets in the day prior to trials.  
In the concluding experimental chapter (Study 5), additional standardisation of 
dietary intake was used. This involved prescribed food and drink intake in the 24 h 
prior to and on the day (breakfast and post-exercise snack) of the main exercise trial. 
Essentially, this was not an addition to provide any greater dietary standardisation 
than previous thesis studies per se but it was to follow the methodology of a previous 
study by Harper-Smith et al. (2011). This latter study demonstrated a depression in 
the induction of an in vivo immune response to a novel antigen (DPCP) in a group 
who performed prolonged exercise compared to seated rest (control) prior to 
sensitisation. Study 5 was designed to investigate the effects of supplementing the 
dietary intake of Harper-Smith et al. (2011) with COL or PLA for 28 days prior to and 
following the prolonged exercise. Any differences between groups would be 
suggested to be due to differences in the induction of immune responses (DTH) to 
an antigen following exercise or changes at rest (elicitation) following COL 
supplementation. With the expectation that the primary factor on the responses 
would be the sensitisation period (immediately following the exercise), matching the 
protocol to that of Harper-Smith et al. (2011) would provide an indicator of how 
groups compared to the control group of the latter study (i.e. extent of 
immunodepression). A summary of the effects of COL on all immunological  
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outcomes within this thesis is provided in Table 8.1 with further discussion on the 
specific measures in the remaining sections of this chapter. 
Table 8.1 Effects of COL supplementation on measured immune parameters within 
the thesis. 
 Supplementation 
Acute  
(pre- and during 
exercise) 
4 weeks  
(pre-exercise) 
12 weeks  
(rest) 
Bacterial-stimulated elastase release + = NA 
Neutrophil oxidative burst + + = 
Salivary bacterial load NA NA + 
Salivary SIgA = = = 
sLac = = = 
sLys + = = 
T-cell-mediated contact hypersensitivity NA + NA 
 + Benefit in COL compared to PLA (trial or trial × interaction: p < 0.05); = No 
difference between COL and PLA (p > 0.05): NA Parameter not analysed in study. 
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8.1 Bovine colostrum and exercise-induced leukocytosis 
It is well established that leukocytosis occurs during and immediately post-exercise 
with the observed changes being dependent on the exercise intensity and duration 
(Gleeson, 2007). In support of previous evidence (Davison et al., 2012; Henson et 
al., 2008; Robson et al., 1999b), the prolonged bouts of exercise (2-2.5 h) within this 
thesis induced significant increases in total and differential leukocytes. Such 
absolute changes in leukocyte trafficking and other indicators (e.g. increases in 
neutrophil:lymphocyte) demonstrate the extent of the physiological stress placed on 
the immune system (Nieman, 1998). The magnitude of these changes could be 
considered lower than previous studies which most likely reflect differences in 
training status of participants and/or intensity (cycling) and/or duration (running) of 
exercise (Davison and Gleeson, 2005, 2006; Davison et al., 2007, 2012; Henson et 
al., 2008; Laing et al., 2005; Nieman et al., 1998).  
Nevertheless, the observed leukocytosis is likely to be due to a combination of the 
activation of the sympathetic nervous system and HPA axis as well as the increased 
cardiac output and subsequent shear stress (increased blood flow) within blood 
vessels during and following prolonged exercise (Anane et al., 2009; Atanackoviv et 
al., 2006; Nieman, 2001). As shown previously (Carol et al., 2011; Davison and 
Diment, 2010), there was a lack of effect of COL on exercise-induced leukocytosis. 
Given the well accepted role of increases in catecholamines and cortisol in leukocyte 
trafficking, the findings of the present thesis may provide further evidence that any 
effects of COL on immune function do not appear to be related to an attenuation of 
such physiological changes during exercise.  
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There was also no evidence of significant changes in leukocyte counts (at rest rather 
than exercise) following 12 weeks of COL supplementation. Although attenuation of 
decreases in cytotoxic/suppressor T cells have been observed previously (Shing et 
al., 2007), this was during and following an intensified training period. Within the 
present thesis, the measurements were taken in a cross-sectional manner where 
participants had avoided exercise for at least 24 h. Generally, evidence suggests 
that leukocyte counts measured in a resting state, as here, are similar between 
athletes and non-exercising controls (Walsh et al., 2011b), thus it is not surprising to 
observe no differences between COL and PLA groups who were matched for 
training volume (duration and intensity). 
8.2 Bovine colostrum and neutrophil responses 
Despite regular exercise training having minimal effects on neutrophil counts, the 
leukocytosis that occurs following prolonged exercise is primarily mediated by a rise 
in circulating neutrophils (Walsh et al., 2011b). This neutrophilia is believed to be 
partly due to an immediate and delayed release of neutrophils from marginated pools 
within the body and bone marrow respectively (Allsop et al., 1992; McCarthy and 
Dale, 1988; Peake, 2002). The circulating post-exercise neutrophil population are 
suggested to include a greater proportion of immature cells (e.g. band cells) 
compared to pre-exercise which has been implicated to play a role in the decrease in 
neutrophil function (on a per cell basis) following prolonged exercise (Berkow and 
Dodson, 1986: Hetherington and Quie, 1985; McCarthy et al., 1991; Yamada et al., 
2002). For this reason, the most effective nutritional countermeasures to exercise-
induced neutrophil dysfunction are those which can attenuate leukocytosis and 
neutrophilia (i.e. carbohydrate) (Nieman, 2008). However, based on previous in vitro 
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co-culture studies (Sugisawa et al., 2001, 2002, 2003), the working hypothesis within 
this thesis was that COL supplementation would have direct effects on neutrophil 
function rather than any effect on their trafficking in response to exercise. 
In line with other leukocyte subsets, there was no effect of COL on neutrophil counts 
at rest or following exercise. However, in support of a previous study (Davison and 
Diment, 2010), study 1 suggested that COL supplementation improves the recovery 
of neutrophil degranulation following prolonged exercise. In contrast to Davison and 
Diment (2010) the present thesis also explored the effects of COL supplementation 
on stimulated neutrophil oxidative burst. Study 1 is the first study to show that acute 
supplementation of COL can result in greater fMLP-stimulated oxidative burst 
compared to PLA and enhance the recovery of neutrophil degranulation following 
prolonged exercise. This supports studies of short term in vitro culture which 
demonstrated that COL possesses the ability to prime neutrophil function upon 
subsequent activation (Benson et al., 2012; Sugisawa et al., 2001, 2002, 2003). 
Sugisawa et al. (2003) proposed that ‘priming’ induced by COL is due to low 
molecular weight proteins (e.g. proteose peptones). The enhancement of fMLP-
stimulated oxidative burst of neutrophils measured at rest (i.e. BAS) and post-
exercise by in vitro pre-incubation with plasma obtained following (acute) COL 
consumption does provide preliminary evidence to suggest that priming or immune 
enhancing components become bioavailable in vivo. 
Study 1 was directed by a pilot study where PMA-stimulated oxidative burst was 
enhanced 1 h after COL consumption in resting healthy participants. There was, 
however, a lack of effect of COL on PMA-stimulated oxidative burst at post-exercise 
timepoints in study 1 and even pre-exercise (1 h post consumption), unlike what was 
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seen in the pilot work of that study. This may highlight a multi-faceted mechanism on 
neutrophil oxidative burst which is affected by the perturbations during and following 
prolonged exercise. For example, the priming of neutrophils is not an irreversible 
process (Kitchen et al., 1996; Summers et al., 2010), thus an effect of ‘depriming’ on 
responses to agonists such as PMA following exercise should be determined. 
Changes in neutrophil effector functions with prolonged exercise have been 
suggested to depend on the balance of immunosuppressive (e.g. ‘refractory period’) 
and immunostimulating factors (e.g. priming agents) (Peake, 2002)  
The role of low molecular weight peptides remains preliminary at present but it must 
be recognised that as cytokines (GM-CSF, G-CSF, IL-8, TNF) which are known to 
regulate neutrophil functions have not been measured (Elbim et al., 1994; Khwaja et 
al., 1992; You et al., 1991), the role of mediators other than the proposed 
components (i.e. proteose peptones) cannot yet to be dismissed in human studies. 
Pancreatic enzymes produce numerous potential biologically active peptides from 
the digestion of COL (Jorgensen et al., 2010). For example, although IgG (a major 
indicator of COL supplement quality, Gulliksen et al., 2008) within non-digested COL 
is unlikely to pass into circulation it may act as precursor to other immune 
modulatory components (metabolites). Tuftsin, a small (~500 Da) tetrapeptide 
produced from the digestion of the Fc heavy chain of IgG has been shown to 
enhance phagocyte (i.e. neutrophil) chemotaxis and oxidative burst (Najjar and 
Nishioka, 1970; Siemion and Kluczyk, 1999; Werner et al., 1986; Wu et al., 2012). 
Additionally, evidence that components of bovine whey protein extracts (-
lactoglobulin, -lactalbumin) can survive gastric digestion and prime neutrophil 
responses to fMLP (Rusu et al., 2009) demonstrates the range of potential 
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immunomodulatory components within COL and related preparations (Severin and 
Wenshui, 2005). 
 
Figure 8.1. Schematic representation of the effects of acute COL supplementation. 
Incubation of  plasma obtained following 1 h of COL or PLA consumption with pre- or 
post-exercise blood (shown as bars) and the responses of the same subset of 
participants to the experimental trials (acute COL supplementation) (shown as line 
and symbol) of study 1.  
Nevertheless, as longer term supplementation (4 weeks, Study 2) had greater effects 
on fMLP oxidative burst than acute supplementation (Study 1) it may suggest that a 
long term exposure to priming agents via full absorption and/or accumulation of COL 
leads to the most effective use of the nutritional intervention. However, it must be 
acknowledged that there remains to be a lack of acute COL supplementation studies 
to conclude a greater effect with chronic supplementation. It is reasonable to suggest 
that acute supplementation would require a higher dosage of COL, future studies 
should expand on the design of the pilot study in this thesis to determine the optimal 
timing and dosage of acute and/or chronic supplementation of COL prior to exercise. 
Such studies are likely to identify the kinetics at which the priming components 
and/or other metabolites involved in enhancement of neutrophil function appear and 
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leave the circulation following COL supplementation. The evidence gathered in this 
thesis does at least suggest that the effects of a large acute dose or longer term 
daily supplementation of COL on neutrophil responses are not related to an up-
regulation of antioxidant defences as found previously with other supplements with 
antioxidant components (Davison and Gleeson, 2007). 
Furthermore, it seems that the effects of COL on neutrophil function are most 
apparent under circumstances of greatest immunodepression. This may be 
supported by the lack of decrease in neutrophil degranulation post-exercise (no 
subsequent effect of COL) in study 2, whereas in Davison and Diment (2010), COL 
enhanced the recovery of this parameter 1 h following exercise compared to a 
sustained decrease in the PLA group. The lack of effect of 12 weeks of COL 
supplementation on fMLP-stimulated oxidative burst in active males at rest may also 
support a hypothesis that the effects of COL are more apparent during exercise-
induced immune dysfunction. It is worthy to note that a paired t-test analysis of the 
COL group in study 3 did demonstrate an increase in fMLP oxidative burst (p = 
0.008) across the 12 weeks. The lack of significant difference between the groups 
may have resulted from a lack of statistical power. 
In general, the effects of COL on neutrophil responses, in particular with exercise-
induced immune dysfunction, appear to be receptor dependent (fMLP oxidative 
burst, bacterial-stimulated degranulation). The physiological relevance of these 
responses is that the investigated agonists (fMLP, LPS) are known to be released at 
sites of inflammation (as a result of infection or tissue damage) (Carp, 1982; 
Mantovani et al., 2011; Marasco et al., 1984; Tennenberg and Solomkin, 1990). The 
importance of neutrophil function is also exemplified within individuals who are prone 
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to recurrent bacterial and fungal infections as a result of inherited defects in such 
pathways (Summers et al., 2010).  
Shing et al. (2007) observed a minor enhancement of cell surface receptor (CD89) 
expression on neutrophils at rest during 5 consecutive days of high-intensity training 
but not following exercise in the COL-supplemented group. Despite impaired 
receptor expression resulting in decreased oxidative burst activity in clinical settings 
(e.g. Lin et al., 1994; Rosenbloom et al., 1995), investigators have failed to find any 
consistent association following exercise (Peake et al., 2004). Neutrophil priming has 
been shown to increase the surface expression of the receptor for fMLP but there 
has been conflicting evidence to whether this results in increased oxidative burst 
responses (Condliffe et al., 1996; Elbim et al., 1994; O’Flaherty et al., 1991). 
Furthermore, cell surface receptor expression is considered to have limited value as 
a marker of human immune modulation within intervention studies (Albers et al., 
2005). Although this may be relevant for receptor expression, little is known about 
receptor function and coupling to intracellular signals (Mooren et al., 2001). 
Therefore, the inclusion of measures of cell surface receptors within future studies 
should provide a more detailed investigation of the mechanisms underlying the 
effects of COL on neutrophils.  
8.3 Bovine colostrum and mucosal immunity 
Given the potential for COL to promote the integrity of the human epithelium (He et 
al., 2001), stimulate GALT and act as a source of growth factors (TGFconsidered 
to play a role in mucosal biosynthesis and secretion of Ig (Chen et al., 1990), it may 
be expected to see benefits on mucosal immunity. The secondary outcomes of study 
1, 2 and 3 were to determine any effect of COL on mucosal parameters. As IgA is 
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the most predominant mucosal Ig, the majority of previous investigations had 
focused on this parameter (Bishop and Gleeson, 2009; Walsh et al., 2011b). 
Although there was a decrease in saliva SIgA:osmolality, the concentration and 
secretion rate of salivary SIgA remained unchanged following prolonged cycling in 
this thesis. The lack of change following exercise agrees with some (MacKinnon and 
Hooper, 1994; Nieman et al., 2003; Sari-Sarraf et al., 2006) but not others (Nieman 
et al., 2002a; Palmer et al., 2003; Tomasi, et al., 1982). It seems that the 
combination of high-intensity and long duration exercise that has the most significant 
impact (i.e. depressive) on salivary SIgA concentration (Mackinnon, 1996; Nieman et 
al., 2002a). Therefore, it would be reasonable to suggest that the cycling protocol 
used in the exercise studies in this thesis was not of sufficient intensity and/or 
duration to induce dysfunction of all mucosal parameters and therefore identify an 
effect of COL on salivary SIgA.  
In contrast to directly preventing a decrease post-exercise, an alternative way in 
which an intervention could enhance salivary SIgA would be to elevate 
concentrations at rest (i.e. pre-exercise). Some investigators had found increases in 
resting saliva IgA (Appukutty et al., 2010; Crooks et al., 2006; Mero et al., 2002) 
concentrations following COL supplementation but others have failed to support such 
findings (Crooks et al., 2010; Davison and Diment, 2010; Patiroglu and Kondolot, 
2013; Shing et al., 2007, 2013). The variability in study design makes interpretation 
of the effects of COL difficult, highlighting similar issues with investigations of other 
supplements in the area of exercise immunology (Moreira et al., 2007). Mero et al. 
(2002) found a 33% increase in resting salivary IgA concentration, following 2 weeks 
of COL supplementation where dosage was split across the day (4 × 5 g). Such 
changes in Mero et al. (2002) may be due to the multiple dosages having a 
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cumulative stimulatory effect on IgA synthesis and/or secretion. The lack of 
macronutrient and caloric matched PLA in Mero et al. (2002) does confound the 
findings. The findings of no change in salivary SIgA with acute consumption of COL 
prior and during the exercise (Study 1), would not support any direct effect of COL 
on production or release. Given that the half-life of IgA is ~ 3-6 days (Miletic et al., 
1996), it may be suggested that longer term supplementation may be required to 
have a significant impact on the SIgA pool. However, a similar total daily COL 
dosage as Mero et al (2002), split twice a day, but taken for a longer period (4 
weeks) had no effect on resting salivary SIgA concentration in study 2 or Davison 
and Diment (2010).   
Crooks et al. (2006) found a 79% increase in resting median IgA concentration in 
saliva but this effect was only significant following 12 weeks of supplementation and 
not at 4 or 8 weeks. The authors of this study did, however, report a large variability 
in IgA concentrations across participants. Study 3 observed no significant effect of 
12 weeks of COL on resting salivary SIgA expressed as total concentration, 
secretion rate or relative to osmolality. When comparing the baseline to the 12 week 
timepoint only, there were minimal changes in IgA concentration or IgA:osmolality in 
the COL group. There was, however, a 23% increase in salivary SIgA secretion rate 
compared to a decrease in secretion rate in PLA (13%).  There was also a 17% and 
14% decrease in PLA concentration and IgA:osmolality respectively at 12 weeks. 
The clinical relevance of such changes are unclear as they are somewhat lower than 
the 40% decrease in salivary SIgA that was associated with a 50% risk of contracting 
URI in a group of yachtsmen (Neville et al., 2006). Nevertheless, this would suggest 
a stabilising effect of COL rather than an enhancement of salivary SIgA per se. As 
large variability in salivary SIgA may again be a confounding factor here, further 
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longitudinal investigations involving athletes who partake in greater weekly training 
loads (e.g. Gleeson et al., 2012b) and the same type of sport is required (as in 
Crooks et al., 2006) to clarify the effects of COL.  
In addition to SIgA, saliva contains an abundance of AMPs which have received little 
attention to date in relation to response to prolonged exercise (Walsh et al., 2011b). 
In a study involving a prolonged exercise bout (2 h cycling at 64% 
2OV
  max), 
Davison and Diment (2010) found that 4 weeks of COL supplementation (20 g∙day-1) 
reduced the exercise-induced decrements in sLys concentration and secretion rate 
(immediately post-exercise). A similar pattern was found with acute consumption of 
COL in study 1. The effects occurred despite the lack of significant exercise-induced 
decrease in sLys that was observed in Davison and Diment (2010). Such findings 
may provide further evidence to the aforementioned proposals regarding COL and 
priming of the effector responses of neutrophils. Studies (Davison and Diment, 2010; 
Study 1) which have found benefits on sLys thus far have also seen enhancements 
in neutrophil degranulation responses. The lack of influence of COL on sLys and 
neutrophil degranulation in study 2 may provide indirect evidence to support this 
hypothesis. As neutrophils are considered an important source of sLys, further 
research is required to determine whether changes in some salivary AMPs with COL 
and/or exercise are due to differences in neutrophil activation in the circulation and 
oral cavity.   
In contrast to study 1, no other studies in this thesis reported any beneficial effects of 
COL on sLys or sLac. There are a limited number of investigations that have 
assessed the change of AMPs during regular training (He et al., 2013a; West et al., 
2006). sLys or sLac remained unchanged or increased over the 12 week period in 
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study 3. The changes in the sLac at rest are consistent with exercise-induced 
changes in study 3 and other investigations of sLac and other AMPs with similar 
sources (e.g. LL37) (Davison et al., 2009; Gullim et al., 2013; Usui et al., 2011). 
Compared to salivary SIgA, the functional significance of changes in sLac is unclear 
at present but it may reflect an inflammatory response to exercise-induced damage 
to mucosal surfaces (Davison et al., 2009; Usui et al., 2011). It must be recognised 
that the studies within this thesis have only investigated a narrow range of an 
available wide range of AMPs within the oral cavity (West et al., 2006). Despite the 
well accepted role of AMPs in oral health and infection (Dale et al. 2006; Putsep et 
al., 2002; Tanida et al., 2003; Tao et al., 2005), there remains few investigations of 
their contribution towards protection against URI. Furthermore, the existence of 
synergism between these peptides (De Smet and Contreras, 2005), highlights the 
need for an integrated, holistic immune marker which may account for changes in 
any of the AMPs.  
The oral cavity is colonised by a diverse range of commensal microbes (Bosch et al., 
2013; Watson et al., 2006). As the surfaces of the oral cavity are bathed with saliva, 
the oral fluid is considered to provide a ‘fingerprint’ of the vast range of the resident 
microorganisms (Boutaga et al., 2007; Dewhirst et al., 2010; Fabian et al., 2008; Li et 
al., 2005). The commensal bacteria are tightly regulated by local immune factors 
including but not limited to the synergic arsenal of AMPs (Boman, 1995). The 
importance of such defences has been demonstrated within in vitro models whereby 
reduced expression of AMPs leads to changes in bacterial colonisation (Bals, 1999; 
Liu and Modlin, 2008). Furthermore, perturbations in the balance of the microbiota 
on the mucosal surface can lead to overgrowth and further amplification of microbes 
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as seen in conditions of dysregulated innate immunity (e.g. aging, obesity) (Amar 
and Leeman, 2013; Krone et al., 2013).  
Study 3 is the first study on salivary microbiome in participants involved in regular 
training, showing increased bacterial load during winter months which was limited 
with COL supplementation. It is proposed that over the course of the 12 weeks the 
COL group suffered fewer incidences of transient immune perturbations, and/or 
smaller or shorter disturbance (in response to training and/or seasonal variation), 
which may have limited conditions for changes in the salivary microbiome to occur. 
The lack of direct antimicrobial effect of COL within study 3 may provide additional 
support that these effects are related to the immune-modulatory properties of COL. 
As the oral cavity provides the main route of transmission for pathogen entry, saliva 
bacterial load may provide to be a sensitive in vivo marker of immunity and 
susceptibility to URI.   
8.4 Bovine colostrum, delayed-type hypersensitivity and upper respiratory 
     illness  
It is apparent that the magnitude of change in immunity immediately following each 
bout of strenuous exercise may have more clinical significance than training-induced 
alterations in resting immunity (Abbasi et al., 2013; Nieman et al., 1994; Pedersen 
and Bruunsgaard, 1995). The importance of in vivo measures of immunity to 
determine the clinical relevance of an intervention have been recognised (Albers et 
al., 2005). Contact sensitisation can be used as an experimental model to determine 
the effects of interventions on the induction and elicitation phases of in vivo T-cell-
mediated immune response (Albers et al., 2005; Friedmann, 2007; Palmer and 
Friedmann, 2004). Harper-Smith et al. (2011) demonstrated that participation in a 
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single bout of prolonged moderate intensity exercise compared to rest significantly 
reduced both the induction as well as the elicitation of the cell-mediated immune 
response to a novel antigen, DPCP.  
Study 5 showed a lack of effect of COL supplementation compared to PLA on the 
magnitude of the immune response (measured by oedema) to DPCP where 
induction of T-cell-mediated immunity was preceded by prolonged exercise (as in 
Harper-Smith et al., 2011). However, there was evidence of an increase in the 
sensitivity of the response at 24 h and 48 h following the recall of immune memory to 
DPCP whereby a lower dose was required to elicit a positive response in the COL 
group. Such findings may support a similar priming effect on the host that has been 
proposed for other immune measures (e.g. neutrophil oxidative burst) but the 
mechanisms of how COL may be having an effect on the sensitivity of the responses 
are unclear at present. Nevertheless, it is reasonable to suggest that if COL does 
modulate human immunity in such a way that it responds to lower dose of a novel 
antigen (e.g. viral antigen) it would be beneficial to the host. This is particularly 
relevant for the recovery window (e.g. 24 h) following prolonged exercise where 
athletes may be exposed to pathogens on a regular basis during training and 
competition schedules.  
Further research is required to determine the use of this DPCP experimental model 
as an indicator of susceptibility to URI. Furthermore, as most of the 
immunoprotection with COL in an exercise setting thus far has been limited to 
innate/mucosal parameters, this experimental model (purely a T-cell-mediated 
response) may not be at the most relevant site to indicate the extent of effectiveness 
of a COL intervention. An increasing number of animal inoculation studies are 
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showing that COL can increase the amelioration of bacterial (e.g. Streptococcus) 
and viral (e.g. Influenza A) infection due to up-regulation of local immune defence 
(e.g. mucosal tissue within the respiratory tract) (Benson et al., 2012; Uchida et al., 
2012; Xu et al., 2013). Furthermore, the findings from human studies demonstrating 
an increased vaccination response and/or subsequent lower number of episodes of 
illness with COL supplementation may suggest the inclusion of in vivo makers of 
humoral immunity are warranted in future investigations (Cesarone et al., 2007; He 
et al., 2001).          
In support of previous evidence (Brinkworth and Buckley, 2003; Crooks et al., 2010), 
COL supplementation reduced the susceptibility to URI (Study 3). In contrast to 
previous studies, study 3 indicated that the beneficial effect of COL may become 
apparent with shorter supplementation (< 4 weeks). Although findings from some 
immune parameters (e.g. fMLP oxidative burst) suggest that longer term 
supplementation (e.g. 4 weeks) of COL has greater effects, it seems that there may 
also be clinical relevance to shorter term supplementation. It was, however, 
concluded in this study that the benefits of COL are most apparent during periods of 
greatest prevalence of URI. This may have relevance to previous discussions within 
this thesis. It has been suggested that COL may reduce the duration and/or severity 
of the ‘open window’ following acute, prolonged/strenuous exercise. During a 
longitudinal study (e.g. Study 3), such effects may reduce the overall risk of URI for 
each individual in the COL group. 
As shown by others, there was no effect of COL on the duration and/or severity of 
reported URI episodes (Brinkworth and Buckley, 2003; Crooks et al., 2006, 2010). 
Patiroglu and Kondolot (2013) did report a reduction in the severity of URI with COL 
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supplementation but this did involve a cohort of children who were clinically immune 
(IgA) deficient at rest. Further evidence is required to determine whether COL would 
affect duration and/or severity of URI in athletes who are exposed to a greater load 
of training stress (i.e. than participants used in study 3), hence are at risk for greater 
immune-dysfunction. At present, however, the lack of pathogen identification within 
human studies of COL and risk of URI cannot dismiss other underlying mechanisms 
related to ‘non-infectious’ stimuli. Animal studies report that bovine milk products 
(e.g. whey protein extract) via TGF activity can increase the population of Treg cells 
resulting in reduced Th2 related cytokine production and airway 
inflammation/hyperresponsiveness (Chen et al., 2013). It would be prudent for future 
investigations to identify the effects of COL on the typical polarisation of Th cells 
toward the Th2 phenotype with chronic exercise training and hence the potential 
pathways of non-infectious, inflammatory causes of URI (Bermon, 2007, Lakier-
Smith, 2003; Steensberg et al., 2001)  
Study 4 did report a fewer number of URI days in participants in a COL group who 
were EBV
+
 compared to EBV
-
 counterparts. This data should be interpreted with 
caution as the outcome does depend on the duration of each URI. Such influence 
could be heightened considerably in a small group of participants and/or low number 
of illnesses. Nevertheless, this provides a prudent area of research given that latent 
herpesviruses may also influence the susceptibility to URI (He et al., 2013b). This 
potential cumulative effect of COL and EBV status on URI duration reported in study 
4 alongside the findings of He et al. (2013b) does contradict earlier hypotheses 
which suggested that prior infection with herpesviruses may have a detrimental 
effect on health of the athlete. There was no apparent enhancement in immune 
parameters taken at rest in study 4 to suggest a cumulative effect but the findings 
209 
 
are limited with an absence of such investigation during URI episodes. Despite a 
potential role of prior EBV infection with this measure, it is worthy to note that the 
effects of COL on incidence of URI compared to PLA was evident whether 
participants were seronegative or seropositive or if both groups together were 
considered. 
8.5 Summary and conclusions 
The general findings in this thesis provide convincing evidence that 1 h to 4 weeks of 
COL supplementation can have beneficial effects on human immunity (e.g. 
neutrophil oxidative burst) during exposure to an acute physical stressor (prolonged 
exercise) and lower the incidence of URI during regular endurance training. As it 
may be expected, such effects become more evident when there is greater 
immunodepression or prevalence of illness. Study 1 and study 2 of this thesis have 
substantiated previous findings from our laboratory (Davison and Diment, 2010) that 
COL can augment parameters of innate immunity. These studies, in combination, 
have alluded to the possible mechanisms underlying the effects of COL on human 
immune function. It is suggested that the mechanisms, in part, are due to small 
bioactive components that survive digestion and/or are produced upon digestion of 
COL. Study 1 suggests that these effects are apparent 1 h after COL consumption 
but a longer period of supplementation (4 weeks, study 2) leads to greater effects, 
possibly due to greater absorption and/or accumulation of these components and 
hence greater effects as a nutritional countermeasure. Taken together, the findings 
of these studies suggest that COL primes the effector functions of neutrophils for 
subsequent activation by bacterial stimulation. 
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During winter months (Study 3), an increase in salivary bacterial load in a PLA group 
(likely triggered by seasonal effects and/or repeated/frequent ‘open window’ of 
exercise-induced immune dysfunction during regular training) but this increase was 
blunted by COL supplementation. Although there was a lack of effect of COL on 
isolated immune measures at rest (fMLP oxidative burst, salivary SIgA, sLac, sLys), 
it is proposed that salivary bacterial load represents a relevant integrated, holistic 
marker of in vivo (innate) immunity in the oral cavity which may be a further 
mechanism underlying immune-modulation and risk of URI with COL 
supplementation. Although COL supplementation did reduce the incidence of URI in 
a cohort of active males (Study 3), there was a lack of effect on duration and severity 
of episodes. Investigation of other potential risk factors (EBV serostatus) did not 
influence susceptibility to incidence of URI (Study 4). However, comparison of EBV+ 
and EBV- males did indicate that prior infection with herpesvirus (EBV+) and COL 
supplementation may together reduce the duration of URI episodes. 
In a model of contact hypersensitivity, COL did not influence the magnitude of T-cell-
mediated responses to a novel DPCP where induction of immune memory took 
place following an exercise bout shown previously to trigger a ~ 50% fall in 
responses (Harper-Smith et al., 2011). There was, however, evidence that COL may 
lower the threshold for an immune response to a previously encountered antigen. 
Such effects may be related to the aforementioned mechanisms and/or increase in 
the ‘sensitivity’ of other inflammatory cells which respond in the immediate period 
following challenge by a novel antigen.  
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8.6 Practical implications 
The series of studies in this thesis aimed to investigate the use of a nutritional 
supplement which was proposed to act as countermeasure to prolonged exercise-
induced immunodepression and reduce the incidence of URI during regular exercise 
training. Based on the findings the following practical implications have been 
developed. 
1. Consumption of COL in the morning (1 h) prior (35 g) to and 5 g during a 
prolonged (> 2.5 h) bout of cycling can have beneficial effects on immune 
function. This is likely to be most effective during an intensified period of training 
where there are cumulative bouts of strenuous exercise.  
2. Longer periods (e.g. 4 weeks) of COL supplementation (20 g per day) have 
greater effects on immune function in those participating in prolonged cycling. 
Due to larger effects than acute supplementation, this practice may be suitable 
for such exertions that are completed in a low carbohydrate (i.e. fasted state). 
3. Daily COL supplementation (20 g per day) reduces the incidence of upper 
respiratory illness. Such immunoprotection is likely within 4 weeks and will 
continue to be of further benefit, particularly in the periods of greatest prevalence 
of URI (i.e. winter). 
8.7 Future directions 
1. Following the findings of study 1, further research is required to define the optimal 
timing and/or dosage of COL to have the greatest effect on exercise-induced  
modulation of neutrophil function. Furthermore, it remains unclear whether the 
supplementation protocol of study 1 could be combined with that of study 2 to 
have additive effects on neutrophil responses. In relation to the practical 
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implications discussed above, it would be advantageous to identify how long the 
immune enhancing effects of COL last for, following consumption. 
2. The pilot study prior to study 1 suggested that acute COL consumption enhances 
neutrophil responses to stimulation by PMA. Within an exercise stress model, the 
effects of COL were most apparent in receptor-dependent responses of 
neutrophils (i.e. not PMA). Further research is required to determine the effects of 
acute consumption of COL at rest and following exercise in order to identify 
whether mechanisms are independent of activation of PKC and limited to signal 
transduction distal to cell surface receptors. Investigations of any changes in 
receptor expression on the surface of the neutrophils are likely to clarify possible 
mechanisms of COL supplementation.  
3. The findings of study 1 suggest that the effects of COL are at least partly due to 
the bioactive peptides (or other substances) that become bioavailable upon 
consumption of COL. Further research should attempt to determine such 
components through a combination of metabolomic and proteomic approaches. 
Based on the available evidence, future studies should perform analyses of 
plasma/serum for molecules within the range 1.4-10 kDa. Upon identification, 
such analyses may allow for the amplification or separation of the components 
from COL to identify whether immune enhancing effects (e.g. priming of 
neutrophil oxidative burst) of COL that occur in vitro also exist in vivo and not 
initiated by multiple mechanisms. 
4. The lack of effect of COL on salivary SIgA at rest or in response to exercise in 
this thesis contradicts other studies. However, there was also a lack of effect of 
acute exercise or regular training on salivary SIgA. Future studies should employ 
a more strenuous exercise bout (≥ 3 h) and/or conduct longitudinal monitoring of 
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athletes (e.g. elite) who have higher weekly training loads. These study designs 
would provide scope to elucidate any effect of COL on salivary SIgA and 
determine whether previously reported effects are not only limited to the type of 
supplement and/or methodology used.    
5. Study 3 proposed the use of a novel in vivo marker of innate immunity (salivary 
bacterial load). Further research is required to investigate these findings in both a 
longitudinal and acute setting. It is expected that next generation sequencing of 
salivary bacteria would also provide a clearer indication of how salivary bacteria 
may be related to risk of URI. 
6. Further study is required to determine why COL limited the increase observed in 
salivary bacteria load during the winter months. If salivary bacterial load does act 
as a risk factor for URI and the effects of COL purely reflect a blunting of 
seasonal variation only, then it is possible that COL may also be useful for the 
general population. It would be prudent to identify whether the effect of COL is 
due to maintaining immunity in response to factors (e.g. low Vitamin D status, He 
et al., 2013a) other than exercise training. Alternatively, more frequent analyses 
of salivary SIgA, sLac, sLys and other AMPs not yet considered (e.g. during the 
‘open window’) in a training period may provide evidence to whether COL limits 
seasonal variation, acute changes in immunity or a combination of both. 
7. It is becoming increasingly apparent that prior infection with latent herpesviruses 
(CMV, EBV) influences susceptibility to URI. Although there is conflicting 
evidence on the direction of this influence (positive or negative), it would be 
worthy to identify whether COL or any other nutritional countermeasure may 
modify such risk as reflected by possible preliminary evidence in study 4. 
Although there was no apparent role of EBV serostatus alone in risk of URI/URS 
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in Study 4, this thesis did not explore the incidence of EBV reactivations and/or 
its potential role as an in vivo marker of (acquired) immunity. 
8. Following findings from study 5, further research is required to determine the 
relevance of the magnitude and/or the minimum threshold of contact 
hypersensitivity (response to DPCP) towards the risk of URI. Additionally, it would 
be prudent for investigators to perform concurrent analyses on other immune 
parameters during the induction and/or elicitation phase in order to determine 
where COL may be increasing the ‘sensitivity’ of the response or influencing host 
defence.   
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Appendix C 
 
 
 
 
 
 
 
Microbial growth analysis shows no indication of a direct antimicrobial effect of either 
bovine colostrum (COL) or placebo (PLA) supplement (a), and also a level of 
microbial contamination in both the COL and PLA supplement (b). 
 
